id	sid	tid	token	lemma	pos
ct-9336	1	1	introduction	introduction	NOUN
ct-9336	1	2	in	in	ADP
ct-9336	1	3	bulls	bull	NOUN
ct-9336	1	4	,	,	PUNCT
ct-9336	1	5	antibiotics	antibiotic	NOUN
ct-9336	1	6	are	be	AUX
ct-9336	1	7	used	use	VERB
ct-9336	1	8	for	for	ADP
ct-9336	1	9	numerous	numerous	ADJ
ct-9336	1	10	reproductive	reproductive	ADJ
ct-9336	1	11	clinical	clinical	ADJ
ct-9336	1	12	disorders.1	disorders.1	NOUN
ct-9336	1	13	-	-	PUNCT
ct-9336	1	14	3	3	NUM
ct-9336	1	15	seminal	seminal	ADJ
ct-9336	1	16	adenitis	adenitis	NOUN
ct-9336	1	17	syndrome	syndrome	NOUN
ct-9336	1	18	represents	represent	VERB
ct-9336	1	19	1	1	NUM
ct-9336	1	20	of	of	ADP
ct-9336	1	21	the	the	DET
ct-9336	1	22	most	most	ADV
ct-9336	1	23	frequent	frequent	ADJ
ct-9336	1	24	reproductive	reproductive	ADJ
ct-9336	1	25	diseases	disease	NOUN
ct-9336	1	26	in	in	ADP
ct-9336	1	27	young	young	ADJ
ct-9336	1	28	and	and	CCONJ
ct-9336	1	29	old	old	ADJ
ct-9336	1	30	bulls3,4	bulls3,4	PROPN
ct-9336	1	31	and	and	CCONJ
ct-9336	1	32	is	be	AUX
ct-9336	1	33	usually	usually	ADV
ct-9336	1	34	treated	treat	VERB
ct-9336	1	35	with	with	ADP
ct-9336	1	36	antibiotics	antibiotic	NOUN
ct-9336	1	37	given	give	VERB
ct-9336	1	38	locally	locally	ADV
ct-9336	1	39	or	or	CCONJ
ct-9336	1	40	systemically.3,5,6	systemically.3,5,6	VERB
ct-9336	1	41	antibiotic	antibiotic	ADJ
ct-9336	1	42	selection	selection	NOUN
ct-9336	1	43	for	for	ADP
ct-9336	1	44	this	this	DET
ct-9336	1	45	clinical	clinical	ADJ
ct-9336	1	46	condition	condition	NOUN
ct-9336	1	47	and	and	CCONJ
ct-9336	1	48	other	other	ADJ
ct-9336	1	49	genital	genital	ADJ
ct-9336	1	50	infections	infection	NOUN
ct-9336	1	51	(	(	PUNCT
ct-9336	1	52	e.g.	e.g.	ADV
ct-9336	1	53	orchitis	orchitis	NOUN
ct-9336	1	54	)	)	PUNCT
ct-9336	1	55	is	be	AUX
ct-9336	1	56	based	base	VERB
ct-9336	1	57	on	on	ADP
ct-9336	1	58	personal	personal	ADJ
ct-9336	1	59	experience	experience	NOUN
ct-9336	1	60	,	,	PUNCT
ct-9336	1	61	anecdotal	anecdotal	ADJ
ct-9336	1	62	evidence	evidence	NOUN
ct-9336	1	63	,	,	PUNCT
ct-9336	1	64	extrapolation	extrapolation	NOUN
ct-9336	1	65	from	from	ADP
ct-9336	1	66	other	other	ADJ
ct-9336	1	67	species	specie	NOUN
ct-9336	1	68	,	,	PUNCT
ct-9336	1	69	or	or	CCONJ
ct-9336	1	70	based	base	VERB
ct-9336	1	71	on	on	ADP
ct-9336	1	72	the	the	DET
ct-9336	1	73	results	result	NOUN
ct-9336	1	74	of	of	ADP
ct-9336	1	75	microbiological	microbiological	ADJ
ct-9336	1	76	culture	culture	NOUN
ct-9336	1	77	and	and	CCONJ
ct-9336	1	78	sensitivity	sensitivity	NOUN
ct-9336	1	79	tests	test	NOUN
ct-9336	1	80	.	.	PUNCT
ct-9336	2	1	the	the	DET
ct-9336	2	2	chosen	choose	VERB
ct-9336	2	3	antibiotic	antibiotic	NOUN
ct-9336	2	4	has	have	VERB
ct-9336	2	5	to	to	PART
ct-9336	2	6	be	be	AUX
ct-9336	2	7	used	use	VERB
ct-9336	2	8	at	at	ADP
ct-9336	2	9	the	the	DET
ct-9336	2	10	correct	correct	ADJ
ct-9336	2	11	dose	dose	PROPN
ct-9336	2	12	,	,	PUNCT
ct-9336	2	13	route	route	NOUN
ct-9336	2	14	,	,	PUNCT
ct-9336	2	15	and	and	CCONJ
ct-9336	2	16	frequency	frequency	NOUN
ct-9336	2	17	for	for	SCONJ
ct-9336	2	18	an	an	DET
ct-9336	2	19	acceptable	acceptable	ADJ
ct-9336	2	20	period.7	period.7	NOUN
ct-9336	2	21	most	most	ADJ
ct-9336	2	22	of	of	ADP
ct-9336	2	23	the	the	DET
ct-9336	2	24	information	information	NOUN
ct-9336	2	25	regarding	regard	VERB
ct-9336	2	26	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	2	27	of	of	ADP
ct-9336	2	28	antibiotics	antibiotic	NOUN
ct-9336	2	29	in	in	ADP
ct-9336	2	30	the	the	DET
ct-9336	2	31	male	male	ADJ
ct-9336	2	32	genital	genital	ADJ
ct-9336	2	33	tract	tract	NOUN
ct-9336	2	34	is	be	AUX
ct-9336	2	35	derived	derive	VERB
ct-9336	2	36	from	from	ADP
ct-9336	2	37	human	human	ADJ
ct-9336	2	38	and	and	CCONJ
ct-9336	2	39	dog	dog	NOUN
ct-9336	2	40	models.8	models.8	PROPN
ct-9336	2	41	-	-	PUNCT
ct-9336	2	42	10	10	NUM
ct-9336	2	43	however	however	ADV
ct-9336	2	44	,	,	PUNCT
ct-9336	2	45	the	the	DET
ct-9336	2	46	anatomy	anatomy	NOUN
ct-9336	2	47	and	and	CCONJ
ct-9336	2	48	physiology	physiology	NOUN
ct-9336	2	49	of	of	ADP
ct-9336	2	50	these	these	DET
ct-9336	2	51	2	2	NUM
ct-9336	2	52	species	specie	NOUN
ct-9336	2	53	are	be	AUX
ct-9336	2	54	different	different	ADJ
ct-9336	2	55	from	from	ADP
ct-9336	2	56	ruminants.11	ruminants.11	ADJ
ct-9336	2	57	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	2	58	of	of	ADP
ct-9336	2	59	oxytetracycline	oxytetracycline	NOUN
ct-9336	2	60	and	and	CCONJ
ct-9336	2	61	tulathromycin	tulathromycin	NOUN
ct-9336	2	62	in	in	ADP
ct-9336	2	63	plasma	plasma	NOUN
ct-9336	2	64	and	and	CCONJ
ct-9336	2	65	semen	semen	NOUN
ct-9336	2	66	of	of	ADP
ct-9336	2	67	beef	beef	NOUN
ct-9336	2	68	bulls	bulls	PROPN
ct-9336	2	69	juan	juan	PROPN
ct-9336	2	70	romano	romano	PROPN
ct-9336	2	71	,	,	PUNCT
ct-9336	2	72	a	a	DET
ct-9336	2	73	andrea	andrea	PROPN
ct-9336	2	74	barbarossa	barbarossa	PROPN
ct-9336	2	75	,	,	PUNCT
ct-9336	2	76	b	b	PROPN
ct-9336	2	77	,	,	PUNCT
ct-9336	2	78	c	c	PROPN
ct-9336	2	79	giampiero	giampiero	PROPN
ct-9336	2	80	pagliuca	pagliuca	PROPN
ct-9336	2	81	,	,	PUNCT
ct-9336	2	82	b	b	PROPN
ct-9336	2	83	,	,	PUNCT
ct-9336	2	84	c	c	PROPN
ct-9336	2	85	graciela	graciela	PROPN
ct-9336	2	86	villadóniga	villadóniga	PROPN
ct-9336	2	87	,	,	PUNCT
ct-9336	2	88	dteresa	dteresa	PROPN
ct-9336	2	89	gazotti	gazotti	PROPN
ct-9336	2	90	,	,	PUNCT
ct-9336	2	91	b	b	PROPN
ct-9336	2	92	,	,	PUNCT
ct-9336	2	93	c	c	PROPN
ct-9336	2	94	beatrice	beatrice	NOUN
ct-9336	2	95	mislei	mislei	NOUN
ct-9336	2	96	,	,	PUNCT
ct-9336	2	97	e	e	PROPN
ct-9336	2	98	elisa	elisa	PROPN
ct-9336	2	99	zironi	zironi	PROPN
ct-9336	2	100	,	,	PUNCT
ct-9336	2	101	b	b	NOUN
ct-9336	2	102	,	,	PUNCT
ct-9336	2	103	c	c	PROPN
ct-9336	2	104	gaetano	gaetano	PROPN
ct-9336	2	105	marib	marib	PROPN
ct-9336	2	106	,	,	PUNCT
ct-9336	2	107	e	e	NOUN
ct-9336	2	108	alarge	alarge	NOUN
ct-9336	2	109	animal	animal	NOUN
ct-9336	2	110	clinical	clinical	ADJ
ct-9336	2	111	sciences	science	NOUN
ct-9336	2	112	,	,	PUNCT
ct-9336	2	113	college	college	NOUN
ct-9336	2	114	of	of	ADP
ct-9336	2	115	veterinary	veterinary	ADJ
ct-9336	2	116	medicine	medicine	NOUN
ct-9336	2	117	&	&	CCONJ
ct-9336	2	118	biomedical	biomedical	PROPN
ct-9336	2	119	sciences	sciences	PROPN
ct-9336	2	120	,	,	PUNCT
ct-9336	2	121	texas	texas	PROPN
ct-9336	2	122	a&m	a&m	PROPN
ct-9336	2	123	university	university	PROPN
ct-9336	2	124	,	,	PUNCT
ct-9336	2	125	college	college	NOUN
ct-9336	2	126	station	station	NOUN
ct-9336	2	127	,	,	PUNCT
ct-9336	2	128	tx	tx	PROPN
ct-9336	2	129	bdepartment	bdepartment	NOUN
ct-9336	2	130	of	of	ADP
ct-9336	2	131	veterinary	veterinary	ADJ
ct-9336	2	132	medical	medical	PROPN
ct-9336	2	133	sciences	sciences	PROPN
ct-9336	2	134	chealth	chealth	PROPN
ct-9336	2	135	sciences	sciences	PROPN
ct-9336	2	136	and	and	CCONJ
ct-9336	2	137	technologies	technology	NOUN
ct-9336	2	138	interdepartmental	interdepartmental	ADJ
ct-9336	2	139	centre	centre	NOUN
ct-9336	2	140	for	for	ADP
ct-9336	2	141	industrial	industrial	ADJ
ct-9336	2	142	research	research	PROPN
ct-9336	2	143	university	university	PROPN
ct-9336	2	144	of	of	ADP
ct-9336	2	145	bologna	bologna	PROPN
ct-9336	2	146	ozzano	ozzano	PROPN
ct-9336	2	147	dell’emilia	dell’emilia	PROPN
ct-9336	2	148	,	,	PUNCT
ct-9336	2	149	bologna	bologna	PROPN
ct-9336	2	150	,	,	PUNCT
ct-9336	3	1	italy	italy	PROPN
ct-9336	3	2	dst	dst	PROPN
ct-9336	3	3	.	.	PROPN
ct-9336	4	1	joseph	joseph	PROPN
ct-9336	4	2	regional	regional	PROPN
ct-9336	4	3	health	health	PROPN
ct-9336	4	4	center	center	NOUN
ct-9336	4	5	,	,	PUNCT
ct-9336	4	6	pediatric	pediatric	ADJ
ct-9336	4	7	services	service	NOUN
ct-9336	4	8	,	,	PUNCT
ct-9336	4	9	bryan	bryan	PROPN
ct-9336	4	10	,	,	PUNCT
ct-9336	4	11	tx	tx	PROPN
ct-9336	4	12	enational	enational	PROPN
ct-9336	4	13	institute	institute	PROPN
ct-9336	4	14	of	of	ADP
ct-9336	4	15	artificial	artificial	ADJ
ct-9336	4	16	insemination	insemination	NOUN
ct-9336	4	17	,	,	PUNCT
ct-9336	4	18	university	university	NOUN
ct-9336	4	19	of	of	ADP
ct-9336	4	20	bologna	bologna	PROPN
ct-9336	4	21	,	,	PUNCT
ct-9336	4	22	cadriano	cadriano	PROPN
ct-9336	4	23	,	,	PUNCT
ct-9336	4	24	italy	italy	PROPN
ct-9336	4	25	abstract	abstract	ADJ
ct-9336	4	26	objectives	objective	NOUN
ct-9336	4	27	were	be	AUX
ct-9336	4	28	to	to	PART
ct-9336	4	29	evaluate	evaluate	VERB
ct-9336	4	30	the	the	DET
ct-9336	4	31	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	4	32	parameters	parameter	NOUN
ct-9336	4	33	of	of	ADP
ct-9336	4	34	tulathromycin	tulathromycin	NOUN
ct-9336	4	35	and	and	CCONJ
ct-9336	4	36	long	long	ADV
ct-9336	4	37	-	-	PUNCT
ct-9336	4	38	acting	act	VERB
ct-9336	4	39	oxytetracycline	oxytetracycline	NOUN
ct-9336	4	40	in	in	ADP
ct-9336	4	41	bulls	bull	NOUN
ct-9336	4	42	’	’	PART
ct-9336	4	43	plasma	plasma	NOUN
ct-9336	4	44	and	and	CCONJ
ct-9336	4	45	semen	semen	NOUN
ct-9336	4	46	.	.	PUNCT
ct-9336	5	1	in	in	ADP
ct-9336	5	2	the	the	DET
ct-9336	5	3	first	first	ADJ
ct-9336	5	4	experiment	experiment	NOUN
ct-9336	5	5	,	,	PUNCT
ct-9336	5	6	long	long	ADV
ct-9336	5	7	-	-	PUNCT
ct-9336	5	8	acting	act	VERB
ct-9336	5	9	oxytetracycline	oxytetracycline	NOUN
ct-9336	5	10	(	(	PUNCT
ct-9336	5	11	10	10	NUM
ct-9336	5	12	or	or	CCONJ
ct-9336	5	13	20	20	NUM
ct-9336	5	14	mg	mg	NUM
ct-9336	5	15	/	/	SYM
ct-9336	5	16	kg	kg	NOUN
ct-9336	5	17	)	)	PUNCT
ct-9336	5	18	were	be	AUX
ct-9336	5	19	given	give	VERB
ct-9336	5	20	to	to	ADP
ct-9336	5	21	bulls	bull	NOUN
ct-9336	5	22	either	either	CCONJ
ct-9336	5	23	subcutaneously	subcutaneously	ADV
ct-9336	5	24	or	or	CCONJ
ct-9336	5	25	intramuscularly	intramuscularly	ADV
ct-9336	5	26	.	.	PUNCT
ct-9336	6	1	in	in	ADP
ct-9336	6	2	the	the	DET
ct-9336	6	3	second	second	ADJ
ct-9336	6	4	experiment	experiment	NOUN
ct-9336	6	5	,	,	PUNCT
ct-9336	6	6	tulathromycin	tulathromycin	NOUN
ct-9336	6	7	(	(	PUNCT
ct-9336	6	8	2.5	2.5	NUM
ct-9336	6	9	mg	mg	PROPN
ct-9336	6	10	/	/	SYM
ct-9336	6	11	kg	kg	PROPN
ct-9336	6	12	)	)	PUNCT
ct-9336	6	13	was	be	AUX
ct-9336	6	14	given	give	VERB
ct-9336	6	15	subcutaneously	subcutaneously	ADV
ct-9336	6	16	.	.	PUNCT
ct-9336	7	1	liquid	liquid	ADJ
ct-9336	7	2	chromatography	chromatography	NOUN
ct-9336	7	3	coupled	couple	VERB
ct-9336	7	4	with	with	ADP
ct-9336	7	5	tandem	tandem	PROPN
ct-9336	7	6	mass	mass	PROPN
ct-9336	7	7	spectrometry	spectrometry	NOUN
ct-9336	7	8	was	be	AUX
ct-9336	7	9	used	use	VERB
ct-9336	7	10	to	to	PART
ct-9336	7	11	measure	measure	VERB
ct-9336	7	12	antibiotic	antibiotic	ADJ
ct-9336	7	13	concentrations	concentration	NOUN
ct-9336	7	14	in	in	ADP
ct-9336	7	15	plasma	plasma	NOUN
ct-9336	7	16	and	and	CCONJ
ct-9336	7	17	semen	semen	NOUN
ct-9336	7	18	samples	sample	NOUN
ct-9336	7	19	.	.	PUNCT
ct-9336	8	1	plasma	plasma	NOUN
ct-9336	8	2	maximum	maximum	ADJ
ct-9336	8	3	concentration	concentration	NOUN
ct-9336	8	4	(	(	PUNCT
ct-9336	8	5	cmax	cmax	NOUN
ct-9336	8	6	)	)	PUNCT
ct-9336	8	7	for	for	ADP
ct-9336	8	8	10	10	NUM
ct-9336	8	9	mg	mg	PROPN
ct-9336	8	10	/	/	SYM
ct-9336	8	11	kg	kg	PROPN
ct-9336	8	12	oxytetracycline	oxytetracycline	NOUN
ct-9336	8	13	was	be	AUX
ct-9336	8	14	2,841	2,841	NUM
ct-9336	8	15	ng	ng	NOUN
ct-9336	8	16	/	/	SYM
ct-9336	8	17	ml	ml	NOUN
ct-9336	8	18	at	at	ADP
ct-9336	8	19	12	12	NUM
ct-9336	8	20	hours	hour	NOUN
ct-9336	8	21	(	(	PUNCT
ct-9336	8	22	tmax	tmax	ADV
ct-9336	8	23	)	)	PUNCT
ct-9336	8	24	with	with	ADP
ct-9336	8	25	a	a	DET
ct-9336	8	26	half	half	ADJ
ct-9336	8	27	-	-	PUNCT
ct-9336	8	28	life	life	NOUN
ct-9336	8	29	of	of	ADP
ct-9336	8	30	20.1	20.1	NUM
ct-9336	8	31	±	±	NUM
ct-9336	8	32	5.9	5.9	NUM
ct-9336	8	33	hours	hour	NOUN
ct-9336	8	34	.	.	PUNCT
ct-9336	9	1	semen	semen	NOUN
ct-9336	9	2	cmax	cmax	NOUN
ct-9336	9	3	was	be	AUX
ct-9336	9	4	11,515	11,515	NUM
ct-9336	9	5	ng	ng	NOUN
ct-9336	9	6	/	/	SYM
ct-9336	9	7	ml	ml	NOUN
ct-9336	9	8	at	at	ADP
ct-9336	9	9	24	24	NUM
ct-9336	9	10	hours	hour	NOUN
ct-9336	9	11	(	(	PUNCT
ct-9336	9	12	tmax	tmax	ADV
ct-9336	9	13	)	)	PUNCT
ct-9336	9	14	with	with	ADP
ct-9336	9	15	a	a	DET
ct-9336	9	16	half	half	ADJ
ct-9336	9	17	-	-	PUNCT
ct-9336	9	18	life	life	NOUN
ct-9336	9	19	of	of	ADP
ct-9336	9	20	23.7	23.7	NUM
ct-9336	9	21	±	±	NUM
ct-9336	9	22	4.1	4.1	NUM
ct-9336	9	23	hours	hour	NOUN
ct-9336	9	24	.	.	PUNCT
ct-9336	10	1	for	for	ADP
ct-9336	10	2	20	20	NUM
ct-9336	10	3	mg	mg	PROPN
ct-9336	10	4	/	/	SYM
ct-9336	10	5	kg	kg	PROPN
ct-9336	10	6	,	,	PUNCT
ct-9336	10	7	the	the	DET
ct-9336	10	8	plasma	plasma	NOUN
ct-9336	10	9	cmax	cmax	NOUN
ct-9336	10	10	was	be	AUX
ct-9336	10	11	5,269	5,269	NUM
ct-9336	10	12	ng	ng	NOUN
ct-9336	10	13	/	/	SYM
ct-9336	10	14	ml	ml	NOUN
ct-9336	10	15	at	at	ADP
ct-9336	10	16	12	12	NUM
ct-9336	10	17	hours	hour	NOUN
ct-9336	10	18	(	(	PUNCT
ct-9336	10	19	tmax	tmax	ADV
ct-9336	10	20	)	)	PUNCT
ct-9336	10	21	with	with	ADP
ct-9336	10	22	a	a	DET
ct-9336	10	23	half	half	ADJ
ct-9336	10	24	-	-	PUNCT
ct-9336	10	25	life	life	NOUN
ct-9336	10	26	of	of	ADP
ct-9336	10	27	18.1	18.1	NUM
ct-9336	10	28	±	±	NUM
ct-9336	10	29	0.4	0.4	NUM
ct-9336	10	30	hours	hour	NOUN
ct-9336	10	31	.	.	PUNCT
ct-9336	11	1	semen	semen	NOUN
ct-9336	11	2	cmax	cmax	NOUN
ct-9336	11	3	was	be	AUX
ct-9336	11	4	55,040	55,040	NUM
ct-9336	11	5	ng	ng	NOUN
ct-9336	11	6	/	/	SYM
ct-9336	11	7	ml	ml	NOUN
ct-9336	11	8	at	at	ADP
ct-9336	11	9	24	24	NUM
ct-9336	11	10	hours	hour	NOUN
ct-9336	11	11	(	(	PUNCT
ct-9336	11	12	tmax	tmax	ADV
ct-9336	11	13	)	)	PUNCT
ct-9336	11	14	with	with	ADP
ct-9336	11	15	a	a	DET
ct-9336	11	16	half	half	ADJ
ct-9336	11	17	-	-	PUNCT
ct-9336	11	18	life	life	NOUN
ct-9336	11	19	of	of	ADP
ct-9336	11	20	15.7	15.7	NUM
ct-9336	11	21	±	±	NUM
ct-9336	11	22	1.2	1.2	NUM
ct-9336	11	23	hours	hour	NOUN
ct-9336	11	24	.	.	PUNCT
ct-9336	12	1	plasma	plasma	NOUN
ct-9336	12	2	cmax	cmax	NOUN
ct-9336	12	3	of	of	ADP
ct-9336	12	4	tulathromycin	tulathromycin	PROPN
ct-9336	12	5	was	be	AUX
ct-9336	12	6	160	160	NUM
ct-9336	12	7	ng	ng	NOUN
ct-9336	12	8	/	/	SYM
ct-9336	12	9	ml	ml	NOUN
ct-9336	12	10	at	at	ADP
ct-9336	12	11	21	21	NUM
ct-9336	12	12	±	±	NUM
ct-9336	12	13	6	6	NUM
ct-9336	12	14	hours	hour	NOUN
ct-9336	12	15	(	(	PUNCT
ct-9336	12	16	tmax	tmax	ADV
ct-9336	12	17	)	)	PUNCT
ct-9336	12	18	.	.	PUNCT
ct-9336	13	1	semen	semen	NOUN
ct-9336	13	2	cmax	cmax	PROPN
ct-9336	13	3	was	be	AUX
ct-9336	13	4	1,539	1,539	NUM
ct-9336	13	5	ng	ng	NOUN
ct-9336	13	6	/	/	SYM
ct-9336	13	7	ml	ml	NOUN
ct-9336	13	8	at	at	ADP
ct-9336	13	9	33.0	33.0	NUM
ct-9336	13	10	±	±	NUM
ct-9336	13	11	18.0	18.0	NUM
ct-9336	13	12	hours	hour	NOUN
ct-9336	13	13	(	(	PUNCT
ct-9336	13	14	tmax	tmax	ADV
ct-9336	13	15	)	)	PUNCT
ct-9336	13	16	.	.	PUNCT
ct-9336	14	1	the	the	DET
ct-9336	14	2	cmax	cmax	NOUN
ct-9336	14	3	between	between	ADP
ct-9336	14	4	plasma	plasma	NOUN
ct-9336	14	5	and	and	CCONJ
ct-9336	14	6	semen	semen	NOUN
ct-9336	14	7	was	be	AUX
ct-9336	14	8	different	different	ADJ
ct-9336	14	9	(	(	PUNCT
ct-9336	14	10	p	p	X
ct-9336	14	11	=	=	NOUN
ct-9336	14	12	0.008	0.008	NUM
ct-9336	14	13	)	)	PUNCT
ct-9336	14	14	.	.	PUNCT
ct-9336	15	1	plasma	plasma	NOUN
ct-9336	15	2	terminal	terminal	ADJ
ct-9336	15	3	half	half	ADJ
ct-9336	15	4	-	-	PUNCT
ct-9336	15	5	life	life	NOUN
ct-9336	15	6	(	(	PUNCT
ct-9336	15	7	81.4	81.4	NUM
ct-9336	15	8	±	±	NUM
ct-9336	15	9	27.6	27.6	NUM
ct-9336	15	10	hours	hour	NOUN
ct-9336	15	11	)	)	PUNCT
ct-9336	15	12	of	of	ADP
ct-9336	15	13	tulathromycin	tulathromycin	NOUN
ct-9336	15	14	had	have	VERB
ct-9336	15	15	a	a	DET
ct-9336	15	16	tendency	tendency	NOUN
ct-9336	15	17	(	(	PUNCT
ct-9336	15	18	p	p	X
ct-9336	15	19	=	=	NOUN
ct-9336	15	20	0.10	0.10	NUM
ct-9336	15	21	)	)	PUNCT
ct-9336	15	22	to	to	PART
ct-9336	15	23	be	be	AUX
ct-9336	15	24	shorter	short	ADJ
ct-9336	15	25	than	than	ADP
ct-9336	15	26	semen	semen	NOUN
ct-9336	15	27	(	(	PUNCT
ct-9336	15	28	114.7	114.7	NUM
ct-9336	15	29	±	±	NUM
ct-9336	15	30	21.7	21.7	NUM
ct-9336	15	31	)	)	PUNCT
ct-9336	15	32	.	.	PUNCT
ct-9336	16	1	it	it	PRON
ct-9336	16	2	was	be	AUX
ct-9336	16	3	concluded	conclude	VERB
ct-9336	16	4	that	that	SCONJ
ct-9336	16	5	for	for	ADP
ct-9336	16	6	genital	genital	ADJ
ct-9336	16	7	infections	infection	NOUN
ct-9336	16	8	of	of	ADP
ct-9336	16	9	bulls	bull	NOUN
ct-9336	16	10	either	either	CCONJ
ct-9336	16	11	tulathromycin	tulathromycin	NOUN
ct-9336	16	12	or	or	CCONJ
ct-9336	16	13	long	long	ADV
ct-9336	16	14	-	-	PUNCT
ct-9336	16	15	acting	act	VERB
ct-9336	16	16	oxytetracycline	oxytetracycline	NOUN
ct-9336	16	17	are	be	AUX
ct-9336	16	18	adequate	adequate	ADJ
ct-9336	16	19	antibiotics	antibiotic	NOUN
ct-9336	16	20	based	base	VERB
ct-9336	16	21	on	on	ADP
ct-9336	16	22	their	their	PRON
ct-9336	16	23	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	16	24	properties	property	NOUN
ct-9336	16	25	.	.	PUNCT
ct-9336	17	1	keywords	keyword	NOUN
ct-9336	17	2	:	:	PUNCT
ct-9336	18	1	ruminants	ruminant	NOUN
ct-9336	18	2	,	,	PUNCT
ct-9336	18	3	abortion	abortion	NOUN
ct-9336	18	4	,	,	PUNCT
ct-9336	18	5	diseases	disease	NOUN
ct-9336	18	6	,	,	PUNCT
ct-9336	18	7	pregnancy	pregnancy	NOUN
ct-9336	18	8	loss	loss	NOUN
ct-9336	18	9	all	all	DET
ct-9336	18	10	tetracyclines	tetracycline	NOUN
ct-9336	18	11	are	be	AUX
ct-9336	18	12	equally	equally	ADV
ct-9336	18	13	active	active	ADJ
ct-9336	18	14	and	and	CCONJ
ct-9336	18	15	typically	typically	ADV
ct-9336	18	16	have	have	VERB
ct-9336	18	17	similar	similar	ADJ
ct-9336	18	18	broad	broad	ADJ
ct-9336	18	19	spectrum	spectrum	NOUN
ct-9336	18	20	for	for	ADP
ct-9336	18	21	both	both	CCONJ
ct-9336	18	22	aerobic	aerobic	ADJ
ct-9336	18	23	and	and	CCONJ
ct-9336	18	24	anaerobic	anaerobic	ADJ
ct-9336	18	25	gram	gram	NOUN
ct-9336	18	26	-	-	PUNCT
ct-9336	18	27	positive	positive	ADJ
ct-9336	18	28	and	and	CCONJ
ct-9336	18	29	gram	gram	NOUN
ct-9336	18	30	-	-	PUNCT
ct-9336	18	31	negative	negative	ADJ
ct-9336	18	32	bacteria	bacteria	NOUN
ct-9336	18	33	,	,	PUNCT
ct-9336	18	34	mycoplasmas	mycoplasma	NOUN
ct-9336	18	35	,	,	PUNCT
ct-9336	18	36	rickettsia	rickettsia	NOUN
ct-9336	18	37	,	,	PUNCT
ct-9336	18	38	chlamydia	chlamydia	NOUN
ct-9336	18	39	,	,	PUNCT
ct-9336	18	40	and	and	CCONJ
ct-9336	18	41	even	even	ADV
ct-9336	18	42	some	some	DET
ct-9336	18	43	protozoa	protozoan	NOUN
ct-9336	18	44	,	,	PUNCT
ct-9336	18	45	e.g.	e.g.	ADV
ct-9336	18	46	amoeba.12	amoeba.12	NOUN
ct-9336	18	47	oxytetracycline	oxytetracycline	ADJ
ct-9336	18	48	povidone	povidone	NOUN
ct-9336	18	49	is	be	AUX
ct-9336	18	50	a	a	DET
ct-9336	18	51	broad	broad	ADJ
ct-9336	18	52	-	-	PUNCT
ct-9336	18	53	spectrum	spectrum	NOUN
ct-9336	18	54	antibiotic	antibiotic	NOUN
ct-9336	18	55	with	with	ADP
ct-9336	18	56	a	a	DET
ct-9336	18	57	long	long	ADJ
ct-9336	18	58	half	half	ADJ
ct-9336	18	59	-	-	PUNCT
ct-9336	18	60	life	life	NOUN
ct-9336	18	61	and	and	CCONJ
ct-9336	18	62	is	be	AUX
ct-9336	18	63	used	use	VERB
ct-9336	18	64	for	for	ADP
ct-9336	18	65	wide	wide	ADJ
ct-9336	18	66	range	range	NOUN
ct-9336	18	67	of	of	ADP
ct-9336	18	68	diseases	disease	NOUN
ct-9336	18	69	.	.	PUNCT
ct-9336	19	1	tetracyclines	tetracycline	NOUN
ct-9336	19	2	inhibits	inhibit	VERB
ct-9336	19	3	binding	bind	VERB
ct-9336	19	4	of	of	ADP
ct-9336	19	5	the	the	DET
ct-9336	19	6	bacterial	bacterial	ADJ
ct-9336	19	7	30s	30	NOUN
ct-9336	19	8	ribosomal	ribosomal	NOUN
ct-9336	19	9	subunit	subunit	NOUN
ct-9336	19	10	,	,	PUNCT
ct-9336	19	11	specifically	specifically	ADV
ct-9336	19	12	at	at	ADP
ct-9336	19	13	the	the	DET
ct-9336	19	14	aminoacyl	aminoacyl	PROPN
ct-9336	19	15	-	-	PUNCT
ct-9336	19	16	trna	trna	NOUN
ct-9336	19	17	acceptor	acceptor	NOUN
ct-9336	19	18	(	(	PUNCT
ct-9336	19	19	«	«	PUNCT
ct-9336	19	20	a	a	DET
ct-9336	19	21	»	»	NOUN
ct-9336	19	22	)	)	PUNCT
ct-9336	19	23	site	site	NOUN
ct-9336	19	24	on	on	ADP
ct-9336	19	25	the	the	DET
ct-9336	19	26	mrna	mrna	PROPN
ct-9336	19	27	ribosomal	ribosomal	PROPN
ct-9336	19	28	complex	complex	NOUN
ct-9336	19	29	,	,	PUNCT
ct-9336	19	30	thus	thus	ADV
ct-9336	19	31	preventing	prevent	VERB
ct-9336	19	32	ribosomal	ribosomal	NOUN
ct-9336	19	33	translation.12	translation.12	PROPN
ct-9336	19	34	tulathromycin	tulathromycin	PROPN
ct-9336	19	35	is	be	AUX
ct-9336	19	36	a	a	DET
ct-9336	19	37	macrolide	macrolide	ADJ
ct-9336	19	38	triamilide	triamilide	NOUN
ct-9336	19	39	antibiotic	antibiotic	NOUN
ct-9336	19	40	approved	approve	VERB
ct-9336	19	41	for	for	ADP
ct-9336	19	42	the	the	DET
ct-9336	19	43	treatment	treatment	NOUN
ct-9336	19	44	and	and	CCONJ
ct-9336	19	45	prevention	prevention	NOUN
ct-9336	19	46	of	of	ADP
ct-9336	19	47	respiratory	respiratory	ADJ
ct-9336	19	48	diseases	disease	NOUN
ct-9336	19	49	in	in	ADP
ct-9336	19	50	cattle	cattle	NOUN
ct-9336	19	51	,	,	PUNCT
ct-9336	19	52	pigs	pig	NOUN
ct-9336	19	53	,	,	PUNCT
ct-9336	19	54	and	and	CCONJ
ct-9336	19	55	other	other	ADJ
ct-9336	19	56	animals.13,14	animals.13,14	NOUN
ct-9336	19	57	like	like	ADP
ct-9336	19	58	other	other	ADJ
ct-9336	19	59	macrolides	macrolide	NOUN
ct-9336	19	60	,	,	PUNCT
ct-9336	19	61	it	it	PRON
ct-9336	19	62	binds	bind	VERB
ct-9336	19	63	to	to	ADP
ct-9336	19	64	the	the	DET
ct-9336	19	65	50s	50	NOUN
ct-9336	19	66	subunit	subunit	NOUN
ct-9336	19	67	of	of	ADP
ct-9336	19	68	bacterial	bacterial	ADJ
ct-9336	19	69	ribosomes	ribosome	NOUN
ct-9336	19	70	and	and	CCONJ
ct-9336	19	71	consequently	consequently	ADV
ct-9336	19	72	inhibits	inhibit	VERB
ct-9336	19	73	protein	protein	NOUN
ct-9336	19	74	synthesis	synthesis	NOUN
ct-9336	19	75	,	,	PUNCT
ct-9336	19	76	leading	lead	VERB
ct-9336	19	77	to	to	ADP
ct-9336	19	78	inhibition	inhibition	NOUN
ct-9336	19	79	of	of	ADP
ct-9336	19	80	cell	cell	NOUN
ct-9336	19	81	division	division	NOUN
ct-9336	19	82	and	and	CCONJ
ct-9336	19	83	cell	cell	NOUN
ct-9336	19	84	death	death	NOUN
ct-9336	19	85	.	.	PUNCT
ct-9336	20	1	tulathromycin	tulathromycin	PROPN
ct-9336	20	2	’s	’s	PART
ct-9336	20	3	spectrum	spectrum	NOUN
ct-9336	20	4	of	of	ADP
ct-9336	20	5	activity	activity	NOUN
ct-9336	20	6	includes	include	VERB
ct-9336	20	7	gram	gram	NOUN
ct-9336	20	8	-	-	PUNCT
ct-9336	20	9	negative	negative	ADJ
ct-9336	20	10	,	,	PUNCT
ct-9336	20	11	clinical	clinical	ADJ
ct-9336	20	12	theriogenology	theriogenology	NOUN
ct-9336	20	13	2021	2021	NUM
ct-9336	20	14	;	;	PUNCT
ct-9336	20	15	13	13	NUM
ct-9336	20	16	:	:	SYM
ct-9336	20	17	206	206	NUM
ct-9336	20	18	gram	gram	NOUN
ct-9336	20	19	-	-	PUNCT
ct-9336	20	20	positive	positive	ADJ
ct-9336	20	21	,	,	PUNCT
ct-9336	20	22	and	and	CCONJ
ct-9336	20	23	mycoplasma	mycoplasma	VERB
ct-9336	20	24	microorganisms.13,15	microorganisms.13,15	NOUN
ct-9336	20	25	in	in	ADP
ct-9336	20	26	cattle	cattle	NOUN
ct-9336	20	27	,	,	PUNCT
ct-9336	20	28	tulathromycin	tulathromycin	NOUN
ct-9336	20	29	presents	present	VERB
ct-9336	20	30	unique	unique	ADJ
ct-9336	20	31	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	20	32	characteristics	characteristic	NOUN
ct-9336	20	33	such	such	ADJ
ct-9336	20	34	as	as	ADP
ct-9336	20	35	rapid	rapid	ADJ
ct-9336	20	36	absorption	absorption	NOUN
ct-9336	20	37	from	from	ADP
ct-9336	20	38	the	the	DET
ct-9336	20	39	injection	injection	NOUN
ct-9336	20	40	site	site	NOUN
ct-9336	20	41	,	,	PUNCT
ct-9336	20	42	extensive	extensive	ADJ
ct-9336	20	43	tissue	tissue	NOUN
ct-9336	20	44	and	and	CCONJ
ct-9336	20	45	high	high	ADJ
ct-9336	20	46	-	-	PUNCT
ct-9336	20	47	volume	volume	NOUN
ct-9336	20	48	distribution	distribution	NOUN
ct-9336	20	49	,	,	PUNCT
ct-9336	20	50	elevated	elevated	ADJ
ct-9336	20	51	and	and	CCONJ
ct-9336	20	52	sustained	sustained	ADJ
ct-9336	20	53	drug	drug	NOUN
ct-9336	20	54	concentration	concentration	NOUN
ct-9336	20	55	in	in	ADP
ct-9336	20	56	lungs	lung	NOUN
ct-9336	20	57	,	,	PUNCT
ct-9336	20	58	and	and	CCONJ
ct-9336	20	59	slow	slow	ADJ
ct-9336	20	60	elimination.13	elimination.13	PROPN
ct-9336	20	61	although	although	SCONJ
ct-9336	20	62	oxytetracycline	oxytetracycline	ADJ
ct-9336	20	63	and	and	CCONJ
ct-9336	20	64	tulathromycin	tulathromycin	NOUN
ct-9336	20	65	are	be	AUX
ct-9336	20	66	used	use	VERB
ct-9336	20	67	in	in	ADP
ct-9336	20	68	bulls	bull	NOUN
ct-9336	20	69	for	for	ADP
ct-9336	20	70	genital	genital	ADJ
ct-9336	20	71	infections	infection	NOUN
ct-9336	20	72	,	,	PUNCT
ct-9336	20	73	their	their	PRON
ct-9336	20	74	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	20	75	in	in	ADP
ct-9336	20	76	bulls	bull	NOUN
ct-9336	20	77	’	'	PUNCT
ct-9336	20	78	semen	semen	NOUN
ct-9336	20	79	has	have	AUX
ct-9336	20	80	not	not	PART
ct-9336	20	81	been	be	AUX
ct-9336	20	82	investigated	investigate	VERB
ct-9336	20	83	.	.	PUNCT
ct-9336	21	1	the	the	DET
ct-9336	21	2	objective	objective	NOUN
ct-9336	21	3	was	be	AUX
ct-9336	21	4	to	to	PART
ct-9336	21	5	investigate	investigate	VERB
ct-9336	21	6	the	the	DET
ct-9336	21	7	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	21	8	of	of	ADP
ct-9336	21	9	oxytetracycline	oxytetracycline	NOUN
ct-9336	21	10	and	and	CCONJ
ct-9336	21	11	tulathromycin	tulathromycin	NOUN
ct-9336	21	12	in	in	ADP
ct-9336	21	13	plasma	plasma	NOUN
ct-9336	21	14	and	and	CCONJ
ct-9336	21	15	semen	semen	NOUN
ct-9336	21	16	after	after	ADP
ct-9336	21	17	a	a	DET
ct-9336	21	18	single	single	ADJ
ct-9336	21	19	parenteral	parenteral	ADJ
ct-9336	21	20	route	route	NOUN
ct-9336	21	21	treatment	treatment	NOUN
ct-9336	21	22	in	in	ADP
ct-9336	21	23	beef	beef	NOUN
ct-9336	21	24	bulls	bull	NOUN
ct-9336	21	25	.	.	PUNCT
ct-9336	22	1	materials	material	NOUN
ct-9336	22	2	and	and	CCONJ
ct-9336	22	3	methods	method	NOUN
ct-9336	22	4	the	the	DET
ct-9336	22	5	study	study	NOUN
ct-9336	22	6	was	be	AUX
ct-9336	22	7	approved	approve	VERB
ct-9336	22	8	by	by	ADP
ct-9336	22	9	the	the	DET
ct-9336	22	10	university	university	PROPN
ct-9336	22	11	of	of	ADP
ct-9336	22	12	bologna	bologna	PROPN
ct-9336	22	13	animal	animal	NOUN
ct-9336	22	14	welfare	welfare	NOUN
ct-9336	22	15	committee	committee	NOUN
ct-9336	22	16	and	and	CCONJ
ct-9336	22	17	conducted	conduct	VERB
ct-9336	22	18	at	at	ADP
ct-9336	22	19	the	the	DET
ct-9336	22	20	university	university	NOUN
ct-9336	22	21	national	national	PROPN
ct-9336	22	22	institute	institute	PROPN
ct-9336	22	23	of	of	ADP
ct-9336	22	24	artificial	artificial	ADJ
ct-9336	22	25	insemination	insemination	NOUN
ct-9336	22	26	.	.	PUNCT
ct-9336	23	1	oxytetracycline	oxytetracycline	ADJ
ct-9336	23	2	animals	animal	NOUN
ct-9336	23	3	four	four	NUM
ct-9336	23	4	simmental	simmental	ADJ
ct-9336	23	5	bulls	bull	NOUN
ct-9336	23	6	were	be	AUX
ct-9336	23	7	randomly	randomly	ADV
ct-9336	23	8	selected	select	VERB
ct-9336	23	9	and	and	CCONJ
ct-9336	23	10	subjected	subject	VERB
ct-9336	23	11	to	to	ADP
ct-9336	23	12	physical	physical	ADJ
ct-9336	23	13	and	and	CCONJ
ct-9336	23	14	breeding	breeding	NOUN
ct-9336	23	15	soundness	soundness	NOUN
ct-9336	23	16	examinations.16	examinations.16	PROPN
ct-9336	23	17	average	average	ADJ
ct-9336	23	18	age	age	NOUN
ct-9336	23	19	was	be	AUX
ct-9336	23	20	15.3	15.3	NUM
ct-9336	23	21	±	±	NUM
ct-9336	23	22	0.3	0.3	NUM
ct-9336	23	23	months	month	NOUN
ct-9336	23	24	(	(	PUNCT
ct-9336	23	25	range	range	NOUN
ct-9336	23	26	;	;	PUNCT
ct-9336	23	27	15	15	NUM
ct-9336	23	28	16	16	NUM
ct-9336	23	29	months	month	NOUN
ct-9336	23	30	)	)	PUNCT
ct-9336	23	31	,	,	PUNCT
ct-9336	23	32	weight	weight	NOUN
ct-9336	23	33	was	be	AUX
ct-9336	23	34	648.9	648.9	NUM
ct-9336	23	35	±	±	NUM
ct-9336	23	36	25.9	25.9	NUM
ct-9336	23	37	kg	kg	NOUN
ct-9336	23	38	(	(	PUNCT
ct-9336	23	39	range	range	NOUN
ct-9336	23	40	;	;	PUNCT
ct-9336	23	41	645	645	NUM
ct-9336	23	42	680	680	NUM
ct-9336	23	43	kg	kg	NOUN
ct-9336	23	44	)	)	PUNCT
ct-9336	23	45	,	,	PUNCT
ct-9336	23	46	and	and	CCONJ
ct-9336	23	47	body	body	NOUN
ct-9336	23	48	condition	condition	NOUN
ct-9336	23	49	score17	score17	NOUN
ct-9336	23	50	was	be	AUX
ct-9336	23	51	6.0	6.0	NUM
ct-9336	23	52	±	±	NUM
ct-9336	23	53	0.4	0.4	NUM
ct-9336	23	54	(	(	PUNCT
ct-9336	23	55	range	range	NOUN
ct-9336	23	56	;	;	PUNCT
ct-9336	23	57	5.5	5.5	NUM
ct-9336	23	58	6.5	6.5	NUM
ct-9336	23	59	)	)	PUNCT
ct-9336	23	60	.	.	PUNCT
ct-9336	24	1	bulls	bull	NOUN
ct-9336	24	2	were	be	AUX
ct-9336	24	3	maintained	maintain	VERB
ct-9336	24	4	in	in	ADP
ct-9336	24	5	individual	individual	ADJ
ct-9336	24	6	pens	pen	NOUN
ct-9336	24	7	and	and	CCONJ
ct-9336	24	8	received	receive	VERB
ct-9336	24	9	a	a	DET
ct-9336	24	10	ration	ration	NOUN
ct-9336	24	11	of	of	ADP
ct-9336	24	12	corn	corn	NOUN
ct-9336	24	13	silage	silage	NOUN
ct-9336	24	14	,	,	PUNCT
ct-9336	24	15	mixed	mixed	ADJ
ct-9336	24	16	hay	hay	NOUN
ct-9336	24	17	,	,	PUNCT
ct-9336	24	18	and	and	CCONJ
ct-9336	24	19	alfalfa	alfalfa	NOUN
ct-9336	24	20	with	with	ADP
ct-9336	24	21	water	water	NOUN
ct-9336	24	22	ad	ad	NOUN
ct-9336	24	23	libitum	libitum	X
ct-9336	24	24	.	.	PUNCT
ct-9336	25	1	additionally	additionally	ADV
ct-9336	25	2	,	,	PUNCT
ct-9336	25	3	each	each	DET
ct-9336	25	4	bull	bull	NOUN
ct-9336	25	5	received	receive	VERB
ct-9336	25	6	once	once	ADV
ct-9336	25	7	a	a	DET
ct-9336	25	8	day	day	NOUN
ct-9336	25	9	2.5	2.5	NUM
ct-9336	25	10	kg	kg	NOUN
ct-9336	25	11	of	of	ADP
ct-9336	25	12	concentrate	concentrate	NOUN
ct-9336	25	13	(	(	PUNCT
ct-9336	25	14	pellets	pellet	NOUN
ct-9336	25	15	with	with	ADP
ct-9336	25	16	14	14	NUM
ct-9336	25	17	%	%	NOUN
ct-9336	25	18	crude	crude	ADJ
ct-9336	25	19	protein	protein	NOUN
ct-9336	25	20	)	)	PUNCT
ct-9336	25	21	.	.	PUNCT
ct-9336	26	1	experimental	experimental	ADJ
ct-9336	26	2	design	design	NOUN
ct-9336	26	3	bulls	bull	NOUN
ct-9336	26	4	had	have	VERB
ct-9336	26	5	no	no	DET
ct-9336	26	6	history	history	NOUN
ct-9336	26	7	of	of	ADP
ct-9336	26	8	oxytetracycline	oxytetracycline	ADJ
ct-9336	26	9	treatment	treatment	NOUN
ct-9336	26	10	.	.	PUNCT
ct-9336	27	1	a	a	DET
ct-9336	27	2	single	single	ADJ
ct-9336	27	3	dose	dose	NOUN
ct-9336	27	4	(	(	PUNCT
ct-9336	27	5	10	10	NUM
ct-9336	27	6	or	or	CCONJ
ct-9336	27	7	20	20	NUM
ct-9336	27	8	mg	mg	NUM
ct-9336	27	9	/	/	SYM
ct-9336	27	10	kg	kg	NOUN
ct-9336	27	11	)	)	PUNCT
ct-9336	27	12	of	of	ADP
ct-9336	27	13	long	long	ADV
ct-9336	27	14	-	-	PUNCT
ct-9336	27	15	acting	act	VERB
ct-9336	27	16	oxytetracycline	oxytetracycline	NOUN
ct-9336	27	17	(	(	PUNCT
ct-9336	27	18	terramicina	terramicina	PROPN
ct-9336	27	19	,	,	PUNCT
ct-9336	27	20	zoetis	zoetis	PROPN
ct-9336	27	21	italy	italy	PROPN
ct-9336	27	22	,	,	PUNCT
ct-9336	27	23	rome	rome	PROPN
ct-9336	27	24	)	)	PUNCT
ct-9336	27	25	was	be	AUX
ct-9336	27	26	given	give	VERB
ct-9336	27	27	.	.	PUNCT
ct-9336	28	1	two	two	NUM
ct-9336	28	2	bulls	bull	NOUN
ct-9336	28	3	received	receive	VERB
ct-9336	28	4	10	10	NUM
ct-9336	28	5	mg/	mg/	ADJ
ct-9336	28	6	kg	kg	NOUN
ct-9336	28	7	and	and	CCONJ
ct-9336	28	8	2	2	NUM
ct-9336	28	9	bulls	bull	NOUN
ct-9336	28	10	received	receive	VERB
ct-9336	28	11	20	20	NUM
ct-9336	28	12	mg	mg	PROPN
ct-9336	28	13	/	/	SYM
ct-9336	28	14	kg	kg	PROPN
ct-9336	28	15	,	,	PUNCT
ct-9336	28	16	either	either	CCONJ
ct-9336	28	17	subcutaneously	subcutaneously	ADV
ct-9336	28	18	or	or	CCONJ
ct-9336	28	19	intramuscularly	intramuscularly	ADV
ct-9336	28	20	on	on	ADP
ct-9336	28	21	the	the	DET
ct-9336	28	22	right	right	ADJ
ct-9336	28	23	-	-	PUNCT
ct-9336	28	24	side	side	NOUN
ct-9336	28	25	neck	neck	NOUN
ct-9336	28	26	.	.	PUNCT
ct-9336	29	1	each	each	DET
ct-9336	29	2	bull	bull	NOUN
ct-9336	29	3	received	receive	VERB
ct-9336	29	4	<	<	X
ct-9336	29	5	10	10	NUM
ct-9336	29	6	ml	ml	NOUN
ct-9336	29	7	per	per	ADP
ct-9336	29	8	injection	injection	NOUN
ct-9336	29	9	site	site	NOUN
ct-9336	29	10	.	.	PUNCT
ct-9336	30	1	plasma	plasma	NOUN
ct-9336	30	2	and	and	CCONJ
ct-9336	30	3	semen	semen	NOUN
ct-9336	30	4	samples	sample	NOUN
ct-9336	30	5	were	be	AUX
ct-9336	30	6	collected	collect	VERB
ct-9336	30	7	at	at	ADP
ct-9336	30	8	0	0	NUM
ct-9336	30	9	,	,	PUNCT
ct-9336	30	10	12	12	NUM
ct-9336	30	11	,	,	PUNCT
ct-9336	30	12	24	24	NUM
ct-9336	30	13	,	,	PUNCT
ct-9336	30	14	36	36	NUM
ct-9336	30	15	,	,	PUNCT
ct-9336	30	16	48	48	NUM
ct-9336	30	17	,	,	PUNCT
ct-9336	30	18	72	72	NUM
ct-9336	30	19	,	,	PUNCT
ct-9336	30	20	and	and	CCONJ
ct-9336	30	21	96	96	NUM
ct-9336	30	22	hours	hour	NOUN
ct-9336	30	23	after	after	ADP
ct-9336	30	24	treatment	treatment	NOUN
ct-9336	30	25	.	.	PUNCT
ct-9336	31	1	blood	blood	NOUN
ct-9336	31	2	(	(	PUNCT
ct-9336	31	3	10	10	NUM
ct-9336	31	4	ml	ml	NOUN
ct-9336	31	5	)	)	PUNCT
ct-9336	31	6	was	be	AUX
ct-9336	31	7	collected	collect	VERB
ct-9336	31	8	from	from	ADP
ct-9336	31	9	caudal	caudal	NOUN
ct-9336	31	10	vessels	vessel	NOUN
ct-9336	31	11	in	in	ADP
ct-9336	31	12	vacuum	vacuum	NOUN
ct-9336	31	13	tubes	tube	NOUN
ct-9336	31	14	containing	contain	VERB
ct-9336	31	15	lithium	lithium	NOUN
ct-9336	31	16	heparin	heparin	NOUN
ct-9336	31	17	.	.	PUNCT
ct-9336	32	1	semen	seman	NOUN
ct-9336	32	2	was	be	AUX
ct-9336	32	3	collected	collect	VERB
ct-9336	32	4	via	via	ADP
ct-9336	32	5	electroejaculation	electroejaculation	NOUN
ct-9336	32	6	using	use	VERB
ct-9336	32	7	an	an	DET
ct-9336	32	8	automatic	automatic	ADJ
ct-9336	32	9	electroejaculator	electroejaculator	NOUN
ct-9336	32	10	(	(	PUNCT
ct-9336	32	11	60	60	NUM
ct-9336	32	12	mm	mm	NOUN
ct-9336	32	13	2	2	NUM
ct-9336	32	14	electrode	electrode	NOUN
ct-9336	32	15	;	;	PUNCT
ct-9336	32	16	pulsator	pulsator	NOUN
ct-9336	32	17	v	v	NOUN
ct-9336	32	18	,	,	PUNCT
ct-9336	32	19	lane	lane	NOUN
ct-9336	32	20	manufacturing	manufacturing	NOUN
ct-9336	32	21	,	,	PUNCT
ct-9336	32	22	denver	denver	PROPN
ct-9336	32	23	,	,	PUNCT
ct-9336	32	24	co	co	NOUN
ct-9336	32	25	)	)	PUNCT
ct-9336	32	26	.	.	PUNCT
ct-9336	33	1	samples	sample	NOUN
ct-9336	33	2	were	be	AUX
ct-9336	33	3	immediately	immediately	ADV
ct-9336	33	4	refrigerated	refrigerate	VERB
ct-9336	33	5	,	,	PUNCT
ct-9336	33	6	centrifuged	centrifuge	VERB
ct-9336	33	7	(	(	PUNCT
ct-9336	33	8	600	600	NUM
ct-9336	33	9	×	×	NOUN
ct-9336	33	10	g	g	NOUN
ct-9336	33	11	for	for	ADP
ct-9336	33	12	30	30	NUM
ct-9336	33	13	minutes	minute	NOUN
ct-9336	33	14	)	)	PUNCT
ct-9336	33	15	within	within	ADP
ct-9336	33	16	1	1	NUM
ct-9336	33	17	hour	hour	NOUN
ct-9336	33	18	after	after	ADP
ct-9336	33	19	collection	collection	NOUN
ct-9336	33	20	,	,	PUNCT
ct-9336	33	21	and	and	CCONJ
ct-9336	33	22	stored	store	VERB
ct-9336	33	23	at	at	ADP
ct-9336	33	24	80˚c	80˚c	NUM
ct-9336	33	25	.	.	PUNCT
ct-9336	34	1	oxytetracycline	oxytetracycline	ADJ
ct-9336	34	2	analysis	analysis	NOUN
ct-9336	34	3	oxytetracycline	oxytetracycline	ADJ
ct-9336	34	4	concentrations	concentration	NOUN
ct-9336	34	5	in	in	ADP
ct-9336	34	6	plasma	plasma	NOUN
ct-9336	34	7	and	and	CCONJ
ct-9336	34	8	semen	seman	NOUN
ct-9336	34	9	were	be	AUX
ct-9336	34	10	measured18	measured18	VERB
ct-9336	34	11	using	use	VERB
ct-9336	34	12	liquid	liquid	ADJ
ct-9336	34	13	chromatography	chromatography	NOUN
ct-9336	34	14	coupled	couple	VERB
ct-9336	34	15	with	with	ADP
ct-9336	34	16	tandem	tandem	PROPN
ct-9336	34	17	mass	mass	PROPN
ct-9336	34	18	spectrometry	spectrometry	NOUN
ct-9336	34	19	.	.	PUNCT
ct-9336	35	1	tulathromycin	tulathromycin	NOUN
ct-9336	35	2	animals	animal	NOUN
ct-9336	35	3	four	four	NUM
ct-9336	35	4	simmental	simmental	ADJ
ct-9336	35	5	bulls	bull	NOUN
ct-9336	35	6	were	be	AUX
ct-9336	35	7	randomly	randomly	ADV
ct-9336	35	8	selected	select	VERB
ct-9336	35	9	and	and	CCONJ
ct-9336	35	10	subjected	subject	VERB
ct-9336	35	11	to	to	ADP
ct-9336	35	12	a	a	DET
ct-9336	35	13	physical	physical	ADJ
ct-9336	35	14	examination	examination	NOUN
ct-9336	35	15	and	and	CCONJ
ct-9336	35	16	a	a	DET
ct-9336	35	17	breeding	breeding	NOUN
ct-9336	35	18	soundness	soundness	NOUN
ct-9336	35	19	examination.16	examination.16	PROPN
ct-9336	35	20	average	average	ADJ
ct-9336	35	21	age	age	NOUN
ct-9336	35	22	was	be	AUX
ct-9336	35	23	15	15	NUM
ct-9336	35	24	months	month	NOUN
ct-9336	35	25	±	±	NOUN
ct-9336	35	26	0.2	0.2	NUM
ct-9336	35	27	months	month	NOUN
ct-9336	35	28	(	(	PUNCT
ct-9336	35	29	range	range	NOUN
ct-9336	35	30	;	;	PUNCT
ct-9336	35	31	15	15	NUM
ct-9336	35	32	16	16	NUM
ct-9336	35	33	months	month	NOUN
ct-9336	35	34	)	)	PUNCT
ct-9336	35	35	,	,	PUNCT
ct-9336	35	36	average	average	ADJ
ct-9336	35	37	weight	weight	NOUN
ct-9336	35	38	was	be	AUX
ct-9336	35	39	639.3	639.3	NUM
ct-9336	35	40	±	±	NUM
ct-9336	35	41	32.9	32.9	NUM
ct-9336	35	42	kg	kg	NOUN
ct-9336	35	43	(	(	PUNCT
ct-9336	35	44	604	604	NUM
ct-9336	35	45	681	681	NUM
ct-9336	35	46	kg	kg	NOUN
ct-9336	35	47	)	)	PUNCT
ct-9336	35	48	,	,	PUNCT
ct-9336	35	49	and	and	CCONJ
ct-9336	35	50	average	average	ADJ
ct-9336	35	51	body	body	NOUN
ct-9336	35	52	condition	condition	NOUN
ct-9336	35	53	score17	score17	NOUN
ct-9336	35	54	was	be	AUX
ct-9336	35	55	6.1	6.1	NUM
ct-9336	35	56	±	±	NUM
ct-9336	35	57	0.5	0.5	NUM
ct-9336	35	58	(	(	PUNCT
ct-9336	35	59	5.5	5.5	NUM
ct-9336	35	60	6.5	6.5	NUM
ct-9336	35	61	)	)	PUNCT
ct-9336	35	62	.	.	PUNCT
ct-9336	36	1	bulls	bull	NOUN
ct-9336	36	2	were	be	AUX
ct-9336	36	3	maintained	maintain	VERB
ct-9336	36	4	in	in	ADP
ct-9336	36	5	individual	individual	ADJ
ct-9336	36	6	pens	pen	NOUN
ct-9336	36	7	and	and	CCONJ
ct-9336	36	8	received	receive	VERB
ct-9336	36	9	a	a	DET
ct-9336	36	10	ration	ration	NOUN
ct-9336	36	11	of	of	ADP
ct-9336	36	12	corn	corn	NOUN
ct-9336	36	13	silage	silage	NOUN
ct-9336	36	14	,	,	PUNCT
ct-9336	36	15	mixed	mixed	ADJ
ct-9336	36	16	hay	hay	NOUN
ct-9336	36	17	,	,	PUNCT
ct-9336	36	18	and	and	CCONJ
ct-9336	36	19	alfalfa	alfalfa	NOUN
ct-9336	36	20	with	with	ADP
ct-9336	36	21	water	water	NOUN
ct-9336	36	22	ad	ad	NOUN
ct-9336	36	23	libitum	libitum	X
ct-9336	36	24	.	.	PUNCT
ct-9336	37	1	additionally	additionally	ADV
ct-9336	37	2	,	,	PUNCT
ct-9336	37	3	each	each	DET
ct-9336	37	4	bull	bull	NOUN
ct-9336	37	5	received	receive	VERB
ct-9336	37	6	once	once	ADV
ct-9336	37	7	a	a	DET
ct-9336	37	8	day	day	NOUN
ct-9336	37	9	2.5	2.5	NUM
ct-9336	37	10	kg	kg	NOUN
ct-9336	37	11	of	of	ADP
ct-9336	37	12	concentrate	concentrate	NOUN
ct-9336	37	13	(	(	PUNCT
ct-9336	37	14	pellets	pellet	NOUN
ct-9336	37	15	with	with	ADP
ct-9336	37	16	14	14	NUM
ct-9336	37	17	%	%	NOUN
ct-9336	37	18	crude	crude	ADJ
ct-9336	37	19	protein	protein	NOUN
ct-9336	37	20	)	)	PUNCT
ct-9336	37	21	.	.	PUNCT
ct-9336	38	1	experimental	experimental	ADJ
ct-9336	38	2	design	design	NOUN
ct-9336	38	3	bulls	bull	NOUN
ct-9336	38	4	had	have	VERB
ct-9336	38	5	no	no	DET
ct-9336	38	6	history	history	NOUN
ct-9336	38	7	of	of	ADP
ct-9336	38	8	tulathromycin	tulathromycin	NOUN
ct-9336	38	9	treatment	treatment	NOUN
ct-9336	38	10	.	.	PUNCT
ct-9336	39	1	a	a	DET
ct-9336	39	2	single	single	ADJ
ct-9336	39	3	dose	dose	NOUN
ct-9336	39	4	(	(	PUNCT
ct-9336	39	5	2.5	2.5	NUM
ct-9336	39	6	mg	mg	PROPN
ct-9336	39	7	/	/	SYM
ct-9336	39	8	kg	kg	NOUN
ct-9336	39	9	)	)	PUNCT
ct-9336	39	10	of	of	ADP
ct-9336	39	11	tulathromycin	tulathromycin	PROPN
ct-9336	39	12	(	(	PUNCT
ct-9336	39	13	draxxin	draxxin	PROPN
ct-9336	39	14	,	,	PUNCT
ct-9336	39	15	zoetis	zoetis	PROPN
ct-9336	39	16	italy	italy	PROPN
ct-9336	39	17	,	,	PUNCT
ct-9336	39	18	rome	rome	PROPN
ct-9336	39	19	)	)	PUNCT
ct-9336	39	20	was	be	AUX
ct-9336	39	21	given	give	VERB
ct-9336	39	22	subcutaneously	subcutaneously	ADV
ct-9336	39	23	either	either	CCONJ
ct-9336	39	24	at	at	ADP
ct-9336	39	25	left	left	ADJ
ct-9336	39	26	ear	ear	NOUN
ct-9336	39	27	base	base	NOUN
ct-9336	39	28	(	(	PUNCT
ct-9336	39	29	n	n	NOUN
ct-9336	39	30	=	=	SYM
ct-9336	39	31	2	2	NUM
ct-9336	39	32	)	)	PUNCT
ct-9336	39	33	or	or	CCONJ
ct-9336	39	34	on	on	ADP
ct-9336	39	35	the	the	DET
ct-9336	39	36	left	left	ADJ
ct-9336	39	37	side	side	NOUN
ct-9336	39	38	neck	neck	NOUN
ct-9336	39	39	(	(	PUNCT
ct-9336	39	40	n	n	NOUN
ct-9336	39	41	=	=	SYM
ct-9336	39	42	2	2	NUM
ct-9336	39	43	)	)	PUNCT
ct-9336	39	44	.	.	PUNCT
ct-9336	40	1	plasma	plasma	NOUN
ct-9336	40	2	and	and	CCONJ
ct-9336	40	3	semen	seman	NOUN
ct-9336	40	4	were	be	AUX
ct-9336	40	5	collected	collect	VERB
ct-9336	40	6	at	at	ADP
ct-9336	40	7	0	0	NUM
ct-9336	40	8	,	,	PUNCT
ct-9336	40	9	12	12	NUM
ct-9336	40	10	,	,	PUNCT
ct-9336	40	11	24	24	NUM
ct-9336	40	12	,	,	PUNCT
ct-9336	40	13	48	48	NUM
ct-9336	40	14	,	,	PUNCT
ct-9336	40	15	72	72	NUM
ct-9336	40	16	,	,	PUNCT
ct-9336	40	17	96	96	NUM
ct-9336	40	18	,	,	PUNCT
ct-9336	40	19	144	144	NUM
ct-9336	40	20	,	,	PUNCT
ct-9336	40	21	192	192	NUM
ct-9336	40	22	,	,	PUNCT
ct-9336	40	23	and	and	CCONJ
ct-9336	40	24	240	240	NUM
ct-9336	40	25	hours	hour	NOUN
ct-9336	40	26	after	after	ADP
ct-9336	40	27	treatment	treatment	NOUN
ct-9336	40	28	,	,	PUNCT
ct-9336	40	29	as	as	SCONJ
ct-9336	40	30	described	describe	VERB
ct-9336	40	31	above	above	ADV
ct-9336	40	32	for	for	ADP
ct-9336	40	33	oxytetracycline	oxytetracycline	ADJ
ct-9336	40	34	treatment	treatment	NOUN
ct-9336	40	35	.	.	PUNCT
ct-9336	41	1	tulathromycin	tulathromycin	NOUN
ct-9336	41	2	analysis	analysis	NOUN
ct-9336	41	3	liquid	liquid	ADJ
ct-9336	41	4	chromatography	chromatography	NOUN
ct-9336	41	5	coupled	couple	VERB
ct-9336	41	6	with	with	ADP
ct-9336	41	7	tandem	tandem	PROPN
ct-9336	41	8	mass	mass	PROPN
ct-9336	41	9	spectrometry	spectrometry	NOUN
ct-9336	41	10	was	be	AUX
ct-9336	41	11	used	use	VERB
ct-9336	41	12	to	to	PART
ct-9336	41	13	measure19	measure19	VERB
ct-9336	41	14	tulathromycin	tulathromycin	NOUN
ct-9336	41	15	concentrations	concentration	NOUN
ct-9336	41	16	in	in	ADP
ct-9336	41	17	plasma	plasma	NOUN
ct-9336	41	18	and	and	CCONJ
ct-9336	41	19	semen	semen	NOUN
ct-9336	41	20	.	.	PUNCT
ct-9336	42	1	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	42	2	parameters	parameter	NOUN
ct-9336	42	3	noncompartmental	noncompartmental	ADJ
ct-9336	42	4	analysis	analysis	NOUN
ct-9336	42	5	was	be	AUX
ct-9336	42	6	performed	perform	VERB
ct-9336	42	7	to	to	PART
ct-9336	42	8	estimate	estimate	VERB
ct-9336	42	9	the	the	DET
ct-9336	42	10	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	42	11	parameters	parameter	NOUN
ct-9336	42	12	in	in	ADP
ct-9336	42	13	plasma	plasma	NOUN
ct-9336	42	14	and	and	CCONJ
ct-9336	42	15	semen	semen	NOUN
ct-9336	42	16	for	for	ADP
ct-9336	42	17	each	each	DET
ct-9336	42	18	individual	individual	ADJ
ct-9336	42	19	animal	animal	NOUN
ct-9336	42	20	.	.	PUNCT
ct-9336	43	1	a	a	DET
ct-9336	43	2	standard	standard	ADJ
ct-9336	43	3	software	software	NOUN
ct-9336	43	4	,	,	PUNCT
ct-9336	43	5	pk	pk	NOUN
ct-9336	43	6	-	-	PUNCT
ct-9336	43	7	solver	solver	NOUN
ct-9336	43	8	add	add	NOUN
ct-9336	43	9	-	-	PUNCT
ct-9336	43	10	in	in	NOUN
ct-9336	43	11	for	for	ADP
ct-9336	43	12	excel,20	excel,20	NUM
ct-9336	43	13	was	be	AUX
ct-9336	43	14	used	use	VERB
ct-9336	43	15	to	to	PART
ct-9336	43	16	estimate	estimate	VERB
ct-9336	43	17	the	the	DET
ct-9336	43	18	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	43	19	parameters	parameter	NOUN
ct-9336	43	20	.	.	PUNCT
ct-9336	44	1	following	follow	VERB
ct-9336	44	2	variables	variable	NOUN
ct-9336	44	3	were	be	AUX
ct-9336	44	4	calculated	calculate	VERB
ct-9336	44	5	for	for	ADP
ct-9336	44	6	plasma	plasma	NOUN
ct-9336	44	7	and	and	CCONJ
ct-9336	44	8	semen	semen	NOUN
ct-9336	44	9	of	of	ADP
ct-9336	44	10	each	each	DET
ct-9336	44	11	animal	animal	NOUN
ct-9336	44	12	:	:	PUNCT
ct-9336	44	13	time	time	NOUN
ct-9336	44	14	of	of	ADP
ct-9336	44	15	peak	peak	NOUN
ct-9336	44	16	drug	drug	NOUN
ct-9336	44	17	concentration	concentration	NOUN
ct-9336	44	18	(	(	PUNCT
ct-9336	44	19	tmax	tmax	ADJ
ct-9336	44	20	)	)	PUNCT
ct-9336	44	21	,	,	PUNCT
ct-9336	44	22	peak	peak	NOUN
ct-9336	44	23	drug	drug	NOUN
ct-9336	44	24	concentration	concentration	NOUN
ct-9336	44	25	(	(	PUNCT
ct-9336	44	26	cmax	cmax	NOUN
ct-9336	44	27	)	)	PUNCT
ct-9336	44	28	,	,	PUNCT
ct-9336	44	29	apparent	apparent	ADJ
ct-9336	44	30	elimination	elimination	NOUN
ct-9336	44	31	half	half	ADJ
ct-9336	44	32	-	-	PUNCT
ct-9336	44	33	life	life	NOUN
ct-9336	44	34	(	(	PUNCT
ct-9336	44	35	t1/2	t1/2	PROPN
ct-9336	44	36	)	)	PUNCT
ct-9336	44	37	,	,	PUNCT
ct-9336	44	38	calculated	calculate	VERB
ct-9336	44	39	as	as	ADP
ct-9336	44	40	ln	ln	ADJ
ct-9336	44	41	(	(	PUNCT
ct-9336	44	42	2)/λz	2)/λz	PROPN
ct-9336	44	43	,	,	PUNCT
ct-9336	44	44	λz	λz	X
ct-9336	44	45	being	be	AUX
ct-9336	44	46	the	the	DET
ct-9336	44	47	first	first	ADJ
ct-9336	44	48	order	order	NOUN
ct-9336	44	49	rate	rate	NOUN
ct-9336	44	50	constant	constant	ADJ
ct-9336	44	51	associated	associate	VERB
ct-9336	44	52	with	with	ADP
ct-9336	44	53	the	the	DET
ct-9336	44	54	terminal	terminal	ADJ
ct-9336	44	55	portion	portion	NOUN
ct-9336	44	56	of	of	ADP
ct-9336	44	57	the	the	DET
ct-9336	44	58	time	time	NOUN
ct-9336	44	59	-	-	PUNCT
ct-9336	44	60	concentration	concentration	NOUN
ct-9336	44	61	curve	curve	NOUN
ct-9336	44	62	as	as	SCONJ
ct-9336	44	63	estimated	estimate	VERB
ct-9336	44	64	by	by	ADP
ct-9336	44	65	linear	linear	PROPN
ct-9336	44	66	regression	regression	NOUN
ct-9336	44	67	of	of	ADP
ct-9336	44	68	time	time	NOUN
ct-9336	44	69	versus	versus	ADP
ct-9336	44	70	log	log	NOUN
ct-9336	44	71	concentration	concentration	NOUN
ct-9336	44	72	,	,	PUNCT
ct-9336	44	73	and	and	CCONJ
ct-9336	44	74	area	area	NOUN
ct-9336	44	75	under	under	ADP
ct-9336	44	76	the	the	DET
ct-9336	44	77	time	time	NOUN
ct-9336	44	78	-	-	PUNCT
ct-9336	44	79	concentration	concentration	NOUN
ct-9336	44	80	curve	curve	NOUN
ct-9336	44	81	from	from	ADP
ct-9336	44	82	time	time	NOUN
ct-9336	44	83	zero	zero	NUM
ct-9336	44	84	to	to	ADP
ct-9336	44	85	the	the	DET
ct-9336	44	86	last	last	ADJ
ct-9336	44	87	observed	observe	VERB
ct-9336	44	88	concentration	concentration	NOUN
ct-9336	44	89	(	(	PUNCT
ct-9336	44	90	auc0	auc0	NOUN
ct-9336	44	91	-	-	PUNCT
ct-9336	44	92	last	last	ADJ
ct-9336	44	93	)	)	PUNCT
ct-9336	44	94	,	,	PUNCT
ct-9336	44	95	calculated	calculate	VERB
ct-9336	44	96	by	by	ADP
ct-9336	44	97	the	the	DET
ct-9336	44	98	linear	linear	PROPN
ct-9336	44	99	trapezoidal	trapezoidal	ADJ
ct-9336	44	100	rule	rule	NOUN
ct-9336	44	101	.	.	PUNCT
ct-9336	45	1	data	datum	NOUN
ct-9336	45	2	analyses	analyse	VERB
ct-9336	45	3	statistical	statistical	ADJ
ct-9336	45	4	software21	software21	NOUN
ct-9336	45	5	was	be	AUX
ct-9336	45	6	used	use	VERB
ct-9336	45	7	to	to	PART
ct-9336	45	8	determine	determine	VERB
ct-9336	45	9	parameters	parameter	NOUN
ct-9336	45	10	(	(	PUNCT
ct-9336	45	11	mean	mean	ADJ
ct-9336	45	12	,	,	PUNCT
ct-9336	45	13	standard	standard	ADJ
ct-9336	45	14	deviation	deviation	NOUN
ct-9336	45	15	,	,	PUNCT
ct-9336	45	16	and	and	CCONJ
ct-9336	45	17	range	range	NOUN
ct-9336	45	18	)	)	PUNCT
ct-9336	45	19	.	.	PUNCT
ct-9336	46	1	a	a	DET
ct-9336	46	2	paired	pair	VERB
ct-9336	46	3	student	student	NOUN
ct-9336	46	4	’s	’s	PART
ct-9336	46	5	t	t	PROPN
ct-9336	46	6	-	-	PUNCT
ct-9336	46	7	test	test	NOUN
ct-9336	46	8	and	and	CCONJ
ct-9336	46	9	a	a	DET
ct-9336	46	10	software	software	NOUN
ct-9336	46	11	program	program	NOUN
ct-9336	46	12	(	(	PUNCT
ct-9336	46	13	pk	pk	NOUN
ct-9336	46	14	-	-	PUNCT
ct-9336	46	15	solver	solver	NOUN
ct-9336	46	16	)	)	PUNCT
ct-9336	46	17	for	for	ADP
ct-9336	46	18	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	46	19	parameters20	parameters20	NOUN
ct-9336	46	20	were	be	AUX
ct-9336	46	21	used	use	VERB
ct-9336	46	22	.	.	PUNCT
ct-9336	47	1	an	an	DET
ct-9336	47	2	alpha	alpha	NOUN
ct-9336	47	3	error	error	NOUN
ct-9336	47	4	of	of	ADP
ct-9336	47	5	5	5	NUM
ct-9336	47	6	%	%	NOUN
ct-9336	47	7	was	be	AUX
ct-9336	47	8	used	use	VERB
ct-9336	47	9	to	to	PART
ct-9336	47	10	accept	accept	VERB
ct-9336	47	11	the	the	DET
ct-9336	47	12	alternative	alternative	ADJ
ct-9336	47	13	hypothesis	hypothesis	NOUN
ct-9336	47	14	.	.	PUNCT
ct-9336	48	1	results	result	NOUN
ct-9336	48	2	oxytetracycline	oxytetracycline	VERB
ct-9336	48	3	all	all	DET
ct-9336	48	4	bulls	bull	NOUN
ct-9336	48	5	had	have	VERB
ct-9336	48	6	a	a	DET
ct-9336	48	7	mild	mild	ADJ
ct-9336	48	8	swelling	swelling	NOUN
ct-9336	48	9	at	at	ADP
ct-9336	48	10	the	the	DET
ct-9336	48	11	injection	injection	NOUN
ct-9336	48	12	site	site	NOUN
ct-9336	48	13	.	.	PUNCT
ct-9336	49	1	plasma	plasma	NOUN
ct-9336	49	2	clinical	clinical	ADJ
ct-9336	49	3	theriogenology	theriogenology	NOUN
ct-9336	49	4	2021	2021	NUM
ct-9336	49	5	;	;	PUNCT
ct-9336	49	6	13	13	NUM
ct-9336	49	7	:	:	SYM
ct-9336	49	8	207	207	NUM
ct-9336	49	9	oxytetracycline	oxytetracycline	ADJ
ct-9336	49	10	concentrations	concentration	NOUN
ct-9336	49	11	in	in	ADP
ct-9336	49	12	bulls	bull	NOUN
ct-9336	49	13	treated	treat	VERB
ct-9336	49	14	with	with	ADP
ct-9336	49	15	10	10	NUM
ct-9336	49	16	mg	mg	NUM
ct-9336	49	17	/	/	SYM
ct-9336	49	18	kg	kg	NOUN
ct-9336	49	19	of	of	ADP
ct-9336	49	20	oxytetracycline	oxytetracycline	NOUN
ct-9336	49	21	either	either	CCONJ
ct-9336	49	22	subcutaneously	subcutaneously	ADV
ct-9336	49	23	(	(	PUNCT
ct-9336	49	24	1,470	1,470	NUM
ct-9336	49	25	±	±	NUM
ct-9336	49	26	1,090	1,090	NUM
ct-9336	49	27	ng	ng	NOUN
ct-9336	49	28	/	/	SYM
ct-9336	49	29	ml	ml	NOUN
ct-9336	49	30	)	)	PUNCT
ct-9336	49	31	or	or	CCONJ
ct-9336	49	32	intramuscularly	intramuscularly	ADV
ct-9336	49	33	(	(	PUNCT
ct-9336	49	34	1,330	1,330	NUM
ct-9336	49	35	±	±	NUM
ct-9336	49	36	990	990	NUM
ct-9336	49	37	ng	ng	PROPN
ct-9336	49	38	/	/	SYM
ct-9336	49	39	ml	ml	PROPN
ct-9336	49	40	)	)	PUNCT
ct-9336	49	41	were	be	AUX
ct-9336	49	42	not	not	PART
ct-9336	49	43	different	different	ADJ
ct-9336	49	44	(	(	PUNCT
ct-9336	49	45	p	p	X
ct-9336	49	46	=	=	NOUN
ct-9336	49	47	0.82	0.82	NUM
ct-9336	49	48	)	)	PUNCT
ct-9336	49	49	.	.	PUNCT
ct-9336	50	1	similarly	similarly	ADV
ct-9336	50	2	,	,	PUNCT
ct-9336	50	3	mean	mean	VERB
ct-9336	50	4	semen	semen	NOUN
ct-9336	50	5	concentrations	concentration	NOUN
ct-9336	50	6	(	(	PUNCT
ct-9336	50	7	5,710	5,710	NUM
ct-9336	50	8	±	±	NUM
ct-9336	50	9	4,640	4,640	NUM
ct-9336	50	10	ng	ng	PROPN
ct-9336	50	11	/	/	SYM
ct-9336	50	12	ml	ml	NOUN
ct-9336	50	13	and	and	CCONJ
ct-9336	50	14	5,390	5,390	NUM
ct-9336	50	15	±	±	NUM
ct-9336	50	16	3,160	3,160	NUM
ct-9336	50	17	ng	ng	PROPN
ct-9336	50	18	/	/	SYM
ct-9336	50	19	ml	ml	PROPN
ct-9336	50	20	)	)	PUNCT
ct-9336	50	21	were	be	AUX
ct-9336	50	22	not	not	PART
ct-9336	50	23	different	different	ADJ
ct-9336	50	24	(	(	PUNCT
ct-9336	50	25	p	p	X
ct-9336	50	26	=	=	NOUN
ct-9336	50	27	0.88	0.88	NUM
ct-9336	50	28	)	)	PUNCT
ct-9336	50	29	.	.	PUNCT
ct-9336	51	1	plasma	plasma	NOUN
ct-9336	51	2	oxytetracycline	oxytetracycline	ADJ
ct-9336	51	3	concentrations	concentration	NOUN
ct-9336	51	4	in	in	ADP
ct-9336	51	5	bulls	bull	NOUN
ct-9336	51	6	treated	treat	VERB
ct-9336	51	7	with	with	ADP
ct-9336	51	8	20	20	NUM
ct-9336	51	9	mg	mg	NUM
ct-9336	51	10	/	/	SYM
ct-9336	51	11	kg	kg	PROPN
ct-9336	51	12	of	of	ADP
ct-9336	51	13	oxytetracycline	oxytetracycline	NOUN
ct-9336	51	14	either	either	CCONJ
ct-9336	51	15	subcutaneously	subcutaneously	ADV
ct-9336	51	16	(	(	PUNCT
ct-9336	51	17	2,540	2,540	NUM
ct-9336	51	18	±	±	NUM
ct-9336	51	19	1,970	1,970	NUM
ct-9336	51	20	ng	ng	PROPN
ct-9336	51	21	/	/	SYM
ct-9336	51	22	ml	ml	NOUN
ct-9336	51	23	)	)	PUNCT
ct-9336	51	24	or	or	CCONJ
ct-9336	51	25	intramuscularly	intramuscularly	ADV
ct-9336	51	26	(	(	PUNCT
ct-9336	51	27	2,590	2,590	NUM
ct-9336	51	28	±	±	NUM
ct-9336	51	29	2,030	2,030	NUM
ct-9336	51	30	ng	ng	PROPN
ct-9336	51	31	/	/	SYM
ct-9336	51	32	ml	ml	PROPN
ct-9336	51	33	)	)	PUNCT
ct-9336	51	34	were	be	AUX
ct-9336	51	35	not	not	PART
ct-9336	51	36	different	different	ADJ
ct-9336	51	37	(	(	PUNCT
ct-9336	51	38	p	p	X
ct-9336	51	39	=	=	NOUN
ct-9336	51	40	0.96	0.96	NUM
ct-9336	51	41	)	)	PUNCT
ct-9336	51	42	.	.	PUNCT
ct-9336	52	1	similarly	similarly	ADV
ct-9336	52	2	,	,	PUNCT
ct-9336	52	3	mean	mean	VERB
ct-9336	52	4	semen	semen	NOUN
ct-9336	52	5	concentrations	concentration	NOUN
ct-9336	52	6	(	(	PUNCT
ct-9336	52	7	25,600	25,600	NUM
ct-9336	52	8	±	±	NUM
ct-9336	52	9	22,900	22,900	NUM
ct-9336	52	10	ng	ng	PROPN
ct-9336	52	11	/	/	SYM
ct-9336	52	12	ml	ml	PROPN
ct-9336	52	13	and	and	CCONJ
ct-9336	52	14	19,400	19,400	NUM
ct-9336	52	15	±	±	NUM
ct-9336	52	16	17,200	17,200	NUM
ct-9336	52	17	ng	ng	PROPN
ct-9336	52	18	/	/	SYM
ct-9336	52	19	ml	ml	PROPN
ct-9336	52	20	)	)	PUNCT
ct-9336	52	21	were	be	AUX
ct-9336	52	22	not	not	PART
ct-9336	52	23	different	different	ADJ
ct-9336	52	24	(	(	PUNCT
ct-9336	52	25	p	p	X
ct-9336	52	26	=	=	NOUN
ct-9336	52	27	0.58	0.58	NUM
ct-9336	52	28	)	)	PUNCT
ct-9336	52	29	.	.	PUNCT
ct-9336	53	1	because	because	SCONJ
ct-9336	53	2	there	there	PRON
ct-9336	53	3	were	be	VERB
ct-9336	53	4	no	no	DET
ct-9336	53	5	significant	significant	ADJ
ct-9336	53	6	differences	difference	NOUN
ct-9336	53	7	for	for	ADP
ct-9336	53	8	the	the	DET
ct-9336	53	9	2	2	NUM
ct-9336	53	10	sites	site	NOUN
ct-9336	53	11	of	of	ADP
ct-9336	53	12	treatment	treatment	NOUN
ct-9336	53	13	,	,	PUNCT
ct-9336	53	14	the	the	DET
ct-9336	53	15	means	mean	NOUN
ct-9336	53	16	for	for	ADP
ct-9336	53	17	plasma	plasma	NOUN
ct-9336	53	18	and	and	CCONJ
ct-9336	53	19	semen	semen	NOUN
ct-9336	53	20	were	be	AUX
ct-9336	53	21	analyzed	analyze	VERB
ct-9336	53	22	together	together	ADV
ct-9336	53	23	.	.	PUNCT
ct-9336	54	1	plasma	plasma	NOUN
ct-9336	54	2	and	and	CCONJ
ct-9336	54	3	semen	semen	NOUN
ct-9336	54	4	concentrations	concentration	NOUN
ct-9336	54	5	for	for	ADP
ct-9336	54	6	the	the	DET
ct-9336	54	7	10	10	NUM
ct-9336	54	8	mg	mg	PROPN
ct-9336	54	9	/	/	SYM
ct-9336	54	10	kg	kg	PROPN
ct-9336	54	11	dose	dose	NOUN
ct-9336	54	12	(	(	PUNCT
ct-9336	54	13	1,400	1,400	NUM
ct-9336	54	14	±	±	NUM
ct-9336	54	15	990	990	NUM
ct-9336	54	16	and	and	CCONJ
ct-9336	54	17	6,480	6,480	NUM
ct-9336	54	18	±	±	NUM
ct-9336	54	19	3,520	3,520	NUM
ct-9336	54	20	ng	ng	PROPN
ct-9336	54	21	/	/	SYM
ct-9336	54	22	ml	ml	PROPN
ct-9336	54	23	)	)	PUNCT
ct-9336	54	24	and	and	CCONJ
ct-9336	54	25	20	20	NUM
ct-9336	54	26	mg	mg	NUM
ct-9336	54	27	/	/	SYM
ct-9336	54	28	kg	kg	PROPN
ct-9336	54	29	dose	dose	NOUN
ct-9336	54	30	(	(	PUNCT
ct-9336	54	31	2,570	2,570	NUM
ct-9336	54	32	±	±	NUM
ct-9336	54	33	1,910	1,910	NUM
ct-9336	54	34	and	and	CCONJ
ct-9336	54	35	26,200	26,200	NUM
ct-9336	54	36	±	±	NUM
ct-9336	54	37	18,700	18,700	NUM
ct-9336	54	38	ng	ng	PROPN
ct-9336	54	39	/	/	SYM
ct-9336	54	40	ml	ml	PROPN
ct-9336	54	41	)	)	PUNCT
ct-9336	54	42	were	be	AUX
ct-9336	54	43	different	different	ADJ
ct-9336	54	44	(	(	PUNCT
ct-9336	54	45	p	p	X
ct-9336	54	46	=	=	NOUN
ct-9336	54	47	0.001	0.001	NUM
ct-9336	54	48	and	and	CCONJ
ct-9336	54	49	p	p	NOUN
ct-9336	54	50	=	=	NOUN
ct-9336	54	51	0.001	0.001	NUM
ct-9336	54	52	)	)	PUNCT
ct-9336	54	53	.	.	PUNCT
ct-9336	55	1	oxytetracycline	oxytetracycline	PROPN
ct-9336	55	2	doses	dose	NOUN
ct-9336	55	3	of	of	ADP
ct-9336	55	4	10	10	NUM
ct-9336	55	5	mg	mg	NUM
ct-9336	55	6	/	/	SYM
ct-9336	55	7	kg	kg	PROPN
ct-9336	55	8	and	and	CCONJ
ct-9336	55	9	20	20	NUM
ct-9336	55	10	mg	mg	NUM
ct-9336	55	11	/	/	SYM
ct-9336	55	12	kg	kg	PROPN
ct-9336	55	13	resulted	result	VERB
ct-9336	55	14	in	in	ADP
ct-9336	55	15	different	different	ADJ
ct-9336	55	16	(	(	PUNCT
ct-9336	55	17	p	p	X
ct-9336	55	18	=	=	NOUN
ct-9336	55	19	0.07	0.07	NUM
ct-9336	55	20	)	)	PUNCT
ct-9336	55	21	mean	mean	VERB
ct-9336	55	22	plasma	plasma	NOUN
ct-9336	55	23	concentrations	concentration	NOUN
ct-9336	55	24	(	(	PUNCT
ct-9336	55	25	1,400	1,400	NUM
ct-9336	55	26	±	±	NUM
ct-9336	55	27	990	990	NUM
ct-9336	55	28	and	and	CCONJ
ct-9336	55	29	2,570	2,570	NUM
ct-9336	55	30	±	±	NUM
ct-9336	55	31	1,910	1,910	NUM
ct-9336	55	32	ng	ng	PROPN
ct-9336	55	33	/	/	SYM
ct-9336	55	34	ml	ml	PROPN
ct-9336	55	35	)	)	PUNCT
ct-9336	55	36	and	and	CCONJ
ct-9336	55	37	in	in	ADP
ct-9336	55	38	different	different	ADJ
ct-9336	55	39	(	(	PUNCT
ct-9336	55	40	p	p	X
ct-9336	55	41	=	=	NOUN
ct-9336	55	42	0.004	0.004	NUM
ct-9336	55	43	)	)	PUNCT
ct-9336	55	44	mean	mean	VERB
ct-9336	55	45	semen	semen	NOUN
ct-9336	55	46	concentrations	concentration	NOUN
ct-9336	55	47	(	(	PUNCT
ct-9336	55	48	6,480	6,480	NUM
ct-9336	55	49	±	±	NUM
ct-9336	55	50	3,520	3,520	NUM
ct-9336	55	51	ng	ng	PROPN
ct-9336	55	52	/	/	SYM
ct-9336	55	53	ml	ml	PROPN
ct-9336	55	54	and	and	CCONJ
ct-9336	55	55	26,200	26,200	NUM
ct-9336	55	56	±	±	NUM
ct-9336	55	57	18,700	18,700	NUM
ct-9336	55	58	ng	ng	PROPN
ct-9336	55	59	/	/	SYM
ct-9336	55	60	ml	ml	PROPN
ct-9336	55	61	)	)	PUNCT
ct-9336	55	62	.	.	PUNCT
ct-9336	56	1	oxytetracycline	oxytetracycline	ADJ
ct-9336	56	2	plasma	plasma	NOUN
ct-9336	56	3	concentrations	concentration	NOUN
ct-9336	56	4	above	above	ADP
ct-9336	56	5	1,000	1,000	NUM
ct-9336	56	6	ng	ng	NOUN
ct-9336	56	7	/	/	SYM
ct-9336	56	8	ml	ml	PROPN
ct-9336	56	9	persisted	persist	VERB
ct-9336	56	10	(	(	PUNCT
ct-9336	56	11	p	p	NOUN
ct-9336	56	12	=	=	NOUN
ct-9336	56	13	0.001	0.001	NUM
ct-9336	56	14	)	)	PUNCT
ct-9336	56	15	for	for	ADP
ct-9336	56	16	48	48	NUM
ct-9336	56	17	hours	hour	NOUN
ct-9336	56	18	for	for	ADP
ct-9336	56	19	the	the	DET
ct-9336	56	20	10	10	NUM
ct-9336	56	21	mg	mg	PROPN
ct-9336	56	22	/	/	SYM
ct-9336	56	23	kg	kg	PROPN
ct-9336	56	24	dose	dose	NOUN
ct-9336	56	25	compared	compare	VERB
ct-9336	56	26	to	to	ADP
ct-9336	56	27	66	66	NUM
ct-9336	56	28	hours	hour	NOUN
ct-9336	56	29	for	for	ADP
ct-9336	56	30	the	the	DET
ct-9336	56	31	20	20	NUM
ct-9336	56	32	mg	mg	PROPN
ct-9336	56	33	/	/	SYM
ct-9336	56	34	kg	kg	PROPN
ct-9336	56	35	dose	dose	PROPN
ct-9336	56	36	.	.	PUNCT
ct-9336	57	1	oxytetracycline	oxytetracycline	PROPN
ct-9336	57	2	semen	semen	PROPN
ct-9336	57	3	concentrations	concentration	NOUN
ct-9336	57	4	above	above	ADP
ct-9336	57	5	1,000	1,000	NUM
ct-9336	57	6	ng	ng	NOUN
ct-9336	57	7	/	/	SYM
ct-9336	57	8	ml	ml	PROPN
ct-9336	57	9	remained	remain	VERB
ct-9336	57	10	elevated	elevated	ADJ
ct-9336	57	11	for	for	ADP
ct-9336	57	12	over	over	ADP
ct-9336	57	13	96	96	NUM
ct-9336	57	14	hours	hour	NOUN
ct-9336	57	15	for	for	SCONJ
ct-9336	57	16	both	both	CCONJ
ct-9336	57	17	the	the	DET
ct-9336	57	18	10	10	NUM
ct-9336	57	19	and	and	CCONJ
ct-9336	57	20	20	20	NUM
ct-9336	57	21	mg	mg	NUM
ct-9336	57	22	/	/	SYM
ct-9336	57	23	kg	kg	PROPN
ct-9336	57	24	dose	dose	VERB
ct-9336	57	25	and	and	CCONJ
ct-9336	57	26	remained	remain	VERB
ct-9336	57	27	above	above	ADV
ct-9336	57	28	that	that	DET
ct-9336	57	29	threshold	threshold	NOUN
ct-9336	57	30	longer	long	ADV
ct-9336	57	31	(	(	PUNCT
ct-9336	57	32	p	p	X
ct-9336	57	33	=	=	NOUN
ct-9336	57	34	0.0001	0.0001	NUM
ct-9336	57	35	)	)	PUNCT
ct-9336	57	36	compared	compare	VERB
ct-9336	57	37	with	with	ADP
ct-9336	57	38	plasma	plasma	NOUN
ct-9336	57	39	levels	level	NOUN
ct-9336	57	40	(	(	PUNCT
ct-9336	57	41	96	96	NUM
ct-9336	57	42	versus	versus	ADP
ct-9336	57	43	57	57	NUM
ct-9336	57	44	hours	hour	NOUN
ct-9336	57	45	)	)	PUNCT
ct-9336	57	46	.	.	PUNCT
ct-9336	58	1	at	at	ADP
ct-9336	58	2	96	96	NUM
ct-9336	58	3	hours	hour	NOUN
ct-9336	58	4	,	,	PUNCT
ct-9336	58	5	the	the	DET
ct-9336	58	6	oxytetracycline	oxytetracycline	ADJ
ct-9336	58	7	mean	mean	NOUN
ct-9336	58	8	semen	semen	NOUN
ct-9336	58	9	concentrations	concentration	NOUN
ct-9336	58	10	for	for	ADP
ct-9336	58	11	10	10	NUM
ct-9336	58	12	mg	mg	PROPN
ct-9336	58	13	/	/	SYM
ct-9336	58	14	kg	kg	PROPN
ct-9336	58	15	dose	dose	NOUN
ct-9336	58	16	were	be	AUX
ct-9336	58	17	1,700	1,700	NUM
ct-9336	58	18	±	±	NUM
ct-9336	58	19	260	260	NUM
ct-9336	58	20	ng	ng	NOUN
ct-9336	58	21	/	/	SYM
ct-9336	58	22	ml	ml	NOUN
ct-9336	58	23	and	and	CCONJ
ct-9336	58	24	for	for	ADP
ct-9336	58	25	the	the	DET
ct-9336	58	26	20	20	NUM
ct-9336	58	27	mg	mg	PROPN
ct-9336	58	28	/	/	SYM
ct-9336	58	29	kg	kg	PROPN
ct-9336	58	30	dose	dose	NOUN
ct-9336	58	31	were	be	AUX
ct-9336	58	32	3,340	3,340	NUM
ct-9336	58	33	±	±	NUM
ct-9336	58	34	260	260	NUM
ct-9336	58	35	ng	ng	PROPN
ct-9336	58	36	/	/	SYM
ct-9336	58	37	ml	ml	PROPN
ct-9336	58	38	.	.	PUNCT
ct-9336	59	1	for	for	ADP
ct-9336	59	2	the	the	DET
ct-9336	59	3	10	10	NUM
ct-9336	59	4	mg	mg	PROPN
ct-9336	59	5	/	/	SYM
ct-9336	59	6	kg	kg	PROPN
ct-9336	59	7	dose	dose	PROPN
ct-9336	59	8	,	,	PUNCT
ct-9336	59	9	the	the	DET
ct-9336	59	10	plasma	plasma	NOUN
ct-9336	59	11	cmax	cmax	NOUN
ct-9336	59	12	was	be	AUX
ct-9336	59	13	2,841	2,841	NUM
ct-9336	59	14	±	±	NUM
ct-9336	59	15	401	401	NUM
ct-9336	59	16	ng/	ng/	VERB
ct-9336	59	17	ml	ml	NOUN
ct-9336	59	18	at	at	ADP
ct-9336	59	19	12	12	NUM
ct-9336	59	20	hours	hour	NOUN
ct-9336	59	21	(	(	PUNCT
ct-9336	59	22	tmax	tmax	ADV
ct-9336	59	23	)	)	PUNCT
ct-9336	59	24	with	with	ADP
ct-9336	59	25	a	a	DET
ct-9336	59	26	half	half	ADJ
ct-9336	59	27	-	-	PUNCT
ct-9336	59	28	life	life	NOUN
ct-9336	59	29	of	of	ADP
ct-9336	59	30	20.1	20.1	NUM
ct-9336	59	31	±	±	NUM
ct-9336	59	32	5.9	5.9	NUM
ct-9336	59	33	hours	hour	NOUN
ct-9336	59	34	.	.	PUNCT
ct-9336	60	1	the	the	DET
ct-9336	60	2	plasma	plasma	NOUN
ct-9336	60	3	auc0	auc0	NOUN
ct-9336	60	4	-	-	PUNCT
ct-9336	60	5	last	last	PROPN
ct-9336	60	6	was	be	AUX
ct-9336	60	7	112,560	112,560	NUM
ct-9336	60	8	±	±	NUM
ct-9336	60	9	8,067	8,067	NUM
ct-9336	60	10	ng	ng	PROPN
ct-9336	60	11	/	/	SYM
ct-9336	60	12	ml	ml	NOUN
ct-9336	60	13	/	/	PUNCT
ct-9336	60	14	hour	hour	NOUN
ct-9336	60	15	.	.	PUNCT
ct-9336	61	1	the	the	DET
ct-9336	61	2	semen	semen	NOUN
ct-9336	61	3	cmax	cmax	NOUN
ct-9336	61	4	was	be	AUX
ct-9336	61	5	11,515	11,515	NUM
ct-9336	61	6	±	±	NUM
ct-9336	61	7	2,445	2,445	NUM
ct-9336	61	8	ng	ng	PROPN
ct-9336	61	9	/	/	SYM
ct-9336	61	10	ml	ml	NOUN
ct-9336	61	11	at	at	ADP
ct-9336	61	12	24	24	NUM
ct-9336	61	13	hours	hour	NOUN
ct-9336	61	14	(	(	PUNCT
ct-9336	61	15	tmax	tmax	ADV
ct-9336	61	16	)	)	PUNCT
ct-9336	61	17	with	with	ADP
ct-9336	61	18	a	a	DET
ct-9336	61	19	halflife	halflife	NOUN
ct-9336	61	20	of	of	ADP
ct-9336	61	21	23.7	23.7	NUM
ct-9336	61	22	±	±	NUM
ct-9336	61	23	4.1	4.1	NUM
ct-9336	61	24	hours	hour	NOUN
ct-9336	61	25	.	.	PUNCT
ct-9336	62	1	the	the	DET
ct-9336	62	2	semen	semen	NOUN
ct-9336	62	3	auc0	auc0	PROPN
ct-9336	62	4	-	-	PUNCT
ct-9336	62	5	last	last	PROPN
ct-9336	62	6	was	be	AUX
ct-9336	62	7	550,387	550,387	NUM
ct-9336	62	8	±	±	NUM
ct-9336	62	9	13,081	13,081	NUM
ct-9336	62	10	ng	ng	PROPN
ct-9336	62	11	/	/	SYM
ct-9336	62	12	ml	ml	NOUN
ct-9336	62	13	/	/	PUNCT
ct-9336	62	14	hour	hour	NOUN
ct-9336	62	15	.	.	PUNCT
ct-9336	63	1	for	for	ADP
ct-9336	63	2	the	the	DET
ct-9336	63	3	20	20	NUM
ct-9336	63	4	mg	mg	NUM
ct-9336	63	5	/	/	SYM
ct-9336	63	6	ml	ml	X
ct-9336	63	7	dose	dose	PROPN
ct-9336	63	8	,	,	PUNCT
ct-9336	63	9	the	the	DET
ct-9336	63	10	plasma	plasma	NOUN
ct-9336	63	11	cmax	cmax	NOUN
ct-9336	63	12	of	of	ADP
ct-9336	63	13	5,269	5,269	NUM
ct-9336	63	14	±	±	NUM
ct-9336	63	15	111	111	NUM
ct-9336	63	16	ng	ng	PROPN
ct-9336	63	17	/	/	SYM
ct-9336	63	18	ml	ml	PROPN
ct-9336	63	19	was	be	AUX
ct-9336	63	20	achieved	achieve	VERB
ct-9336	63	21	at	at	ADP
ct-9336	63	22	12	12	NUM
ct-9336	63	23	hours	hour	NOUN
ct-9336	63	24	(	(	PUNCT
ct-9336	63	25	tmax	tmax	ADV
ct-9336	63	26	)	)	PUNCT
ct-9336	63	27	with	with	ADP
ct-9336	63	28	a	a	DET
ct-9336	63	29	half	half	ADJ
ct-9336	63	30	-	-	PUNCT
ct-9336	63	31	life	life	NOUN
ct-9336	63	32	of	of	ADP
ct-9336	63	33	18.1	18.1	NUM
ct-9336	63	34	±	±	NUM
ct-9336	63	35	0.4	0.4	NUM
ct-9336	63	36	hours	hour	NOUN
ct-9336	63	37	.	.	PUNCT
ct-9336	64	1	the	the	DET
ct-9336	64	2	semen	semen	NOUN
ct-9336	64	3	cmax	cmax	NOUN
ct-9336	64	4	was	be	AUX
ct-9336	64	5	55,040	55,040	NUM
ct-9336	64	6	±	±	NUM
ct-9336	64	7	10,605	10,605	NUM
ct-9336	64	8	ng	ng	NOUN
ct-9336	64	9	/	/	SYM
ct-9336	64	10	ml	ml	NOUN
ct-9336	64	11	at	at	ADP
ct-9336	64	12	24	24	NUM
ct-9336	64	13	hours	hour	NOUN
ct-9336	64	14	(	(	PUNCT
ct-9336	64	15	tmax	tmax	ADV
ct-9336	64	16	)	)	PUNCT
ct-9336	64	17	with	with	ADP
ct-9336	64	18	a	a	DET
ct-9336	64	19	half	half	ADJ
ct-9336	64	20	-	-	PUNCT
ct-9336	64	21	life	life	NOUN
ct-9336	64	22	of	of	ADP
ct-9336	64	23	15.7	15.7	NUM
ct-9336	64	24	±	±	NUM
ct-9336	64	25	1.2	1.2	NUM
ct-9336	64	26	hours	hour	NOUN
ct-9336	64	27	.	.	PUNCT
ct-9336	65	1	the	the	DET
ct-9336	65	2	semen	semen	NOUN
ct-9336	65	3	auc0	auc0	PROPN
ct-9336	65	4	-	-	PUNCT
ct-9336	65	5	last	last	PROPN
ct-9336	65	6	was	be	AUX
ct-9336	65	7	2,153,942	2,153,942	NUM
ct-9336	65	8	±	±	NUM
ct-9336	65	9	384,669	384,669	NUM
ct-9336	65	10	ng	ng	NOUN
ct-9336	65	11	/	/	SYM
ct-9336	65	12	ml	ml	NOUN
ct-9336	65	13	/	/	PUNCT
ct-9336	65	14	hour	hour	NOUN
ct-9336	65	15	.	.	PUNCT
ct-9336	66	1	tulathromycin	tulathromycin	NOUN
ct-9336	66	2	mean	mean	VERB
ct-9336	66	3	plasma	plasma	NOUN
ct-9336	66	4	concentrations	concentration	NOUN
ct-9336	66	5	of	of	ADP
ct-9336	66	6	tulathromycin	tulathromycin	NOUN
ct-9336	66	7	for	for	ADP
ct-9336	66	8	2	2	NUM
ct-9336	66	9	subcutaneous	subcutaneous	ADJ
ct-9336	66	10	injection	injection	NOUN
ct-9336	66	11	sites	site	NOUN
ct-9336	66	12	(	(	PUNCT
ct-9336	66	13	77.9	77.9	NUM
ct-9336	66	14	±	±	NUM
ct-9336	66	15	43.3	43.3	NUM
ct-9336	66	16	and	and	CCONJ
ct-9336	66	17	73.7	73.7	NUM
ct-9336	66	18	±	±	NUM
ct-9336	66	19	39.7	39.7	NUM
ct-9336	66	20	ng	ng	PROPN
ct-9336	66	21	/	/	SYM
ct-9336	66	22	ml	ml	PROPN
ct-9336	66	23	)	)	PUNCT
ct-9336	66	24	were	be	AUX
ct-9336	66	25	not	not	PART
ct-9336	66	26	different	different	ADJ
ct-9336	66	27	(	(	PUNCT
ct-9336	66	28	p	p	X
ct-9336	66	29	=	=	NOUN
ct-9336	66	30	0.84	0.84	NUM
ct-9336	66	31	)	)	PUNCT
ct-9336	66	32	.	.	PUNCT
ct-9336	67	1	mean	mean	VERB
ct-9336	67	2	semen	semen	NOUN
ct-9336	67	3	concentrations	concentration	NOUN
ct-9336	67	4	of	of	ADP
ct-9336	67	5	tulathromycin	tulathromycin	NOUN
ct-9336	67	6	(	(	PUNCT
ct-9336	67	7	608	608	NUM
ct-9336	67	8	±	±	NUM
ct-9336	67	9	374	374	NUM
ct-9336	67	10	ng	ng	NOUN
ct-9336	67	11	/	/	SYM
ct-9336	67	12	ml	ml	PROPN
ct-9336	67	13	and	and	CCONJ
ct-9336	67	14	867	867	NUM
ct-9336	67	15	±	±	NUM
ct-9336	67	16	599	599	NUM
ct-9336	67	17	ng	ng	PROPN
ct-9336	67	18	/	/	SYM
ct-9336	67	19	ml	ml	NOUN
ct-9336	67	20	)	)	PUNCT
ct-9336	67	21	were	be	AUX
ct-9336	67	22	also	also	ADV
ct-9336	67	23	not	not	PART
ct-9336	67	24	different	different	ADJ
ct-9336	67	25	(	(	PUNCT
ct-9336	67	26	p	p	X
ct-9336	67	27	=	=	NOUN
ct-9336	67	28	0.29	0.29	NUM
ct-9336	67	29	)	)	PUNCT
ct-9336	67	30	.	.	PUNCT
ct-9336	68	1	in	in	ADP
ct-9336	68	2	the	the	DET
ct-9336	68	3	absence	absence	NOUN
ct-9336	68	4	of	of	ADP
ct-9336	68	5	significant	significant	ADJ
ct-9336	68	6	differences	difference	NOUN
ct-9336	68	7	between	between	ADP
ct-9336	68	8	the	the	DET
ct-9336	68	9	2	2	NUM
ct-9336	68	10	injection	injection	NOUN
ct-9336	68	11	sites	site	NOUN
ct-9336	68	12	,	,	PUNCT
ct-9336	68	13	means	mean	VERB
ct-9336	68	14	for	for	ADP
ct-9336	68	15	plasma	plasma	NOUN
ct-9336	68	16	and	and	CCONJ
ct-9336	68	17	semen	semen	NOUN
ct-9336	68	18	were	be	AUX
ct-9336	68	19	analyzed	analyze	VERB
ct-9336	68	20	together	together	ADV
ct-9336	68	21	.	.	PUNCT
ct-9336	69	1	mean	mean	VERB
ct-9336	69	2	plasma	plasma	NOUN
ct-9336	69	3	tulathromycin	tulathromycin	NOUN
ct-9336	69	4	was	be	AUX
ct-9336	69	5	lower	low	ADJ
ct-9336	69	6	(	(	PUNCT
ct-9336	69	7	p	p	X
ct-9336	69	8	=	=	NOUN
ct-9336	69	9	0.001	0.001	NUM
ct-9336	69	10	)	)	PUNCT
ct-9336	69	11	than	than	ADP
ct-9336	69	12	semen	semen	NOUN
ct-9336	69	13	(	(	PUNCT
ct-9336	69	14	75.8	75.8	NUM
ct-9336	69	15	±	±	NUM
ct-9336	69	16	40.2	40.2	NUM
ct-9336	69	17	and	and	CCONJ
ct-9336	69	18	781	781	NUM
ct-9336	69	19	±	±	NUM
ct-9336	69	20	482	482	NUM
ct-9336	69	21	ng	ng	PROPN
ct-9336	69	22	/	/	SYM
ct-9336	69	23	ml	ml	PROPN
ct-9336	69	24	)	)	PUNCT
ct-9336	69	25	.	.	PUNCT
ct-9336	70	1	the	the	DET
ct-9336	70	2	plasma	plasma	NOUN
ct-9336	70	3	cmax	cmax	NOUN
ct-9336	70	4	was	be	AUX
ct-9336	70	5	160	160	NUM
ct-9336	70	6	±	±	NUM
ct-9336	70	7	26	26	NUM
ct-9336	70	8	ng	ng	PROPN
ct-9336	70	9	/	/	SYM
ct-9336	70	10	ml	ml	NOUN
ct-9336	70	11	at	at	ADP
ct-9336	70	12	21.0	21.0	NUM
ct-9336	70	13	±	±	NUM
ct-9336	70	14	6.0	6.0	NUM
ct-9336	70	15	hours	hour	NOUN
ct-9336	70	16	(	(	PUNCT
ct-9336	70	17	tmax	tmax	ADV
ct-9336	70	18	)	)	PUNCT
ct-9336	70	19	.	.	PUNCT
ct-9336	71	1	the	the	DET
ct-9336	71	2	semen	semen	NOUN
ct-9336	71	3	cmax	cmax	NOUN
ct-9336	71	4	was	be	AUX
ct-9336	71	5	1,539	1,539	NUM
ct-9336	71	6	±	±	NUM
ct-9336	71	7	444	444	NUM
ct-9336	71	8	ng	ng	NOUN
ct-9336	71	9	/	/	SYM
ct-9336	71	10	ml	ml	NOUN
ct-9336	71	11	at	at	ADP
ct-9336	71	12	33.00	33.00	NUM
ct-9336	71	13	±	±	NUM
ct-9336	71	14	18.00	18.00	NUM
ct-9336	71	15	hours	hour	NOUN
ct-9336	71	16	(	(	PUNCT
ct-9336	71	17	tmax	tmax	NUM
ct-9336	71	18	)	)	PUNCT
ct-9336	71	19	.	.	PUNCT
ct-9336	72	1	the	the	DET
ct-9336	72	2	cmax	cmax	NOUN
ct-9336	72	3	between	between	ADP
ct-9336	72	4	plasma	plasma	NOUN
ct-9336	72	5	and	and	CCONJ
ct-9336	72	6	semen	semen	NOUN
ct-9336	72	7	was	be	AUX
ct-9336	72	8	different	different	ADJ
ct-9336	72	9	(	(	PUNCT
ct-9336	72	10	p	p	X
ct-9336	72	11	=	=	NOUN
ct-9336	72	12	0.008	0.008	NUM
ct-9336	72	13	)	)	PUNCT
ct-9336	72	14	with	with	ADP
ct-9336	72	15	no	no	DET
ct-9336	72	16	differences	difference	NOUN
ct-9336	72	17	(	(	PUNCT
ct-9336	72	18	p	p	NOUN
ct-9336	72	19	=	=	NOUN
ct-9336	72	20	0.35	0.35	NUM
ct-9336	72	21	)	)	PUNCT
ct-9336	72	22	in	in	ADP
ct-9336	72	23	tmax	tmax	ADV
ct-9336	72	24	between	between	ADP
ct-9336	72	25	plasma	plasma	NOUN
ct-9336	72	26	and	and	CCONJ
ct-9336	72	27	semen	semen	NOUN
ct-9336	72	28	.	.	PUNCT
ct-9336	73	1	the	the	DET
ct-9336	73	2	terminal	terminal	ADJ
ct-9336	73	3	half	half	ADJ
ct-9336	73	4	-	-	PUNCT
ct-9336	73	5	life	life	NOUN
ct-9336	73	6	for	for	ADP
ct-9336	73	7	plasma	plasma	NOUN
ct-9336	73	8	(	(	PUNCT
ct-9336	73	9	81.4	81.4	NUM
ct-9336	73	10	±	±	NUM
ct-9336	73	11	27.6	27.6	NUM
ct-9336	73	12	hours	hour	NOUN
ct-9336	73	13	)	)	PUNCT
ct-9336	73	14	had	have	VERB
ct-9336	73	15	a	a	DET
ct-9336	73	16	tendency	tendency	NOUN
ct-9336	73	17	(	(	PUNCT
ct-9336	73	18	p	p	X
ct-9336	73	19	=	=	NOUN
ct-9336	73	20	0.10	0.10	NUM
ct-9336	73	21	)	)	PUNCT
ct-9336	73	22	to	to	PART
ct-9336	73	23	be	be	AUX
ct-9336	73	24	shorter	short	ADJ
ct-9336	73	25	than	than	ADP
ct-9336	73	26	in	in	ADP
ct-9336	73	27	semen	semen	NOUN
ct-9336	73	28	(	(	PUNCT
ct-9336	73	29	114.7	114.7	NUM
ct-9336	73	30	±	±	NUM
ct-9336	73	31	21.7	21.7	NUM
ct-9336	73	32	hours	hour	NOUN
ct-9336	73	33	)	)	PUNCT
ct-9336	73	34	.	.	PUNCT
ct-9336	74	1	the	the	DET
ct-9336	74	2	plasma	plasma	NOUN
ct-9336	74	3	auc0	auc0	NOUN
ct-9336	74	4	–	–	PUNCT
ct-9336	74	5	last	last	ADJ
ct-9336	74	6	(	(	PUNCT
ct-9336	74	7	15,440	15,440	NUM
ct-9336	74	8	±	±	NUM
ct-9336	74	9	1,717	1,717	NUM
ct-9336	74	10	ng/	ng/	ADJ
ct-9336	74	11	ml	ml	NOUN
ct-9336	74	12	/	/	SYM
ct-9336	74	13	hour	hour	NOUN
ct-9336	74	14	)	)	PUNCT
ct-9336	74	15	was	be	AUX
ct-9336	74	16	lower	low	ADJ
ct-9336	74	17	(	(	PUNCT
ct-9336	74	18	p	p	X
ct-9336	74	19	=	=	NOUN
ct-9336	74	20	0.01	0.01	NUM
ct-9336	74	21	)	)	PUNCT
ct-9336	74	22	compared	compare	VERB
ct-9336	74	23	to	to	ADP
ct-9336	74	24	semen	semen	NOUN
ct-9336	74	25	(	(	PUNCT
ct-9336	74	26	171,071	171,071	NUM
ct-9336	74	27	±	±	NUM
ct-9336	74	28	58,556	58,556	NUM
ct-9336	74	29	ng	ng	PROPN
ct-9336	74	30	/	/	SYM
ct-9336	74	31	ml	ml	NOUN
ct-9336	74	32	/	/	PUNCT
ct-9336	74	33	hour	hour	NOUN
ct-9336	74	34	)	)	PUNCT
ct-9336	74	35	.	.	PUNCT
ct-9336	75	1	discussion	discussion	NOUN
ct-9336	75	2	oxytetracycline	oxytetracycline	PROPN
ct-9336	75	3	oxytetracycline	oxytetracycline	ADJ
ct-9336	75	4	treatment	treatment	NOUN
ct-9336	75	5	has	have	AUX
ct-9336	75	6	been	be	AUX
ct-9336	75	7	reported	report	VERB
ct-9336	75	8	to	to	PART
ct-9336	75	9	produce	produce	VERB
ct-9336	75	10	local	local	ADJ
ct-9336	75	11	irritation	irritation	NOUN
ct-9336	75	12	and	and	CCONJ
ct-9336	75	13	extensive	extensive	ADJ
ct-9336	75	14	tissue	tissue	NOUN
ct-9336	75	15	damage.22	damage.22	NOUN
ct-9336	75	16	therefore	therefore	ADV
ct-9336	75	17	,	,	PUNCT
ct-9336	75	18	subcutaneous	subcutaneous	ADJ
ct-9336	75	19	treatment	treatment	NOUN
ct-9336	75	20	may	may	AUX
ct-9336	75	21	be	be	AUX
ct-9336	75	22	a	a	DET
ct-9336	75	23	better	well	ADJ
ct-9336	75	24	option	option	NOUN
ct-9336	75	25	than	than	ADP
ct-9336	75	26	intramuscular	intramuscular	ADJ
ct-9336	75	27	.	.	PUNCT
ct-9336	76	1	nevertheless	nevertheless	ADV
ct-9336	76	2	,	,	PUNCT
ct-9336	76	3	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	76	4	of	of	ADP
ct-9336	76	5	the	the	DET
ct-9336	76	6	drug	drug	NOUN
ct-9336	76	7	should	should	AUX
ct-9336	76	8	be	be	AUX
ct-9336	76	9	considered	consider	VERB
ct-9336	76	10	before	before	SCONJ
ct-9336	76	11	an	an	DET
ct-9336	76	12	alternative	alternative	ADJ
ct-9336	76	13	route	route	NOUN
ct-9336	76	14	of	of	ADP
ct-9336	76	15	treatment	treatment	NOUN
ct-9336	76	16	is	be	AUX
ct-9336	76	17	recommended	recommend	VERB
ct-9336	76	18	.	.	PUNCT
ct-9336	77	1	similar	similar	ADJ
ct-9336	77	2	to	to	ADP
ct-9336	77	3	reports23	reports23	VERB
ct-9336	77	4	-	-	PUNCT
ct-9336	77	5	27	27	NUM
ct-9336	77	6	for	for	ADP
ct-9336	77	7	5	5	NUM
ct-9336	77	8	,	,	PUNCT
ct-9336	77	9	10	10	NUM
ct-9336	77	10	,	,	PUNCT
ct-9336	77	11	or	or	CCONJ
ct-9336	77	12	20	20	NUM
ct-9336	77	13	%	%	NOUN
ct-9336	77	14	oxytetracycline	oxytetracycline	NOUN
ct-9336	77	15	formulations	formulation	NOUN
ct-9336	77	16	,	,	PUNCT
ct-9336	77	17	mean	mean	ADJ
ct-9336	77	18	plasma	plasma	NOUN
ct-9336	77	19	or	or	CCONJ
ct-9336	77	20	semen	semen	NOUN
ct-9336	77	21	concentrations	concentration	NOUN
ct-9336	77	22	for	for	ADP
ct-9336	77	23	both	both	DET
ct-9336	77	24	doses	dose	NOUN
ct-9336	77	25	of	of	ADP
ct-9336	77	26	oxytetracycline	oxytetracycline	NOUN
ct-9336	77	27	were	be	AUX
ct-9336	77	28	not	not	PART
ct-9336	77	29	different	different	ADJ
ct-9336	77	30	for	for	ADP
ct-9336	77	31	2	2	NUM
ct-9336	77	32	routes	route	NOUN
ct-9336	77	33	of	of	ADP
ct-9336	77	34	treatment	treatment	NOUN
ct-9336	77	35	.	.	PUNCT
ct-9336	78	1	the	the	DET
ct-9336	78	2	area	area	NOUN
ct-9336	78	3	around	around	ADP
ct-9336	78	4	the	the	DET
ct-9336	78	5	injection	injection	NOUN
ct-9336	78	6	site	site	NOUN
ct-9336	78	7	was	be	AUX
ct-9336	78	8	larger	large	ADJ
ct-9336	78	9	in	in	ADP
ct-9336	78	10	the	the	DET
ct-9336	78	11	subcutaneous	subcutaneous	ADJ
ct-9336	78	12	route	route	NOUN
ct-9336	78	13	than	than	ADP
ct-9336	78	14	in	in	ADP
ct-9336	78	15	the	the	DET
ct-9336	78	16	intramuscular	intramuscular	ADJ
ct-9336	78	17	route	route	NOUN
ct-9336	78	18	.	.	PUNCT
ct-9336	79	1	inflammation	inflammation	NOUN
ct-9336	79	2	after	after	SCONJ
ct-9336	79	3	subcutaneous	subcutaneous	ADJ
ct-9336	79	4	treatment	treatment	NOUN
ct-9336	79	5	could	could	AUX
ct-9336	79	6	have	have	AUX
ct-9336	79	7	contributed	contribute	VERB
ct-9336	79	8	to	to	ADP
ct-9336	79	9	more	more	ADJ
ct-9336	79	10	absorption	absorption	NOUN
ct-9336	79	11	of	of	ADP
ct-9336	79	12	oxytetracycline	oxytetracycline	NOUN
ct-9336	79	13	,	,	PUNCT
ct-9336	79	14	resulting	result	VERB
ct-9336	79	15	in	in	ADP
ct-9336	79	16	similar	similar	ADJ
ct-9336	79	17	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	79	18	.	.	PUNCT
ct-9336	80	1	plasma	plasma	NOUN
ct-9336	80	2	cmax	cmax	NOUN
ct-9336	80	3	at	at	ADP
ct-9336	80	4	12	12	NUM
ct-9336	80	5	hours	hour	NOUN
ct-9336	80	6	(	(	PUNCT
ct-9336	80	7	tmax	tmax	ADV
ct-9336	80	8	)	)	PUNCT
ct-9336	80	9	for	for	ADP
ct-9336	80	10	10	10	NUM
ct-9336	80	11	mg	mg	NOUN
ct-9336	80	12	/	/	SYM
ct-9336	80	13	kg	kg	PROPN
ct-9336	80	14	was	be	AUX
ct-9336	80	15	lower	low	ADJ
ct-9336	80	16	than	than	ADP
ct-9336	80	17	reported.28	reported.28	NOUN
ct-9336	80	18	first	first	ADJ
ct-9336	80	19	blood	blood	NOUN
ct-9336	80	20	sample	sample	NOUN
ct-9336	80	21	collected	collect	VERB
ct-9336	80	22	at	at	ADP
ct-9336	80	23	12	12	NUM
ct-9336	80	24	hours	hour	NOUN
ct-9336	80	25	(	(	PUNCT
ct-9336	80	26	plasma	plasma	NOUN
ct-9336	80	27	oxytetracycline	oxytetracycline	ADJ
ct-9336	80	28	concentration	concentration	NOUN
ct-9336	80	29	was	be	AUX
ct-9336	80	30	already	already	ADV
ct-9336	80	31	in	in	ADP
ct-9336	80	32	the	the	DET
ct-9336	80	33	descending	descend	VERB
ct-9336	80	34	phase	phase	NOUN
ct-9336	80	35	)	)	PUNCT
ct-9336	80	36	in	in	ADP
ct-9336	80	37	the	the	DET
ct-9336	80	38	present	present	ADJ
ct-9336	80	39	study	study	NOUN
ct-9336	80	40	could	could	AUX
ct-9336	80	41	explain	explain	VERB
ct-9336	80	42	the	the	DET
ct-9336	80	43	difference	difference	NOUN
ct-9336	80	44	.	.	PUNCT
ct-9336	81	1	plasma	plasma	NOUN
ct-9336	81	2	cmax	cmax	NOUN
ct-9336	81	3	for	for	ADP
ct-9336	81	4	20	20	NUM
ct-9336	81	5	mg	mg	NOUN
ct-9336	81	6	/	/	SYM
ct-9336	81	7	kg	kg	PROPN
ct-9336	81	8	was	be	AUX
ct-9336	81	9	lower	low	ADJ
ct-9336	81	10	than	than	ADP
ct-9336	81	11	reported25,29,30	reported25,29,30	NOUN
ct-9336	81	12	that	that	PRON
ct-9336	81	13	also	also	ADV
ct-9336	81	14	had	have	VERB
ct-9336	81	15	different	different	ADJ
ct-9336	81	16	tmax	tmax	ADP
ct-9336	81	17	(	(	PUNCT
ct-9336	81	18	4.7	4.7	NUM
ct-9336	81	19	6.2,25	6.2,25	NUM
ct-9336	81	20	6,29	6,29	NUM
ct-9336	81	21	and	and	CCONJ
ct-9336	81	22	3.9	3.9	NUM
ct-9336	81	23	hours30	hours30	NOUN
ct-9336	81	24	)	)	PUNCT
ct-9336	81	25	.	.	PUNCT
ct-9336	82	1	first	first	ADJ
ct-9336	82	2	blood	blood	NOUN
ct-9336	82	3	sample	sample	NOUN
ct-9336	82	4	collected	collect	VERB
ct-9336	82	5	at	at	ADP
ct-9336	82	6	12	12	NUM
ct-9336	82	7	hours	hour	NOUN
ct-9336	82	8	in	in	ADP
ct-9336	82	9	the	the	DET
ct-9336	82	10	present	present	ADJ
ct-9336	82	11	study	study	NOUN
ct-9336	82	12	could	could	AUX
ct-9336	82	13	explain	explain	VERB
ct-9336	82	14	the	the	DET
ct-9336	82	15	difference	difference	NOUN
ct-9336	82	16	.	.	PUNCT
ct-9336	83	1	plasma	plasma	NOUN
ct-9336	83	2	auc0	auc0	PROPN
ct-9336	83	3	-	-	PUNCT
ct-9336	83	4	last	last	ADJ
ct-9336	83	5	for	for	ADP
ct-9336	83	6	the	the	DET
ct-9336	83	7	20	20	NUM
ct-9336	83	8	mg	mg	PROPN
ct-9336	83	9	/	/	SYM
ct-9336	83	10	kg	kg	PROPN
ct-9336	83	11	dose	dose	NOUN
ct-9336	83	12	was	be	AUX
ct-9336	83	13	in	in	ADP
ct-9336	83	14	agreement	agreement	NOUN
ct-9336	83	15	with	with	ADP
ct-9336	83	16	a	a	DET
ct-9336	83	17	previous	previous	ADJ
ct-9336	83	18	report.25	report.25	NOUN
ct-9336	83	19	to	to	ADP
ct-9336	83	20	the	the	DET
ct-9336	83	21	authors	author	NOUN
ct-9336	83	22	’	’	PART
ct-9336	83	23	knowledge	knowledge	NOUN
ct-9336	83	24	,	,	PUNCT
ct-9336	83	25	this	this	PRON
ct-9336	83	26	is	be	AUX
ct-9336	83	27	the	the	DET
ct-9336	83	28	first	first	ADJ
ct-9336	83	29	study	study	NOUN
ct-9336	83	30	that	that	PRON
ct-9336	83	31	determined	determine	VERB
ct-9336	83	32	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	83	33	of	of	ADP
ct-9336	83	34	long	long	ADV
ct-9336	83	35	-	-	PUNCT
ct-9336	83	36	acting	act	VERB
ct-9336	83	37	oxytetracycline	oxytetracycline	NOUN
ct-9336	83	38	in	in	ADP
ct-9336	83	39	bull	bull	NOUN
ct-9336	83	40	semen	semen	NOUN
ct-9336	83	41	for	for	ADP
ct-9336	83	42	2	2	NUM
ct-9336	83	43	doses	dose	NOUN
ct-9336	83	44	.	.	PUNCT
ct-9336	84	1	successful	successful	ADJ
ct-9336	84	2	treatment	treatment	NOUN
ct-9336	84	3	requires	require	VERB
ct-9336	84	4	selection	selection	NOUN
ct-9336	84	5	of	of	ADP
ct-9336	84	6	an	an	DET
ct-9336	84	7	antibiotic	antibiotic	NOUN
ct-9336	84	8	based	base	VERB
ct-9336	84	9	on	on	ADP
ct-9336	84	10	the	the	DET
ct-9336	84	11	microbiological	microbiological	ADJ
ct-9336	84	12	results	result	NOUN
ct-9336	84	13	and	and	CCONJ
ct-9336	84	14	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	84	15	properties	property	NOUN
ct-9336	84	16	.	.	PUNCT
ct-9336	85	1	higher	high	ADJ
ct-9336	85	2	concentrations	concentration	NOUN
ct-9336	85	3	in	in	ADP
ct-9336	85	4	semen	semen	NOUN
ct-9336	85	5	than	than	ADP
ct-9336	85	6	plasma	plasma	NOUN
ct-9336	85	7	were	be	AUX
ct-9336	85	8	attributed	attribute	VERB
ct-9336	85	9	to	to	ADP
ct-9336	85	10	a	a	DET
ct-9336	85	11	lipophilic	lipophilic	ADJ
ct-9336	85	12	drug	drug	NOUN
ct-9336	85	13	with	with	ADP
ct-9336	85	14	a	a	DET
ct-9336	85	15	high	high	ADJ
ct-9336	85	16	volume	volume	NOUN
ct-9336	85	17	of	of	ADP
ct-9336	85	18	distribution	distribution	NOUN
ct-9336	85	19	and	and	CCONJ
ct-9336	85	20	high	high	ADJ
ct-9336	85	21	tissue	tissue	NOUN
ct-9336	85	22	concentrations.30	concentrations.30	NOUN
ct-9336	85	23	when	when	SCONJ
ct-9336	85	24	bacteriostatic	bacteriostatic	ADJ
ct-9336	85	25	antibiotics	antibiotic	NOUN
ct-9336	85	26	such	such	ADJ
ct-9336	85	27	as	as	ADP
ct-9336	85	28	long	long	ADV
ct-9336	85	29	-	-	PUNCT
ct-9336	85	30	acting	act	VERB
ct-9336	85	31	oxytetracycline	oxytetracycline	NOUN
ct-9336	85	32	are	be	AUX
ct-9336	85	33	used	use	VERB
ct-9336	85	34	,	,	PUNCT
ct-9336	85	35	the	the	DET
ct-9336	85	36	plasma	plasma	NOUN
ct-9336	85	37	or	or	CCONJ
ct-9336	85	38	semen	semen	NOUN
ct-9336	85	39	concentrations	concentration	NOUN
ct-9336	85	40	should	should	AUX
ct-9336	85	41	not	not	PART
ct-9336	85	42	decrease	decrease	VERB
ct-9336	85	43	below	below	ADP
ct-9336	85	44	the	the	DET
ct-9336	85	45	effective	effective	ADJ
ct-9336	85	46	minimum	minimum	ADJ
ct-9336	85	47	inhibitory	inhibitory	ADJ
ct-9336	85	48	concentrations	concentration	NOUN
ct-9336	85	49	during	during	ADP
ct-9336	85	50	treatment	treatment	NOUN
ct-9336	85	51	.	.	PUNCT
ct-9336	86	1	therefore	therefore	ADV
ct-9336	86	2	,	,	PUNCT
ct-9336	86	3	the	the	DET
ct-9336	86	4	selection	selection	NOUN
ct-9336	86	5	of	of	ADP
ct-9336	86	6	dosing	dosing	NOUN
ct-9336	86	7	intervals	interval	NOUN
ct-9336	86	8	and	and	CCONJ
ct-9336	86	9	the	the	DET
ct-9336	86	10	desired	desire	VERB
ct-9336	86	11	minimum	minimum	NOUN
ct-9336	86	12	semen	semen	NOUN
ct-9336	86	13	concentrations	concentration	NOUN
ct-9336	86	14	require	require	VERB
ct-9336	86	15	basic	basic	ADJ
ct-9336	86	16	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	86	17	information	information	NOUN
ct-9336	86	18	as	as	ADP
ct-9336	86	19	a	a	DET
ct-9336	86	20	guideline	guideline	NOUN
ct-9336	86	21	.	.	PUNCT
ct-9336	87	1	in	in	ADP
ct-9336	87	2	general	general	ADJ
ct-9336	87	3	,	,	PUNCT
ct-9336	87	4	a	a	DET
ct-9336	87	5	serum	serum	NOUN
ct-9336	87	6	concentration	concentration	NOUN
ct-9336	87	7	between	between	ADP
ct-9336	87	8	500	500	NUM
ct-9336	87	9	and	and	CCONJ
ct-9336	87	10	1,000	1,000	NUM
ct-9336	87	11	ng	ng	NOUN
ct-9336	87	12	/	/	SYM
ct-9336	87	13	ml	ml	PROPN
ct-9336	87	14	has	have	AUX
ct-9336	87	15	been	be	AUX
ct-9336	87	16	suggested	suggest	VERB
ct-9336	87	17	as	as	ADP
ct-9336	87	18	the	the	DET
ct-9336	87	19	effective	effective	ADJ
ct-9336	87	20	therapeutic	therapeutic	ADJ
ct-9336	87	21	level	level	NOUN
ct-9336	87	22	.	.	PUNCT
ct-9336	88	1	the	the	DET
ct-9336	88	2	minimum	minimum	ADJ
ct-9336	88	3	inhibitory	inhibitory	ADJ
ct-9336	88	4	concentrations	concentration	NOUN
ct-9336	88	5	for	for	ADP
ct-9336	88	6	clinical	clinical	ADJ
ct-9336	88	7	theriogenology	theriogenology	NOUN
ct-9336	88	8	2021	2021	NUM
ct-9336	88	9	;	;	PUNCT
ct-9336	88	10	13	13	NUM
ct-9336	88	11	:	:	SYM
ct-9336	88	12	208	208	NUM
ct-9336	88	13	tetracyclines	tetracycline	NOUN
ct-9336	88	14	against	against	ADP
ct-9336	88	15	most	most	ADV
ct-9336	88	16	susceptible	susceptible	ADJ
ct-9336	88	17	pathogenic	pathogenic	ADJ
ct-9336	88	18	microorganisms	microorganism	NOUN
ct-9336	88	19	in	in	ADP
ct-9336	88	20	cattle	cattle	NOUN
ct-9336	88	21	(	(	PUNCT
ct-9336	88	22	bacillus	bacillus	NOUN
ct-9336	88	23	anthracis	anthracis	NOUN
ct-9336	88	24	,	,	PUNCT
ct-9336	88	25	mycoplasma	mycoplasma	VERB
ct-9336	88	26	spp	spp	NOUN
ct-9336	88	27	.	.	PROPN
ct-9336	88	28	,	,	PUNCT
ct-9336	88	29	pasteurella	pasteurella	PROPN
ct-9336	88	30	spp	spp	PROPN
ct-9336	88	31	.	.	PROPN
ct-9336	88	32	,	,	PUNCT
ct-9336	88	33	staphylococcus	staphylococcus	NOUN
ct-9336	88	34	aureus	aureus	NOUN
ct-9336	88	35	,	,	PUNCT
ct-9336	88	36	streptococcus	streptococcus	ADJ
ct-9336	88	37	pyogenes	pyogene	NOUN
ct-9336	88	38	,	,	PUNCT
ct-9336	88	39	and	and	CCONJ
ct-9336	88	40	streptococcus	streptococcus	VERB
ct-9336	88	41	pneumoniae	pneumoniae	NOUN
ct-9336	88	42	)	)	PUNCT
ct-9336	88	43	ranged	range	VERB
ct-9336	88	44	from	from	ADP
ct-9336	88	45	120	120	NUM
ct-9336	88	46	1,000	1,000	NUM
ct-9336	88	47	ng	ng	PROPN
ct-9336	88	48	/	/	SYM
ct-9336	88	49	ml.31	ml.31	NOUN
ct-9336	88	50	tulathromycin	tulathromycin	NOUN
ct-9336	88	51	only	only	ADV
ct-9336	88	52	a	a	DET
ct-9336	88	53	mild	mild	ADJ
ct-9336	88	54	swelling	swelling	NOUN
ct-9336	88	55	at	at	ADP
ct-9336	88	56	the	the	DET
ct-9336	88	57	site	site	NOUN
ct-9336	88	58	of	of	ADP
ct-9336	88	59	injection	injection	NOUN
ct-9336	88	60	was	be	AUX
ct-9336	88	61	detected	detect	VERB
ct-9336	88	62	,	,	PUNCT
ct-9336	88	63	especially	especially	ADV
ct-9336	88	64	at	at	ADP
ct-9336	88	65	the	the	DET
ct-9336	88	66	base	base	NOUN
ct-9336	88	67	of	of	ADP
ct-9336	88	68	the	the	DET
ct-9336	88	69	ear	ear	NOUN
ct-9336	88	70	,	,	PUNCT
ct-9336	88	71	that	that	PRON
ct-9336	88	72	had	have	AUX
ct-9336	88	73	disappeared	disappear	VERB
ct-9336	88	74	at	at	ADP
ct-9336	88	75	5	5	NUM
ct-9336	88	76	days	day	NOUN
ct-9336	88	77	after	after	ADP
ct-9336	88	78	treatment	treatment	NOUN
ct-9336	88	79	.	.	PUNCT
ct-9336	89	1	the	the	DET
ct-9336	89	2	average	average	ADJ
ct-9336	89	3	plasma	plasma	NOUN
ct-9336	89	4	cmax	cmax	NOUN
ct-9336	89	5	(	(	PUNCT
ct-9336	89	6	160	160	NUM
ct-9336	89	7	ng	ng	NOUN
ct-9336	89	8	/	/	SYM
ct-9336	89	9	ml	ml	PROPN
ct-9336	89	10	)	)	PUNCT
ct-9336	89	11	was	be	AUX
ct-9336	89	12	lower	low	ADJ
ct-9336	89	13	than	than	SCONJ
ct-9336	89	14	reported	report	VERB
ct-9336	89	15	(	(	PUNCT
ct-9336	89	16	277	277	NUM
ct-9336	89	17	ng	ng	PROPN
ct-9336	89	18	/	/	SYM
ct-9336	89	19	ml,32	ml,32	PROPN
ct-9336	89	20	300	300	NUM
ct-9336	89	21	ng	ng	PROPN
ct-9336	89	22	/	/	SYM
ct-9336	89	23	ml,33	ml,33	PROPN
ct-9336	89	24	and	and	CCONJ
ct-9336	89	25	500	500	NUM
ct-9336	89	26	ng	ng	PROPN
ct-9336	89	27	/	/	SYM
ct-9336	89	28	ml).13,15	ml).13,15	NOUN
ct-9336	89	29	one	one	NUM
ct-9336	89	30	possible	possible	ADJ
ct-9336	89	31	explanation	explanation	NOUN
ct-9336	89	32	for	for	ADP
ct-9336	89	33	this	this	DET
ct-9336	89	34	difference	difference	NOUN
ct-9336	89	35	could	could	AUX
ct-9336	89	36	be	be	AUX
ct-9336	89	37	due	due	ADJ
ct-9336	89	38	to	to	ADP
ct-9336	89	39	the	the	DET
ct-9336	89	40	timing	timing	NOUN
ct-9336	89	41	(	(	PUNCT
ct-9336	89	42	12	12	NUM
ct-9336	89	43	hours	hour	NOUN
ct-9336	89	44	after	after	ADP
ct-9336	89	45	treatment	treatment	NOUN
ct-9336	89	46	)	)	PUNCT
ct-9336	89	47	of	of	ADP
ct-9336	89	48	first	first	ADJ
ct-9336	89	49	blood	blood	NOUN
ct-9336	89	50	sample	sample	NOUN
ct-9336	89	51	,	,	PUNCT
ct-9336	89	52	a	a	DET
ct-9336	89	53	time	time	NOUN
ct-9336	89	54	the	the	DET
ct-9336	89	55	plasma	plasma	NOUN
ct-9336	89	56	concentrations	concentration	NOUN
ct-9336	89	57	of	of	ADP
ct-9336	89	58	tulathromycin	tulathromycin	NOUN
ct-9336	89	59	must	must	AUX
ct-9336	89	60	have	have	AUX
ct-9336	89	61	been	be	AUX
ct-9336	89	62	already	already	ADV
ct-9336	89	63	in	in	ADP
ct-9336	89	64	a	a	DET
ct-9336	89	65	descending	descend	VERB
ct-9336	89	66	phase	phase	NOUN
ct-9336	89	67	.	.	PUNCT
ct-9336	90	1	this	this	PRON
ct-9336	90	2	is	be	AUX
ct-9336	90	3	supported	support	VERB
ct-9336	90	4	by	by	ADP
ct-9336	90	5	2	2	NUM
ct-9336	90	6	reasons	reason	NOUN
ct-9336	90	7	.	.	PUNCT
ct-9336	91	1	first	first	ADV
ct-9336	91	2	,	,	PUNCT
ct-9336	91	3	in	in	ADP
ct-9336	91	4	those	those	DET
ct-9336	91	5	studies	study	NOUN
ct-9336	91	6	,	,	PUNCT
ct-9336	91	7	it	it	PRON
ct-9336	91	8	was	be	AUX
ct-9336	91	9	determined	determine	VERB
ct-9336	91	10	at	at	ADP
ct-9336	91	11	0.25	0.25	NUM
ct-9336	91	12	hour,34	hour,34	NOUN
ct-9336	91	13	<	<	X
ct-9336	91	14	1	1	NUM
ct-9336	91	15	hour,13	hour,13	NOUN
ct-9336	91	16	and	and	CCONJ
ct-9336	91	17	0.7	0.7	NUM
ct-9336	91	18	hour;33	hour;33	ADJ
ct-9336	91	19	second	second	ADJ
ct-9336	91	20	,	,	PUNCT
ct-9336	91	21	24	24	NUM
ct-9336	91	22	240	240	NUM
ct-9336	91	23	hours	hour	NOUN
ct-9336	91	24	concentrations	concentration	NOUN
ct-9336	91	25	were	be	AUX
ct-9336	91	26	similar	similar	ADJ
ct-9336	91	27	to	to	PART
ct-9336	91	28	reported.13,15	reported.13,15	VERB
ct-9336	91	29	the	the	DET
ct-9336	91	30	terminal	terminal	ADJ
ct-9336	91	31	half	half	ADJ
ct-9336	91	32	-	-	PUNCT
ct-9336	91	33	life	life	NOUN
ct-9336	91	34	of	of	ADP
ct-9336	91	35	81.4	81.4	NUM
ct-9336	91	36	±	±	NUM
ct-9336	91	37	27	27	NUM
ct-9336	91	38	.	.	NOUN
ct-9336	92	1	6	6	NUM
ct-9336	92	2	hours	hour	NOUN
ct-9336	92	3	(	(	PUNCT
ct-9336	92	4	range	range	NOUN
ct-9336	92	5	;	;	PUNCT
ct-9336	92	6	71	71	NUM
ct-9336	92	7	96	96	NUM
ct-9336	92	8	hours	hour	NOUN
ct-9336	92	9	)	)	PUNCT
ct-9336	92	10	was	be	AUX
ct-9336	92	11	in	in	ADP
ct-9336	92	12	agreement	agreement	NOUN
ct-9336	92	13	with	with	ADP
ct-9336	92	14	earlier	early	ADJ
ct-9336	92	15	reports.13,15,32,33	reports.13,15,32,33	PROPN
ct-9336	92	16	the	the	DET
ct-9336	92	17	plasma	plasma	NOUN
ct-9336	92	18	auc0	auc0	NOUN
ct-9336	92	19	-	-	PUNCT
ct-9336	92	20	last	last	ADJ
ct-9336	92	21	in	in	ADP
ct-9336	92	22	the	the	DET
ct-9336	92	23	present	present	ADJ
ct-9336	92	24	study	study	NOUN
ct-9336	92	25	(	(	PUNCT
ct-9336	92	26	18,382	18,382	NUM
ct-9336	92	27	ng	ng	NOUN
ct-9336	92	28	/	/	SYM
ct-9336	92	29	ml	ml	NOUN
ct-9336	92	30	/	/	PUNCT
ct-9336	92	31	hour	hour	NOUN
ct-9336	92	32	)	)	PUNCT
ct-9336	92	33	was	be	AUX
ct-9336	92	34	comparable	comparable	ADJ
ct-9336	92	35	to	to	ADP
ct-9336	92	36	earlier	early	ADJ
ct-9336	92	37	reports13,34	reports13,34	NOUN
ct-9336	92	38	(	(	PUNCT
ct-9336	92	39	17,885	17,885	NUM
ct-9336	92	40	and	and	CCONJ
ct-9336	92	41	16,700	16,700	NUM
ct-9336	92	42	ng/	ng/	ADJ
ct-9336	92	43	ml	ml	NOUN
ct-9336	92	44	/	/	SYM
ct-9336	92	45	hour	hour	NOUN
ct-9336	92	46	)	)	PUNCT
ct-9336	92	47	but	but	CCONJ
ct-9336	92	48	higher	high	ADJ
ct-9336	92	49	than	than	ADP
ct-9336	92	50	others.15,32,33,35	others.15,32,33,35	PROPN
ct-9336	92	51	the	the	DET
ct-9336	92	52	efficacy	efficacy	NOUN
ct-9336	92	53	of	of	ADP
ct-9336	92	54	any	any	DET
ct-9336	92	55	antimicrobial	antimicrobial	ADJ
ct-9336	92	56	is	be	AUX
ct-9336	92	57	determined	determine	VERB
ct-9336	92	58	by	by	ADP
ct-9336	92	59	both	both	DET
ct-9336	92	60	its	its	PRON
ct-9336	92	61	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	92	62	and	and	CCONJ
ct-9336	92	63	pharmacodynamic	pharmacodynamic	ADJ
ct-9336	92	64	properties	property	NOUN
ct-9336	92	65	.	.	PUNCT
ct-9336	93	1	antibiotics	antibiotic	NOUN
ct-9336	93	2	have	have	AUX
ct-9336	93	3	been	be	AUX
ct-9336	93	4	classified	classify	VERB
ct-9336	93	5	into	into	ADP
ct-9336	93	6	2	2	NUM
ct-9336	93	7	major	major	ADJ
ct-9336	93	8	groups	group	NOUN
ct-9336	93	9	:	:	PUNCT
ct-9336	93	10	those	those	PRON
ct-9336	93	11	with	with	ADP
ct-9336	93	12	bacteriostatic	bacteriostatic	ADJ
ct-9336	93	13	antimicrobial	antimicrobial	ADJ
ct-9336	93	14	action	action	NOUN
ct-9336	93	15	that	that	PRON
ct-9336	93	16	exhibit	exhibit	VERB
ct-9336	93	17	time	time	NOUN
ct-9336	93	18	-	-	PUNCT
ct-9336	93	19	dependent	dependent	ADJ
ct-9336	93	20	killing	killing	NOUN
ct-9336	93	21	action	action	NOUN
ct-9336	93	22	or	or	CCONJ
ct-9336	93	23	those	those	PRON
ct-9336	93	24	with	with	ADP
ct-9336	93	25	bactericidal	bactericidal	ADJ
ct-9336	93	26	antimicrobial	antimicrobial	ADJ
ct-9336	93	27	action	action	NOUN
ct-9336	93	28	that	that	PRON
ct-9336	93	29	behave	behave	VERB
ct-9336	93	30	with	with	ADP
ct-9336	93	31	either	either	PRON
ct-9336	93	32	time	time	NOUN
ct-9336	93	33	-	-	PUNCT
ct-9336	93	34	dependent	dependent	ADJ
ct-9336	93	35	or	or	CCONJ
ct-9336	93	36	concentration	concentration	NOUN
ct-9336	93	37	-	-	PUNCT
ct-9336	93	38	dependent	dependent	ADJ
ct-9336	93	39	killing	killing	NOUN
ct-9336	93	40	,	,	PUNCT
ct-9336	93	41	or	or	CCONJ
ct-9336	93	42	both.15	both.15	NOUN
ct-9336	93	43	tulathromycin	tulathromycin	NOUN
ct-9336	93	44	has	have	VERB
ct-9336	93	45	both	both	CCONJ
ct-9336	93	46	bacteriostatic	bacteriostatic	ADJ
ct-9336	93	47	antimicrobial	antimicrobial	ADJ
ct-9336	93	48	and	and	CCONJ
ct-9336	93	49	bactericidal	bactericidal	ADJ
ct-9336	93	50	antimicrobial	antimicrobial	ADJ
ct-9336	93	51	time	time	NOUN
ct-9336	93	52	-	-	PUNCT
ct-9336	93	53	dependent	dependent	ADJ
ct-9336	93	54	action.13	action.13	PROPN
ct-9336	93	55	to	to	ADP
ct-9336	93	56	the	the	DET
ct-9336	93	57	authors	author	NOUN
ct-9336	93	58	’	’	PART
ct-9336	93	59	knowledge	knowledge	NOUN
ct-9336	93	60	,	,	PUNCT
ct-9336	93	61	this	this	PRON
ct-9336	93	62	is	be	AUX
ct-9336	93	63	the	the	DET
ct-9336	93	64	first	first	ADJ
ct-9336	93	65	study	study	NOUN
ct-9336	93	66	that	that	PRON
ct-9336	93	67	determined	determine	VERB
ct-9336	93	68	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	93	69	of	of	ADP
ct-9336	93	70	tulathromycin	tulathromycin	NOUN
ct-9336	93	71	in	in	ADP
ct-9336	93	72	bull	bull	NOUN
ct-9336	93	73	semen	semen	NOUN
ct-9336	93	74	using	use	VERB
ct-9336	93	75	a	a	DET
ct-9336	93	76	standard	standard	ADJ
ct-9336	93	77	recommended	recommend	VERB
ct-9336	93	78	dose	dose	NOUN
ct-9336	93	79	for	for	ADP
ct-9336	93	80	cattle	cattle	NOUN
ct-9336	93	81	.	.	PUNCT
ct-9336	94	1	semen	semen	NOUN
ct-9336	94	2	cmax	cmax	NOUN
ct-9336	94	3	of	of	ADP
ct-9336	94	4	tulathromycin	tulathromycin	NOUN
ct-9336	94	5	was	be	AUX
ct-9336	94	6	higher	high	ADJ
ct-9336	94	7	than	than	ADP
ct-9336	94	8	plasma	plasma	NOUN
ct-9336	94	9	with	with	ADP
ct-9336	94	10	a	a	DET
ct-9336	94	11	tendency	tendency	NOUN
ct-9336	94	12	of	of	ADP
ct-9336	94	13	longer	long	ADJ
ct-9336	94	14	half	half	ADJ
ct-9336	94	15	-	-	PUNCT
ct-9336	94	16	life	life	NOUN
ct-9336	94	17	compared	compare	VERB
ct-9336	94	18	to	to	ADP
ct-9336	94	19	plasma	plasma	NOUN
ct-9336	94	20	.	.	PUNCT
ct-9336	95	1	apparently	apparently	ADV
ct-9336	95	2	,	,	PUNCT
ct-9336	95	3	tulathromycin	tulathromycin	NOUN
ct-9336	95	4	elimination	elimination	NOUN
ct-9336	95	5	from	from	ADP
ct-9336	95	6	male	male	NOUN
ct-9336	95	7	’s	’s	PART
ct-9336	95	8	genital	genital	ADJ
ct-9336	95	9	tract	tract	NOUN
ct-9336	95	10	was	be	AUX
ct-9336	95	11	slower	slow	ADJ
ct-9336	95	12	,	,	PUNCT
ct-9336	95	13	probably	probably	ADV
ct-9336	95	14	because	because	SCONJ
ct-9336	95	15	of	of	ADP
ct-9336	95	16	delayed	delay	VERB
ct-9336	95	17	exposure	exposure	NOUN
ct-9336	95	18	in	in	ADP
ct-9336	95	19	the	the	DET
ct-9336	95	20	organs	organ	NOUN
ct-9336	95	21	of	of	ADP
ct-9336	95	22	elimination	elimination	NOUN
ct-9336	95	23	,	,	PUNCT
ct-9336	95	24	and	and	CCONJ
ct-9336	95	25	this	this	PRON
ct-9336	95	26	can	can	AUX
ct-9336	95	27	be	be	AUX
ct-9336	95	28	considered	consider	VERB
ct-9336	95	29	an	an	DET
ct-9336	95	30	advantage	advantage	NOUN
ct-9336	95	31	for	for	ADP
ct-9336	95	32	male	male	ADJ
ct-9336	95	33	reproductive	reproductive	ADJ
ct-9336	95	34	treatments	treatment	NOUN
ct-9336	95	35	.	.	PUNCT
ct-9336	96	1	furthermore	furthermore	ADV
ct-9336	96	2	,	,	PUNCT
ct-9336	96	3	the	the	DET
ct-9336	96	4	semen	semen	NOUN
ct-9336	96	5	auc0	auc0	PROPN
ct-9336	96	6	-	-	PUNCT
ct-9336	96	7	last	last	PROPN
ct-9336	96	8	was	be	AUX
ct-9336	96	9	higher	high	ADJ
ct-9336	96	10	than	than	ADP
ct-9336	96	11	plasma	plasma	NOUN
ct-9336	96	12	.	.	PUNCT
ct-9336	97	1	acknowledgments	acknowledgment	NOUN
ct-9336	97	2	supported	support	VERB
ct-9336	97	3	by	by	ADP
ct-9336	97	4	funds	fund	NOUN
ct-9336	97	5	from	from	ADP
ct-9336	97	6	the	the	DET
ct-9336	97	7	department	department	NOUN
ct-9336	97	8	of	of	ADP
ct-9336	97	9	veterinary	veterinary	ADJ
ct-9336	97	10	medical	medical	ADJ
ct-9336	97	11	sciences	sciences	PROPN
ct-9336	97	12	,	,	PUNCT
ct-9336	97	13	university	university	NOUN
ct-9336	97	14	of	of	ADP
ct-9336	97	15	bologna	bologna	PROPN
ct-9336	97	16	,	,	PUNCT
ct-9336	97	17	italy	italy	PROPN
ct-9336	97	18	(	(	PUNCT
ct-9336	97	19	prot	prot	NOUN
ct-9336	97	20	.	.	PUNCT
ct-9336	98	1	n.	n.	NOUN
ct-9336	98	2	0005783	0005783	NUM
ct-9336	98	3	)	)	PUNCT
ct-9336	98	4	.	.	PUNCT
ct-9336	99	1	authors	author	NOUN
ct-9336	99	2	thank	thank	VERB
ct-9336	99	3	giulia	giulia	PROPN
ct-9336	99	4	cristoni	cristoni	PROPN
ct-9336	99	5	,	,	PUNCT
ct-9336	99	6	angelo	angelo	PROPN
ct-9336	99	7	ferrari	ferrari	PROPN
ct-9336	99	8	,	,	PUNCT
ct-9336	99	9	and	and	CCONJ
ct-9336	99	10	fabrizio	fabrizio	PROPN
ct-9336	99	11	lollini	lollini	PROPN
ct-9336	99	12	for	for	ADP
ct-9336	99	13	their	their	PRON
ct-9336	99	14	assistance	assistance	NOUN
ct-9336	99	15	.	.	PUNCT
ct-9336	100	1	conflict	conflict	NOUN
ct-9336	100	2	of	of	ADP
ct-9336	100	3	interest	interest	NOUN
ct-9336	100	4	all	all	DET
ct-9336	100	5	authors	author	NOUN
ct-9336	100	6	declare	declare	VERB
ct-9336	100	7	that	that	SCONJ
ct-9336	100	8	there	there	PRON
ct-9336	100	9	is	be	VERB
ct-9336	100	10	no	no	DET
ct-9336	100	11	conflict	conflict	NOUN
ct-9336	100	12	of	of	ADP
ct-9336	100	13	interest	interest	NOUN
ct-9336	100	14	that	that	PRON
ct-9336	100	15	could	could	AUX
ct-9336	100	16	be	be	AUX
ct-9336	100	17	perceived	perceive	VERB
ct-9336	100	18	as	as	ADP
ct-9336	100	19	prejudicing	prejudice	VERB
ct-9336	100	20	the	the	DET
ct-9336	100	21	impartiality	impartiality	NOUN
ct-9336	100	22	of	of	ADP
ct-9336	100	23	the	the	DET
ct-9336	100	24	research	research	NOUN
ct-9336	100	25	reported	report	VERB
ct-9336	100	26	.	.	PUNCT
ct-9336	101	1	references	reference	NOUN
ct-9336	101	2	1	1	NUM
ct-9336	101	3	.	.	PUNCT
ct-9336	102	1	welles	welle	NOUN
ct-9336	102	2	eg	eg	PROPN
ct-9336	102	3	,	,	PUNCT
ct-9336	102	4	tyler	tyler	PROPN
ct-9336	102	5	jw	jw	PROPN
ct-9336	102	6	,	,	PUNCT
ct-9336	102	7	wolfe	wolfe	PROPN
ct-9336	102	8	df	df	PROPN
ct-9336	102	9	,	,	PUNCT
ct-9336	102	10	et	et	PROPN
ct-9336	102	11	al	al	PROPN
ct-9336	102	12	:	:	PUNCT
ct-9336	102	13	eperythrozoon	eperythrozoon	NOUN
ct-9336	102	14	infection	infection	NOUN
ct-9336	102	15	in	in	ADP
ct-9336	102	16	young	young	ADJ
ct-9336	102	17	bulls	bull	NOUN
ct-9336	102	18	with	with	ADP
ct-9336	102	19	scrotal	scrotal	ADJ
ct-9336	102	20	and	and	CCONJ
ct-9336	102	21	hindlimb	hindlimb	PROPN
ct-9336	102	22	edema	edema	NOUN
ct-9336	102	23	,	,	PUNCT
ct-9336	102	24	a	a	DET
ct-9336	102	25	herd	herd	NOUN
ct-9336	102	26	outbreak	outbreak	NOUN
ct-9336	102	27	.	.	PUNCT
ct-9336	103	1	theriogenology	theriogenology	NOUN
ct-9336	103	2	1995;43:557	1995;43:557	PROPN
ct-9336	103	3	-	-	SYM
ct-9336	103	4	567	567	NUM
ct-9336	103	5	.	.	NOUN
ct-9336	103	6	2	2	NUM
ct-9336	103	7	.	.	NUM
ct-9336	103	8	montes	montes	PROPN
ct-9336	103	9	aj	aj	PROPN
ct-9336	103	10	,	,	PUNCT
ct-9336	103	11	wolfe	wolfe	PROPN
ct-9336	103	12	df	df	PROPN
ct-9336	103	13	,	,	PUNCT
ct-9336	103	14	welles	welles	PROPN
ct-9336	103	15	eg	eg	PROPN
ct-9336	103	16	,	,	PUNCT
ct-9336	103	17	et	et	PROPN
ct-9336	103	18	al	al	PROPN
ct-9336	103	19	:	:	PUNCT
ct-9336	103	20	infertility	infertility	NOUN
ct-9336	103	21	associated	associate	VERB
ct-9336	103	22	with	with	ADP
ct-9336	103	23	eperythrozoon	eperythrozoon	NOUN
ct-9336	103	24	wenyonii	wenyonii	PROPN
ct-9336	103	25	infection	infection	NOUN
ct-9336	103	26	in	in	ADP
ct-9336	103	27	a	a	DET
ct-9336	103	28	bull	bull	NOUN
ct-9336	103	29	.	.	PUNCT
ct-9336	104	1	j	j	PROPN
ct-9336	104	2	am	be	AUX
ct-9336	104	3	vet	vet	NOUN
ct-9336	104	4	med	med	ADJ
ct-9336	104	5	assoc	assoc	PROPN
ct-9336	104	6	1994;204:261	1994;204:261	NUM
ct-9336	104	7	-	-	SYM
ct-9336	104	8	263	263	NUM
ct-9336	104	9	.	.	PUNCT
ct-9336	105	1	3	3	X
ct-9336	105	2	.	.	X
ct-9336	105	3	romano	romano	PROPN
ct-9336	105	4	je	je	PROPN
ct-9336	105	5	,	,	PUNCT
ct-9336	105	6	brinsko	brinsko	PROPN
ct-9336	105	7	sp	sp	NOUN
ct-9336	105	8	,	,	PUNCT
ct-9336	105	9	blanchard	blanchard	PROPN
ct-9336	105	10	tl	tl	PROPN
ct-9336	105	11	,	,	PUNCT
ct-9336	105	12	et	et	PROPN
ct-9336	105	13	al	al	PROPN
ct-9336	105	14	:	:	PUNCT
ct-9336	105	15	male	male	ADJ
ct-9336	105	16	reproductive	reproductive	ADJ
ct-9336	105	17	disorders	disorder	NOUN
ct-9336	105	18	.	.	PUNCT
ct-9336	106	1	in	in	ADP
ct-9336	106	2	:	:	PUNCT
ct-9336	106	3	smith	smith	PROPN
ct-9336	106	4	bp	bp	PROPN
ct-9336	106	5	,	,	PUNCT
ct-9336	106	6	van	van	NOUN
ct-9336	106	7	metre	metre	NOUN
ct-9336	106	8	d	d	PROPN
ct-9336	106	9	,	,	PUNCT
ct-9336	106	10	pusterla	pusterla	NOUN
ct-9336	106	11	n	n	CCONJ
ct-9336	106	12	,	,	PUNCT
ct-9336	106	13	editors	editor	NOUN
ct-9336	106	14	.	.	PUNCT
ct-9336	107	1	large	large	ADJ
ct-9336	107	2	animal	animal	NOUN
ct-9336	107	3	internal	internal	ADJ
ct-9336	107	4	medicine	medicine	NOUN
ct-9336	107	5	.	.	PUNCT
ct-9336	108	1	6th	6th	ADJ
ct-9336	108	2	edition	edition	PROPN
ct-9336	108	3	,	,	PUNCT
ct-9336	108	4	st	st	PROPN
ct-9336	108	5	.	.	PROPN
ct-9336	108	6	louis	louis	PROPN
ct-9336	108	7	,	,	PUNCT
ct-9336	108	8	mo	mo	PROPN
ct-9336	108	9	;	;	PUNCT
ct-9336	108	10	elsevier	elsevier	NOUN
ct-9336	108	11	:	:	PUNCT
ct-9336	108	12	2020	2020	NUM
ct-9336	108	13	.	.	PUNCT
ct-9336	109	1	p.	p.	NOUN
ct-9336	109	2	1505	1505	NUM
ct-9336	109	3	-	-	SYM
ct-9336	109	4	1519	1519	NUM
ct-9336	109	5	.	.	PUNCT
ct-9336	110	1	4	4	X
ct-9336	110	2	.	.	X
ct-9336	110	3	ball	ball	NOUN
ct-9336	110	4	l	l	NOUN
ct-9336	110	5	,	,	PUNCT
ct-9336	110	6	griner	griner	NOUN
ct-9336	110	7	la	la	PROPN
ct-9336	110	8	,	,	PUNCT
ct-9336	110	9	carroll	carroll	PROPN
ct-9336	110	10	ej	ej	PROPN
ct-9336	110	11	:	:	PUNCT
ct-9336	110	12	the	the	DET
ct-9336	110	13	bovine	bovine	ADJ
ct-9336	110	14	seminal	seminal	ADJ
ct-9336	110	15	vesiculitis	vesiculitis	PROPN
ct-9336	110	16	syndrome	syndrome	NOUN
ct-9336	110	17	.	.	PUNCT
ct-9336	111	1	amer	amer	PROPN
ct-9336	111	2	j	j	PROPN
ct-9336	111	3	vet	vet	NOUN
ct-9336	111	4	res	re	NOUN
ct-9336	111	5	1964;25:291	1964;25:291	NUM
ct-9336	111	6	-	-	SYM
ct-9336	111	7	302	302	NUM
ct-9336	111	8	.	.	NOUN
ct-9336	111	9	5	5	NUM
ct-9336	111	10	.	.	X
ct-9336	111	11	martínez	martínez	PROPN
ct-9336	111	12	mf	mf	PROPN
ct-9336	111	13	,	,	PUNCT
ct-9336	111	14	arteaga	arteaga	NOUN
ct-9336	111	15	aa	aa	PROPN
ct-9336	111	16	,	,	PUNCT
ct-9336	111	17	barth	barth	NOUN
ct-9336	111	18	ad	ad	NOUN
ct-9336	111	19	:	:	PUNCT
ct-9336	111	20	intraglandular	intraglandular	ADJ
ct-9336	111	21	injection	injection	NOUN
ct-9336	111	22	of	of	ADP
ct-9336	111	23	antibiotics	antibiotic	NOUN
ct-9336	111	24	for	for	ADP
ct-9336	111	25	the	the	DET
ct-9336	111	26	treatment	treatment	NOUN
ct-9336	111	27	of	of	ADP
ct-9336	111	28	vesicular	vesicular	ADJ
ct-9336	111	29	adenitis	adenitis	NOUN
ct-9336	111	30	in	in	ADP
ct-9336	111	31	bulls	bull	NOUN
ct-9336	111	32	.	.	PUNCT
ct-9336	112	1	anim	anim	PROPN
ct-9336	112	2	reprod	reprod	PROPN
ct-9336	112	3	sci	sci	PROPN
ct-9336	112	4	2008;104:201	2008;104:201	NUM
ct-9336	112	5	-	-	SYM
ct-9336	112	6	211	211	NUM
ct-9336	112	7	.	.	PUNCT
ct-9336	113	1	6	6	NUM
ct-9336	113	2	.	.	X
ct-9336	113	3	martínez	martínez	PROPN
ct-9336	113	4	mf	mf	PROPN
ct-9336	113	5	,	,	PUNCT
ct-9336	113	6	barth	barth	NOUN
ct-9336	113	7	ad	ad	NOUN
ct-9336	113	8	:	:	PUNCT
ct-9336	113	9	early	early	ADJ
ct-9336	113	10	detection	detection	NOUN
ct-9336	113	11	and	and	CCONJ
ct-9336	113	12	treatment	treatment	NOUN
ct-9336	113	13	of	of	ADP
ct-9336	113	14	vesicular	vesicular	ADJ
ct-9336	113	15	adenitis	adenitis	NOUN
ct-9336	113	16	in	in	ADP
ct-9336	113	17	bulls	bull	NOUN
ct-9336	113	18	.	.	PUNCT
ct-9336	114	1	anim	anim	PROPN
ct-9336	114	2	reprod	reprod	PROPN
ct-9336	114	3	sci	sci	PROPN
ct-9336	114	4	2007;101:252	2007;101:252	NUM
ct-9336	114	5	-	-	PUNCT
ct-9336	114	6	256	256	NUM
ct-9336	114	7	.	.	NOUN
ct-9336	114	8	7	7	X
ct-9336	114	9	.	.	X
ct-9336	115	1	srinivasan	srinivasan	NOUN
ct-9336	115	2	a	a	PRON
ct-9336	115	3	:	:	PUNCT
ct-9336	115	4	antibiotic	antibiotic	ADJ
ct-9336	115	5	stewardship	stewardship	NOUN
ct-9336	115	6	:	:	PUNCT
ct-9336	115	7	why	why	SCONJ
ct-9336	115	8	we	we	PRON
ct-9336	115	9	must	must	AUX
ct-9336	115	10	,	,	PUNCT
ct-9336	115	11	how	how	SCONJ
ct-9336	115	12	we	we	PRON
ct-9336	115	13	can	can	AUX
ct-9336	115	14	.	.	PUNCT
ct-9336	116	1	cleve	cleve	PROPN
ct-9336	116	2	clin	clin	PROPN
ct-9336	116	3	j	j	PROPN
ct-9336	116	4	med	med	PROPN
ct-9336	116	5	2017;84:673	2017;84:673	PROPN
ct-9336	116	6	-	-	PUNCT
ct-9336	116	7	679	679	NUM
ct-9336	116	8	.	.	PUNCT
ct-9336	117	1	8	8	X
ct-9336	117	2	.	.	PUNCT
ct-9336	117	3	bulitta	bulitta	PROPN
ct-9336	117	4	jb	jb	PROPN
ct-9336	117	5	,	,	PUNCT
ct-9336	117	6	kinzig	kinzig	PROPN
ct-9336	117	7	m	m	PROPN
ct-9336	117	8	,	,	PUNCT
ct-9336	117	9	naber	naber	PROPN
ct-9336	117	10	ck	ck	PROPN
ct-9336	117	11	,	,	PUNCT
ct-9336	117	12	et	et	PROPN
ct-9336	117	13	al	al	PROPN
ct-9336	117	14	:	:	PUNCT
ct-9336	117	15	population	population	NOUN
ct-9336	117	16	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	117	17	and	and	CCONJ
ct-9336	117	18	penetration	penetration	NOUN
ct-9336	117	19	into	into	ADP
ct-9336	117	20	prostatic	prostatic	ADJ
ct-9336	117	21	,	,	PUNCT
ct-9336	117	22	seminal	seminal	ADJ
ct-9336	117	23	,	,	PUNCT
ct-9336	117	24	and	and	CCONJ
ct-9336	117	25	vaginal	vaginal	ADJ
ct-9336	117	26	fluid	fluid	NOUN
ct-9336	117	27	for	for	ADP
ct-9336	117	28	ciprofloxacin	ciprofloxacin	NOUN
ct-9336	117	29	,	,	PUNCT
ct-9336	117	30	levofloxacin	levofloxacin	PROPN
ct-9336	117	31	,	,	PUNCT
ct-9336	117	32	and	and	CCONJ
ct-9336	117	33	their	their	PRON
ct-9336	117	34	combination	combination	NOUN
ct-9336	117	35	.	.	PUNCT
ct-9336	118	1	chemotherapy	chemotherapy	NOUN
ct-9336	118	2	2011;57:402	2011;57:402	PROPN
ct-9336	118	3	-	-	SYM
ct-9336	118	4	416	416	NUM
ct-9336	118	5	.	.	NOUN
ct-9336	119	1	9	9	X
ct-9336	119	2	.	.	X
ct-9336	119	3	frimodt	frimodt	NOUN
ct-9336	119	4	-	-	PUNCT
ct-9336	119	5	møller	møller	NOUN
ct-9336	119	6	pc	pc	NOUN
ct-9336	119	7	,	,	PUNCT
ct-9336	119	8	dørflinger	dørflinger	NOUN
ct-9336	119	9	t	t	PROPN
ct-9336	119	10	,	,	PUNCT
ct-9336	119	11	madsen	madsen	PROPN
ct-9336	119	12	po	po	PROPN
ct-9336	119	13	:	:	PUNCT
ct-9336	119	14	distribution	distribution	NOUN
ct-9336	119	15	of	of	ADP
ct-9336	119	16	ciprofloxacin	ciprofloxacin	NOUN
ct-9336	119	17	in	in	ADP
ct-9336	119	18	the	the	DET
ct-9336	119	19	dog	dog	NOUN
ct-9336	119	20	prostate	prostate	NOUN
ct-9336	119	21	and	and	CCONJ
ct-9336	119	22	various	various	ADJ
ct-9336	119	23	tissues	tissue	NOUN
ct-9336	119	24	.	.	PUNCT
ct-9336	120	1	urol	urol	PROPN
ct-9336	120	2	res	re	NOUN
ct-9336	120	3	1984;12:283	1984;12:283	PROPN
ct-9336	120	4	-	-	PUNCT
ct-9336	120	5	286	286	NUM
ct-9336	120	6	.	.	PUNCT
ct-9336	121	1	10	10	NUM
ct-9336	121	2	.	.	PUNCT
ct-9336	122	1	naber	naber	PROPN
ct-9336	122	2	ck	ck	PROPN
ct-9336	122	3	,	,	PUNCT
ct-9336	122	4	steghafner	steghafn	ADJ
ct-9336	122	5	m	m	PROPN
ct-9336	122	6	,	,	PUNCT
ct-9336	122	7	kinzig	kinzig	PROPN
ct-9336	122	8	-	-	PUNCT
ct-9336	122	9	schippers	schipper	NOUN
ct-9336	122	10	m	m	PROPN
ct-9336	122	11	,	,	PUNCT
ct-9336	122	12	et	et	PROPN
ct-9336	122	13	al	al	PROPN
ct-9336	122	14	:	:	PUNCT
ct-9336	122	15	concentrations	concentration	NOUN
ct-9336	122	16	of	of	ADP
ct-9336	122	17	gatifloxacin	gatifloxacin	NOUN
ct-9336	122	18	in	in	ADP
ct-9336	122	19	plasma	plasma	NOUN
ct-9336	122	20	and	and	CCONJ
ct-9336	122	21	urine	urine	NOUN
ct-9336	122	22	and	and	CCONJ
ct-9336	122	23	penetration	penetration	NOUN
ct-9336	122	24	into	into	ADP
ct-9336	122	25	prostatic	prostatic	ADJ
ct-9336	122	26	and	and	CCONJ
ct-9336	122	27	seminal	seminal	ADJ
ct-9336	122	28	fluid	fluid	NOUN
ct-9336	122	29	,	,	PUNCT
ct-9336	122	30	ejaculate	ejaculate	NOUN
ct-9336	122	31	,	,	PUNCT
ct-9336	122	32	and	and	CCONJ
ct-9336	122	33	sperm	sperm	NOUN
ct-9336	122	34	cells	cell	NOUN
ct-9336	122	35	after	after	ADP
ct-9336	122	36	single	single	ADJ
ct-9336	122	37	oral	oral	ADJ
ct-9336	122	38	administrations	administration	NOUN
ct-9336	122	39	of	of	ADP
ct-9336	122	40	400	400	NUM
ct-9336	122	41	milligrams	milligram	NOUN
ct-9336	122	42	to	to	ADP
ct-9336	122	43	volunteers	volunteer	NOUN
ct-9336	122	44	.	.	PUNCT
ct-9336	123	1	antimicrob	antimicrob	PROPN
ct-9336	123	2	agents	agent	NOUN
ct-9336	123	3	chemother	chemother	PROPN
ct-9336	123	4	2001;45:293	2001;45:293	NOUN
ct-9336	123	5	-	-	SYM
ct-9336	123	6	297	297	NUM
ct-9336	123	7	.	.	PUNCT
ct-9336	123	8	11	11	NUM
ct-9336	123	9	.	.	X
ct-9336	124	1	romano	romano	PROPN
ct-9336	124	2	je	je	PROPN
ct-9336	124	3	,	,	PUNCT
ct-9336	124	4	brinsko	brinsko	PROPN
ct-9336	124	5	s	s	PART
ct-9336	124	6	:	:	PUNCT
ct-9336	124	7	reproductive	reproductive	ADJ
ct-9336	124	8	physiology	physiology	NOUN
ct-9336	124	9	of	of	ADP
ct-9336	124	10	the	the	DET
ct-9336	124	11	male	male	NOUN
ct-9336	124	12	.	.	PUNCT
ct-9336	125	1	in	in	ADP
ct-9336	125	2	:	:	PUNCT
ct-9336	125	3	bradley	bradley	PROPN
ct-9336	125	4	g.	g.	PROPN
ct-9336	125	5	klein	klein	PROPN
ct-9336	125	6	,	,	PUNCT
ct-9336	125	7	editor	editor	NOUN
ct-9336	125	8	.	.	PUNCT
ct-9336	126	1	cunningham	cunningham	PROPN
ct-9336	126	2	’s	’s	PART
ct-9336	126	3	textbook	textbook	NOUN
ct-9336	126	4	of	of	ADP
ct-9336	126	5	veterinary	veterinary	ADJ
ct-9336	126	6	physiology	physiology	NOUN
ct-9336	126	7	.	.	PUNCT
ct-9336	127	1	6th	6th	ADJ
ct-9336	127	2	edition	edition	PROPN
ct-9336	127	3	,	,	PUNCT
ct-9336	127	4	st	st	PROPN
ct-9336	127	5	.	.	PROPN
ct-9336	127	6	louis	louis	PROPN
ct-9336	127	7	,	,	PUNCT
ct-9336	127	8	mo	mo	PROPN
ct-9336	127	9	;	;	PUNCT
ct-9336	127	10	saunders	saunders	PROPN
ct-9336	127	11	&	&	CCONJ
ct-9336	127	12	elsevier	elsevier	PROPN
ct-9336	127	13	:	:	PUNCT
ct-9336	127	14	2020	2020	NUM
ct-9336	127	15	.	.	PUNCT
ct-9336	128	1	p.	p.	NOUN
ct-9336	128	2	471	471	NUM
ct-9336	128	3	-	-	SYM
ct-9336	128	4	479	479	NUM
ct-9336	128	5	.	.	PUNCT
ct-9336	129	1	12	12	NUM
ct-9336	129	2	.	.	PUNCT
ct-9336	130	1	baxter	baxter	PROPN
ct-9336	130	2	p	p	PROPN
ct-9336	130	3	,	,	PUNCT
ct-9336	130	4	mckellar	mckellar	PROPN
ct-9336	130	5	q	q	NOUN
ct-9336	130	6	:	:	PUNCT
ct-9336	130	7	plasma	plasma	NOUN
ct-9336	130	8	and	and	CCONJ
ct-9336	130	9	lung	lung	NOUN
ct-9336	130	10	concentrations	concentration	NOUN
ct-9336	130	11	of	of	ADP
ct-9336	130	12	oxytetracycline	oxytetracycline	NOUN
ct-9336	130	13	after	after	ADP
ct-9336	130	14	its	its	PRON
ct-9336	130	15	intramuscular	intramuscular	ADJ
ct-9336	130	16	administration	administration	NOUN
ct-9336	130	17	in	in	ADP
ct-9336	130	18	rats	rat	NOUN
ct-9336	130	19	.	.	PUNCT
ct-9336	131	1	lab	lab	NOUN
ct-9336	131	2	anim	anim	NOUN
ct-9336	131	3	sci	sci	PROPN
ct-9336	131	4	1995;45:107	1995;45:107	PROPN
ct-9336	131	5	-	-	SYM
ct-9336	131	6	109	109	NUM
ct-9336	131	7	.	.	NOUN
ct-9336	131	8	13	13	NUM
ct-9336	131	9	.	.	PUNCT
ct-9336	132	1	evans	evans	PROPN
ct-9336	132	2	na	na	NOUN
ct-9336	132	3	:	:	PUNCT
ct-9336	132	4	tulathromycin	tulathromycin	NOUN
ct-9336	132	5	:	:	PUNCT
ct-9336	132	6	an	an	DET
ct-9336	132	7	overview	overview	NOUN
ct-9336	132	8	of	of	ADP
ct-9336	132	9	a	a	DET
ct-9336	132	10	new	new	ADJ
ct-9336	132	11	triamilide	triamilide	NOUN
ct-9336	132	12	antimicrobial	antimicrobial	NOUN
ct-9336	132	13	for	for	ADP
ct-9336	132	14	livestock	livestock	NOUN
ct-9336	132	15	respiratory	respiratory	ADJ
ct-9336	132	16	disease	disease	NOUN
ct-9336	132	17	.	.	PUNCT
ct-9336	133	1	vet	vet	NOUN
ct-9336	133	2	ther	ther	ADV
ct-9336	133	3	2005;6:83	2005;6:83	NOUN
ct-9336	133	4	-	-	PUNCT
ct-9336	133	5	95	95	NUM
ct-9336	133	6	.	.	PUNCT
ct-9336	134	1	14	14	NUM
ct-9336	134	2	.	.	PUNCT
ct-9336	135	1	villarino	villarino	PROPN
ct-9336	135	2	n	n	CCONJ
ct-9336	135	3	,	,	PUNCT
ct-9336	135	4	brown	brown	PROPN
ct-9336	135	5	sa	sa	PROPN
ct-9336	135	6	,	,	PUNCT
ct-9336	135	7	martín	martín	PROPN
ct-9336	135	8	-	-	PUNCT
ct-9336	135	9	jiménez	jiménez	PROPN
ct-9336	135	10	t	t	PROPN
ct-9336	135	11	:	:	PUNCT
ct-9336	135	12	the	the	DET
ct-9336	135	13	role	role	NOUN
ct-9336	135	14	of	of	ADP
ct-9336	135	15	the	the	DET
ct-9336	135	16	macrolide	macrolide	ADJ
ct-9336	135	17	tulathromycin	tulathromycin	NOUN
ct-9336	135	18	in	in	ADP
ct-9336	135	19	veterinary	veterinary	ADJ
ct-9336	135	20	medicine	medicine	NOUN
ct-9336	135	21	.	.	PUNCT
ct-9336	136	1	vet	vet	NOUN
ct-9336	136	2	j	j	PROPN
ct-9336	136	3	2013;198:352	2013;198:352	NUM
ct-9336	136	4	-	-	SYM
ct-9336	136	5	357	357	NUM
ct-9336	136	6	.	.	NOUN
ct-9336	136	7	15	15	NUM
ct-9336	136	8	.	.	PUNCT
ct-9336	137	1	nowakowski	nowakowski	PROPN
ct-9336	137	2	m	m	PROPN
ct-9336	137	3	,	,	PUNCT
ct-9336	137	4	inskeep	inskeep	VERB
ct-9336	137	5	p	p	NOUN
ct-9336	137	6	,	,	PUNCT
ct-9336	137	7	risk	risk	NOUN
ct-9336	137	8	j	j	PROPN
ct-9336	137	9	,	,	PUNCT
ct-9336	137	10	et	et	PROPN
ct-9336	137	11	al	al	PROPN
ct-9336	137	12	:	:	PUNCT
ct-9336	137	13	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	137	14	and	and	CCONJ
ct-9336	137	15	lung	lung	NOUN
ct-9336	137	16	tissue	tissue	NOUN
ct-9336	137	17	concentrations	concentration	NOUN
ct-9336	137	18	of	of	ADP
ct-9336	137	19	tulathromycin	tulathromycin	NOUN
ct-9336	137	20	,	,	PUNCT
ct-9336	137	21	a	a	DET
ct-9336	137	22	new	new	ADJ
ct-9336	137	23	triamilide	triamilide	NOUN
ct-9336	137	24	antibiotic	antibiotic	NOUN
ct-9336	137	25	in	in	ADP
ct-9336	137	26	cattle	cattle	NOUN
ct-9336	137	27	.	.	PUNCT
ct-9336	138	1	vet	vet	NOUN
ct-9336	138	2	ther	ther	ADV
ct-9336	138	3	2004;5:1	2004;5:1	NOUN
ct-9336	138	4	-	-	SYM
ct-9336	138	5	7	7	NUM
ct-9336	138	6	.	.	NOUN
ct-9336	138	7	16	16	NUM
ct-9336	138	8	.	.	PUNCT
ct-9336	139	1	koziol	koziol	PROPN
ct-9336	139	2	jh	jh	PROPN
ct-9336	139	3	,	,	PUNCT
ct-9336	139	4	armstrong	armstrong	PROPN
ct-9336	139	5	cl	cl	PROPN
ct-9336	139	6	:	:	PUNCT
ct-9336	139	7	manual	manual	NOUN
ct-9336	139	8	for	for	ADP
ct-9336	139	9	breeding	breed	VERB
ct-9336	139	10	soundness	soundness	NOUN
ct-9336	139	11	examination	examination	NOUN
ct-9336	139	12	of	of	ADP
ct-9336	139	13	bulls	bull	NOUN
ct-9336	139	14	.	.	PUNCT
ct-9336	140	1	society	society	NOUN
ct-9336	140	2	for	for	ADP
ct-9336	140	3	theriogenology	theriogenology	NOUN
ct-9336	140	4	:	:	PUNCT
ct-9336	140	5	2nd	2nd	PROPN
ct-9336	140	6	edition	edition	NOUN
ct-9336	140	7	,	,	PUNCT
ct-9336	140	8	2018	2018	NUM
ct-9336	140	9	.	.	PUNCT
ct-9336	141	1	p.	p.	NOUN
ct-9336	141	2	147	147	NUM
ct-9336	141	3	.	.	PUNCT
ct-9336	142	1	17	17	NUM
ct-9336	142	2	.	.	PUNCT
ct-9336	143	1	richards	richards	PROPN
ct-9336	143	2	mw	mw	PROPN
ct-9336	143	3	,	,	PUNCT
ct-9336	143	4	spitzer	spitzer	PROPN
ct-9336	143	5	jc	jc	PROPN
ct-9336	143	6	,	,	PUNCT
ct-9336	143	7	warner	warner	PROPN
ct-9336	143	8	mb	mb	PROPN
ct-9336	143	9	:	:	PUNCT
ct-9336	143	10	effect	effect	NOUN
ct-9336	143	11	of	of	ADP
ct-9336	143	12	varying	vary	VERB
ct-9336	143	13	levels	level	NOUN
ct-9336	143	14	of	of	ADP
ct-9336	143	15	postpartum	postpartum	NOUN
ct-9336	143	16	nutrition	nutrition	NOUN
ct-9336	143	17	and	and	CCONJ
ct-9336	143	18	body	body	NOUN
ct-9336	143	19	condition	condition	NOUN
ct-9336	143	20	at	at	ADP
ct-9336	143	21	calving	calve	VERB
ct-9336	143	22	on	on	ADP
ct-9336	143	23	subsequent	subsequent	ADJ
ct-9336	143	24	reproductive	reproductive	ADJ
ct-9336	143	25	performance	performance	NOUN
ct-9336	143	26	in	in	ADP
ct-9336	143	27	beef	beef	NOUN
ct-9336	143	28	cattle	cattle	NOUN
ct-9336	143	29	.	.	PUNCT
ct-9336	144	1	j	j	PROPN
ct-9336	144	2	anim	anim	NOUN
ct-9336	144	3	sci	sci	PROPN
ct-9336	144	4	1986	1986	NUM
ct-9336	144	5	;	;	PUNCT
ct-9336	144	6	62:300	62:300	NUM
ct-9336	144	7	-	-	SYM
ct-9336	144	8	306	306	NUM
ct-9336	144	9	.	.	PUNCT
ct-9336	144	10	18	18	NUM
ct-9336	144	11	.	.	X
ct-9336	145	1	bayliss	bayliss	PROPN
ct-9336	145	2	maj	maj	PROPN
ct-9336	145	3	,	,	PUNCT
ct-9336	145	4	rigdova	rigdova	X
ct-9336	145	5	k	k	NOUN
ct-9336	145	6	,	,	PUNCT
ct-9336	145	7	kyriakides	kyriakide	VERB
ct-9336	145	8	m	m	PROPN
ct-9336	145	9	,	,	PUNCT
ct-9336	145	10	et	et	PROPN
ct-9336	145	11	al	al	PROPN
ct-9336	145	12	:	:	PUNCT
ct-9336	145	13	development	development	NOUN
ct-9336	145	14	,	,	PUNCT
ct-9336	145	15	validation	validation	NOUN
ct-9336	145	16	and	and	CCONJ
ct-9336	145	17	application	application	NOUN
ct-9336	145	18	of	of	ADP
ct-9336	145	19	a	a	DET
ct-9336	145	20	novel	novel	ADJ
ct-9336	145	21	hplc	hplc	NOUN
ct-9336	145	22	-	-	PUNCT
ct-9336	145	23	ms	ms	PROPN
ct-9336	145	24	/	/	SYM
ct-9336	145	25	ms	ms	PROPN
ct-9336	145	26	method	method	NOUN
ct-9336	145	27	for	for	ADP
ct-9336	145	28	the	the	DET
ct-9336	145	29	measurement	measurement	NOUN
ct-9336	145	30	of	of	ADP
ct-9336	145	31	minocycline	minocycline	NOUN
ct-9336	145	32	in	in	ADP
ct-9336	145	33	human	human	ADJ
ct-9336	145	34	plasma	plasma	NOUN
ct-9336	145	35	and	and	CCONJ
ct-9336	145	36	urine	urine	NOUN
ct-9336	145	37	.	.	PUNCT
ct-9336	146	1	j	j	PROPN
ct-9336	146	2	pharm	pharm	PROPN
ct-9336	146	3	biomed	biome	VERB
ct-9336	146	4	anal	anal	ADJ
ct-9336	146	5	2019;30:90	2019;30:90	NUM
ct-9336	146	6	-	-	SYM
ct-9336	146	7	98	98	NUM
ct-9336	146	8	.	.	PUNCT
ct-9336	147	1	19	19	NUM
ct-9336	147	2	.	.	PUNCT
ct-9336	148	1	zhou	zhou	PROPN
ct-9336	149	1	q	q	PROPN
ct-9336	149	2	,	,	PUNCT
ct-9336	149	3	zhang	zhang	PROPN
ct-9336	149	4	g	g	PROPN
ct-9336	149	5	,	,	PUNCT
ct-9336	149	6	wang	wang	PROPN
ct-9336	149	7	q	q	PROPN
ct-9336	149	8	,	,	PUNCT
ct-9336	149	9	et	et	PROPN
ct-9336	149	10	al	al	PROPN
ct-9336	149	11	:	:	PUNCT
ct-9336	149	12	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	149	13	/	/	SYM
ct-9336	149	14	pharmacodynamic	pharmacodynamic	ADJ
ct-9336	149	15	modelling	modelling	NOUN
ct-9336	149	16	of	of	ADP
ct-9336	149	17	tulathromycin	tulathromycin	NOUN
ct-9336	149	18	against	against	ADP
ct-9336	149	19	pasteurella	pasteurella	PROPN
ct-9336	149	20	multocida	multocida	PROPN
ct-9336	149	21	in	in	ADP
ct-9336	149	22	a	a	DET
ct-9336	149	23	porcine	porcine	NOUN
ct-9336	149	24	tissue	tissue	NOUN
ct-9336	149	25	cage	cage	NOUN
ct-9336	149	26	model	model	NOUN
ct-9336	149	27	.	.	PUNCT
ct-9336	150	1	front	front	ADJ
ct-9336	150	2	pharmacol	pharmacol	PROPN
ct-9336	150	3	2017;28;8:392	2017;28;8:392	NUM
ct-9336	150	4	.	.	PROPN
ct-9336	150	5	20	20	NUM
ct-9336	150	6	.	.	PUNCT
ct-9336	151	1	zhang	zhang	PROPN
ct-9336	151	2	y	y	PROPN
ct-9336	151	3	,	,	PUNCT
ct-9336	151	4	huo	huo	PROPN
ct-9336	151	5	m	m	PROPN
ct-9336	151	6	,	,	PUNCT
ct-9336	151	7	zhou	zhou	PROPN
ct-9336	151	8	j	j	PROPN
ct-9336	151	9	,	,	PUNCT
ct-9336	151	10	et	et	PROPN
ct-9336	151	11	al	al	PROPN
ct-9336	151	12	:	:	PUNCT
ct-9336	151	13	pk	pk	NOUN
ct-9336	151	14	-	-	ADJ
ct-9336	151	15	solver	solver	NOUN
ct-9336	151	16	:	:	PUNCT
ct-9336	151	17	an	an	DET
ct-9336	151	18	add	add	VERB
ct-9336	151	19	-	-	PUNCT
ct-9336	151	20	in	in	ADP
ct-9336	151	21	program	program	NOUN
ct-9336	151	22	for	for	ADP
ct-9336	151	23	clinical	clinical	ADJ
ct-9336	151	24	theriogenology	theriogenology	NOUN
ct-9336	151	25	2021	2021	NUM
ct-9336	151	26	;	;	PUNCT
ct-9336	151	27	13	13	NUM
ct-9336	151	28	:	:	SYM
ct-9336	151	29	209	209	NUM
ct-9336	151	30	pharmacokinetic	pharmacokinetic	ADJ
ct-9336	151	31	and	and	CCONJ
ct-9336	151	32	pharmacodynamic	pharmacodynamic	ADJ
ct-9336	151	33	data	datum	NOUN
ct-9336	151	34	analysis	analysis	NOUN
ct-9336	151	35	in	in	ADP
ct-9336	151	36	microsoft	microsoft	PROPN
ct-9336	151	37	excel	excel	PROPN
ct-9336	151	38	.	.	PUNCT
ct-9336	152	1	comput	comput	NOUN
ct-9336	152	2	methods	method	NOUN
ct-9336	152	3	programs	program	NOUN
ct-9336	152	4	biomed	biome	VERB
ct-9336	152	5	2010;99:306	2010;99:306	NOUN
ct-9336	152	6	-	-	SYM
ct-9336	152	7	314	314	NUM
ct-9336	152	8	.	.	PUNCT
ct-9336	153	1	21	21	NUM
ct-9336	153	2	.	.	PUNCT
ct-9336	154	1	minitab	minitab	PROPN
ct-9336	154	2	17	17	NUM
ct-9336	154	3	:	:	PUNCT
ct-9336	154	4	minitab	minitab	PROPN
ct-9336	154	5	inc	inc	PROPN
ct-9336	154	6	.	.	PROPN
ct-9336	154	7	state	state	PROPN
ct-9336	154	8	college	college	PROPN
ct-9336	154	9	,	,	PUNCT
ct-9336	154	10	pa	pa	PROPN
ct-9336	154	11	,	,	PUNCT
ct-9336	154	12	usa	usa	PROPN
ct-9336	154	13	.	.	PROPN
ct-9336	154	14	22	22	NUM
ct-9336	154	15	.	.	PUNCT
ct-9336	155	1	rasmussen	rasmussen	PROPN
ct-9336	155	2	f	f	PROPN
ct-9336	155	3	,	,	PUNCT
ct-9336	155	4	ladefoged	ladefoge	VERB
ct-9336	155	5	o	o	NOUN
ct-9336	155	6	:	:	PUNCT
ct-9336	155	7	tissue	tissue	NOUN
ct-9336	155	8	damage	damage	NOUN
ct-9336	155	9	at	at	ADP
ct-9336	155	10	the	the	DET
ct-9336	155	11	injection	injection	NOUN
ct-9336	155	12	site	site	NOUN
ct-9336	155	13	after	after	ADP
ct-9336	155	14	intramuscular	intramuscular	ADJ
ct-9336	155	15	injection	injection	NOUN
ct-9336	155	16	of	of	ADP
ct-9336	155	17	drug	drug	NOUN
ct-9336	155	18	preparations	preparation	NOUN
ct-9336	155	19	formulated	formulate	VERB
ct-9336	155	20	by	by	ADP
ct-9336	155	21	addition	addition	NOUN
ct-9336	155	22	of	of	ADP
ct-9336	155	23	polyvinyl	polyvinyl	NOUN
ct-9336	155	24	-	-	PUNCT
ct-9336	155	25	pyrrolidone	pyrrolidone	NOUN
ct-9336	155	26	.	.	PUNCT
ct-9336	156	1	acta	acta	PROPN
ct-9336	156	2	vet	vet	PROPN
ct-9336	156	3	scand	scand	PROPN
ct-9336	156	4	1974;15:636	1974;15:636	PROPN
ct-9336	156	5	-	-	NOUN
ct-9336	156	6	638	638	NUM
ct-9336	156	7	.	.	PUNCT
ct-9336	156	8	23	23	NUM
ct-9336	156	9	.	.	X
ct-9336	157	1	nouws	nouws	PROPN
ct-9336	157	2	jfm	jfm	PROPN
ct-9336	157	3	,	,	PUNCT
ct-9336	157	4	vree	vree	NOUN
ct-9336	157	5	tb	tb	NOUN
ct-9336	157	6	:	:	PUNCT
ct-9336	157	7	effect	effect	NOUN
ct-9336	157	8	of	of	ADP
ct-9336	157	9	injection	injection	NOUN
ct-9336	157	10	site	site	NOUN
ct-9336	157	11	on	on	ADP
ct-9336	157	12	the	the	DET
ct-9336	157	13	bioavailability	bioavailability	NOUN
ct-9336	157	14	of	of	ADP
ct-9336	157	15	an	an	DET
ct-9336	157	16	oxytetracycline	oxytetracycline	ADJ
ct-9336	157	17	formulation	formulation	NOUN
ct-9336	157	18	in	in	ADP
ct-9336	157	19	ruminant	ruminant	NOUN
ct-9336	157	20	calves	calf	NOUN
ct-9336	157	21	.	.	PUNCT
ct-9336	158	1	vet	vet	NOUN
ct-9336	158	2	quart	quart	NOUN
ct-9336	158	3	1983;5:165	1983;5:165	NUM
ct-9336	158	4	-	-	SYM
ct-9336	158	5	170	170	NUM
ct-9336	158	6	.	.	PUNCT
ct-9336	159	1	24	24	NUM
ct-9336	159	2	.	.	X
ct-9336	159	3	de	de	PROPN
ct-9336	159	4	laistre	laistre	PROPN
ct-9336	159	5	banting	banting	PROPN
ct-9336	159	6	a	a	PRON
ct-9336	159	7	,	,	PUNCT
ct-9336	159	8	fanneau	fanneau	PROPN
ct-9336	159	9	de	de	PROPN
ct-9336	159	10	la	la	X
ct-9336	159	11	horie	horie	PROPN
ct-9336	159	12	gc	gc	PROPN
ct-9336	159	13	:	:	PUNCT
ct-9336	159	14	subcutaneous	subcutaneous	ADJ
ct-9336	159	15	and	and	CCONJ
ct-9336	159	16	intramuscular	intramuscular	ADJ
ct-9336	159	17	injection	injection	NOUN
ct-9336	159	18	of	of	ADP
ct-9336	159	19	oxytetracycline	oxytetracycline	NOUN
ct-9336	159	20	in	in	ADP
ct-9336	159	21	calves	calf	NOUN
ct-9336	159	22	:	:	PUNCT
ct-9336	159	23	comparison	comparison	NOUN
ct-9336	159	24	of	of	ADP
ct-9336	159	25	serum	serum	NOUN
ct-9336	159	26	concentration	concentration	NOUN
ct-9336	159	27	and	and	CCONJ
ct-9336	159	28	local	local	ADJ
ct-9336	159	29	tolerance	tolerance	NOUN
ct-9336	159	30	.	.	PUNCT
ct-9336	160	1	j	j	PROPN
ct-9336	160	2	vet	vet	NOUN
ct-9336	160	3	pharmacol	pharmacol	PROPN
ct-9336	160	4	therap	therap	NOUN
ct-9336	160	5	1987;10:184	1987;10:184	NOUN
ct-9336	160	6	-	-	SYM
ct-9336	160	7	186	186	NUM
ct-9336	160	8	.	.	PUNCT
ct-9336	160	9	25	25	NUM
ct-9336	160	10	.	.	PUNCT
ct-9336	161	1	clarke	clarke	PROPN
ct-9336	161	2	cr	cr	PROPN
ct-9336	161	3	,	,	PUNCT
ct-9336	161	4	wang	wang	PROPN
ct-9336	161	5	z	z	PROPN
ct-9336	161	6	,	,	PUNCT
ct-9336	161	7	burrows	burrow	VERB
ct-9336	161	8	ge	ge	PROPN
ct-9336	161	9	,	,	PUNCT
ct-9336	161	10	et	et	PROPN
ct-9336	161	11	al	al	PROPN
ct-9336	161	12	:	:	PUNCT
ct-9336	161	13	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	161	14	of	of	ADP
ct-9336	161	15	two	two	NUM
ct-9336	161	16	long	long	ADV
ct-9336	161	17	-	-	PUNCT
ct-9336	161	18	acting	act	VERB
ct-9336	161	19	oxytetracycline	oxytetracycline	ADJ
ct-9336	161	20	products	product	NOUN
ct-9336	161	21	administered	administer	VERB
ct-9336	161	22	subcutaneously	subcutaneously	ADV
ct-9336	161	23	and	and	CCONJ
ct-9336	161	24	intramuscularly	intramuscularly	ADV
ct-9336	161	25	.	.	PUNCT
ct-9336	162	1	j	j	PROPN
ct-9336	162	2	vet	vet	NOUN
ct-9336	162	3	pharmacol	pharmacol	PROPN
ct-9336	162	4	therap	therap	NOUN
ct-9336	162	5	1999;22:65	1999;22:65	NUM
ct-9336	162	6	-	-	SYM
ct-9336	162	7	67	67	NUM
ct-9336	162	8	.	.	PUNCT
ct-9336	162	9	26	26	NUM
ct-9336	162	10	.	.	PUNCT
ct-9336	163	1	ames	ames	PROPN
ct-9336	163	2	tr	tr	VERB
ct-9336	163	3	,	,	PUNCT
ct-9336	163	4	larson	larson	PROPN
ct-9336	163	5	vl	vl	PROPN
ct-9336	163	6	,	,	PUNCT
ct-9336	163	7	stowe	stowe	PROPN
ct-9336	163	8	cm	cm	PROPN
ct-9336	163	9	:	:	PUNCT
ct-9336	163	10	oxytetracycline	oxytetracycline	ADJ
ct-9336	163	11	concentrations	concentration	NOUN
ct-9336	163	12	in	in	ADP
ct-9336	163	13	healthy	healthy	ADJ
ct-9336	163	14	and	and	CCONJ
ct-9336	163	15	diseased	diseased	ADJ
ct-9336	163	16	calves	calf	NOUN
ct-9336	163	17	.	.	PUNCT
ct-9336	164	1	am	be	AUX
ct-9336	164	2	j	j	PROPN
ct-9336	164	3	vet	vet	NOUN
ct-9336	164	4	res	re	NOUN
ct-9336	164	5	1985;44:1353	1985;44:1353	PROPN
ct-9336	164	6	-	-	SYM
ct-9336	164	7	1357	1357	NUM
ct-9336	164	8	.	.	PUNCT
ct-9336	165	1	27	27	NUM
ct-9336	165	2	.	.	PUNCT
ct-9336	166	1	davey	davey	PROPN
ct-9336	166	2	la	la	PROPN
ct-9336	166	3	,	,	PUNCT
ct-9336	166	4	ferber	ferber	PROPN
ct-9336	166	5	mt	mt	PROPN
ct-9336	166	6	,	,	PUNCT
ct-9336	166	7	kaye	kaye	PROPN
ct-9336	166	8	b	b	PROPN
ct-9336	166	9	:	:	PUNCT
ct-9336	166	10	comparison	comparison	NOUN
ct-9336	166	11	of	of	ADP
ct-9336	166	12	the	the	DET
ct-9336	166	13	serum	serum	NOUN
ct-9336	166	14	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	166	15	of	of	ADP
ct-9336	166	16	a	a	DET
ct-9336	166	17	long	long	ADJ
ct-9336	166	18	acting	acting	NOUN
ct-9336	166	19	and	and	CCONJ
ct-9336	166	20	a	a	DET
ct-9336	166	21	conventional	conventional	ADJ
ct-9336	166	22	oxytetracycline	oxytetracycline	ADJ
ct-9336	166	23	injection	injection	NOUN
ct-9336	166	24	.	.	PUNCT
ct-9336	167	1	vet	vet	NOUN
ct-9336	167	2	rec	rec	X
ct-9336	167	3	1985;117:426	1985;117:426	NUM
ct-9336	167	4	-	-	SYM
ct-9336	167	5	429	429	NUM
ct-9336	167	6	.	.	PUNCT
ct-9336	167	7	28	28	NUM
ct-9336	167	8	.	.	PUNCT
ct-9336	168	1	mevius	mevius	PROPN
ct-9336	168	2	dj	dj	PROPN
ct-9336	168	3	,	,	PUNCT
ct-9336	168	4	nouws	nouws	PROPN
ct-9336	168	5	jfm	jfm	PROPN
ct-9336	168	6	,	,	PUNCT
ct-9336	168	7	breukink	breukink	PROPN
ct-9336	168	8	hj	hj	PROPN
ct-9336	168	9	,	,	PUNCT
ct-9336	168	10	et	et	PROPN
ct-9336	168	11	al	al	PROPN
ct-9336	168	12	:	:	PUNCT
ct-9336	168	13	comparative	comparative	ADJ
ct-9336	168	14	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	168	15	,	,	PUNCT
ct-9336	168	16	bioavailability	bioavailability	NOUN
ct-9336	168	17	and	and	CCONJ
ct-9336	168	18	renal	renal	ADJ
ct-9336	168	19	clearance	clearance	NOUN
ct-9336	168	20	of	of	ADP
ct-9336	168	21	five	five	NUM
ct-9336	168	22	parenteral	parenteral	ADJ
ct-9336	168	23	oxytetracycline‐20	oxytetracycline‐20	NOUN
ct-9336	168	24	%	%	NOUN
ct-9336	168	25	formulations	formulation	NOUN
ct-9336	168	26	in	in	ADP
ct-9336	168	27	dairy	dairy	NOUN
ct-9336	168	28	cows	cow	NOUN
ct-9336	168	29	,	,	PUNCT
ct-9336	168	30	vet	vet	NOUN
ct-9336	168	31	quart	quart	NOUN
ct-9336	168	32	1986;8:285	1986;8:285	NUM
ct-9336	168	33	-	-	SYM
ct-9336	168	34	294	294	NUM
ct-9336	168	35	.	.	PUNCT
ct-9336	169	1	29	29	NUM
ct-9336	169	2	.	.	PUNCT
ct-9336	170	1	breeze	breeze	ADJ
ct-9336	170	2	r	r	NOUN
ct-9336	170	3	,	,	PUNCT
ct-9336	170	4	gay	gay	NOUN
ct-9336	170	5	c	c	NOUN
ct-9336	170	6	:	:	PUNCT
ct-9336	170	7	plasma	plasma	NOUN
ct-9336	170	8	levels	level	NOUN
ct-9336	170	9	of	of	ADP
ct-9336	170	10	a	a	DET
ct-9336	170	11	long	long	ADV
ct-9336	170	12	-	-	PUNCT
ct-9336	170	13	acting	act	VERB
ct-9336	170	14	oxytetracycline	oxytetracycline	NOUN
ct-9336	170	15	in	in	ADP
ct-9336	170	16	cattle	cattle	NOUN
ct-9336	170	17	.	.	PUNCT
ct-9336	171	1	bov	bov	PROPN
ct-9336	171	2	pract	pract	PROPN
ct-9336	171	3	1981;16:22	1981;16:22	NUM
ct-9336	171	4	-	-	SYM
ct-9336	171	5	23	23	NUM
ct-9336	171	6	.	.	PUNCT
ct-9336	172	1	30	30	NUM
ct-9336	172	2	.	.	PUNCT
ct-9336	172	3	mestorino	mestorino	PROPN
ct-9336	172	4	ne	ne	PROPN
ct-9336	172	5	.	.	PUNCT
ct-9336	173	1	mariño	mariño	PROPN
ct-9336	173	2	hernández	hernández	PROPN
ct-9336	173	3	e	e	PROPN
ct-9336	173	4	,	,	PUNCT
ct-9336	173	5	marchetti	marchetti	PROPN
ct-9336	173	6	l	l	PROPN
ct-9336	173	7	,	,	PUNCT
ct-9336	173	8	et	et	PROPN
ct-9336	173	9	al	al	PROPN
ct-9336	173	10	:	:	PUNCT
ct-9336	173	11	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	173	12	and	and	CCONJ
ct-9336	173	13	tissue	tissue	NOUN
ct-9336	173	14	residues	residue	NOUN
ct-9336	173	15	of	of	ADP
ct-9336	173	16	an	an	DET
ct-9336	173	17	oxytetracycline	oxytetracycline	ADJ
ct-9336	173	18	/	/	SYM
ct-9336	173	19	diclofenac	diclofenac	NOUN
ct-9336	173	20	combination	combination	NOUN
ct-9336	173	21	in	in	ADP
ct-9336	173	22	cattle	cattle	NOUN
ct-9336	173	23	.	.	PUNCT
ct-9336	174	1	rev	rev	VERB
ct-9336	174	2	sci	sci	PROPN
ct-9336	174	3	tech	tech	PROPN
ct-9336	174	4	off	off	ADP
ct-9336	174	5	int	int	PROPN
ct-9336	174	6	epiz	epiz	PROPN
ct-9336	174	7	2007:26:679	2007:26:679	NUM
ct-9336	174	8	-	-	SYM
ct-9336	174	9	690	690	NUM
ct-9336	174	10	.	.	PUNCT
ct-9336	174	11	31	31	NUM
ct-9336	174	12	.	.	X
ct-9336	175	1	de	de	PROPN
ct-9336	175	2	boer	boer	PROPN
ct-9336	175	3	m	m	PROPN
ct-9336	175	4	,	,	PUNCT
ct-9336	175	5	heuer	heuer	PROPN
ct-9336	175	6	c	c	PROPN
ct-9336	175	7	,	,	PUNCT
ct-9336	175	8	hussein	hussein	PROPN
ct-9336	175	9	h	h	PROPN
ct-9336	175	10	,	,	PUNCT
ct-9336	175	11	et	et	PROPN
ct-9336	175	12	al	al	PROPN
ct-9336	175	13	:	:	PUNCT
ct-9336	175	14	minimum	minimum	ADJ
ct-9336	175	15	inhibitory	inhibitory	ADJ
ct-9336	175	16	concentrations	concentration	NOUN
ct-9336	175	17	of	of	ADP
ct-9336	175	18	selected	select	VERB
ct-9336	175	19	antimicrobials	antimicrobial	NOUN
ct-9336	175	20	against	against	ADP
ct-9336	175	21	escherichia	escherichia	NOUN
ct-9336	175	22	coli	coli	NOUN
ct-9336	175	23	and	and	CCONJ
ct-9336	175	24	truperella	truperella	NOUN
ct-9336	175	25	pyogenes	pyogene	NOUN
ct-9336	175	26	of	of	ADP
ct-9336	175	27	bovine	bovine	ADJ
ct-9336	175	28	uterine	uterine	ADJ
ct-9336	175	29	origin	origin	NOUN
ct-9336	175	30	.	.	PUNCT
ct-9336	176	1	j	j	PROPN
ct-9336	176	2	dairy	dairy	NOUN
ct-9336	176	3	sci	sci	PROPN
ct-9336	176	4	2015;98:4427	2015;98:4427	PROPN
ct-9336	176	5	-	-	SYM
ct-9336	176	6	4438	4438	NUM
ct-9336	176	7	.	.	PUNCT
ct-9336	177	1	32	32	NUM
ct-9336	177	2	.	.	PUNCT
ct-9336	178	1	cox	cox	PROPN
ct-9336	178	2	sr	sr	PROPN
ct-9336	178	3	,	,	PUNCT
ct-9336	178	4	mclaughlin	mclaughlin	PROPN
ct-9336	178	5	c	c	PROPN
ct-9336	178	6	,	,	PUNCT
ct-9336	178	7	fielder	fielder	NOUN
ct-9336	178	8	ae	ae	PROPN
ct-9336	178	9	,	,	PUNCT
ct-9336	178	10	et	et	PROPN
ct-9336	178	11	al	al	PROPN
ct-9336	178	12	:	:	PUNCT
ct-9336	178	13	rapid	rapid	ADJ
ct-9336	178	14	and	and	CCONJ
ct-9336	178	15	prolonged	prolonged	ADJ
ct-9336	178	16	distribution	distribution	NOUN
ct-9336	178	17	of	of	ADP
ct-9336	178	18	tulathromycin	tulathromycin	NOUN
ct-9336	178	19	into	into	ADP
ct-9336	178	20	lung	lung	NOUN
ct-9336	178	21	homogenate	homogenate	NOUN
ct-9336	178	22	and	and	CCONJ
ct-9336	178	23	pulmonary	pulmonary	ADJ
ct-9336	178	24	epithelial	epithelial	ADJ
ct-9336	178	25	lining	lining	NOUN
ct-9336	178	26	fluid	fluid	NOUN
ct-9336	178	27	of	of	ADP
ct-9336	178	28	holstein	holstein	NOUN
ct-9336	178	29	calves	calf	NOUN
ct-9336	178	30	following	follow	VERB
ct-9336	178	31	a	a	DET
ct-9336	178	32	single	single	ADJ
ct-9336	178	33	subcutaneous	subcutaneous	ADJ
ct-9336	178	34	administration	administration	NOUN
ct-9336	178	35	of	of	ADP
ct-9336	178	36	2.5	2.5	NUM
ct-9336	178	37	mg	mg	PROPN
ct-9336	178	38	/	/	SYM
ct-9336	178	39	kg	kg	PROPN
ct-9336	178	40	body	body	NOUN
ct-9336	178	41	weight	weight	NOUN
ct-9336	178	42	.	.	PUNCT
ct-9336	179	1	intern	intern	PROPN
ct-9336	179	2	j	j	PROPN
ct-9336	179	3	appl	appl	PROPN
ct-9336	179	4	res	res	PROPN
ct-9336	179	5	vet	vet	PROPN
ct-9336	179	6	med	med	PROPN
ct-9336	179	7	2010;8:129	2010;8:129	PROPN
ct-9336	179	8	-	-	SYM
ct-9336	179	9	137	137	NUM
ct-9336	179	10	.	.	PUNCT
ct-9336	180	1	33	33	NUM
ct-9336	180	2	.	.	PUNCT
ct-9336	181	1	gáler	gáler	PROPN
ct-9336	181	2	d	d	PROPN
ct-9336	181	3	,	,	PUNCT
ct-9336	181	4	hessong	hessong	PROPN
ct-9336	181	5	s	s	PROPN
ct-9336	181	6	,	,	PUNCT
ct-9336	181	7	beato	beato	PROPN
ct-9336	181	8	b	b	PROPN
ct-9336	181	9	,	,	PUNCT
ct-9336	181	10	et	et	PROPN
ct-9336	181	11	al	al	PROPN
ct-9336	181	12	:	:	PUNCT
ct-9336	181	13	an	an	DET
ct-9336	181	14	analytical	analytical	ADJ
ct-9336	181	15	method	method	NOUN
ct-9336	181	16	for	for	ADP
ct-9336	181	17	the	the	DET
ct-9336	181	18	analysis	analysis	NOUN
ct-9336	181	19	of	of	ADP
ct-9336	181	20	tulathromycin	tulathromycin	NOUN
ct-9336	181	21	,	,	PUNCT
ct-9336	181	22	an	an	DET
ct-9336	181	23	equilibrating	equilibrating	NOUN
ct-9336	181	24	triamilide	triamilide	NOUN
ct-9336	181	25	,	,	PUNCT
ct-9336	181	26	in	in	ADP
ct-9336	181	27	bovine	bovine	NOUN
ct-9336	181	28	and	and	CCONJ
ct-9336	181	29	porcine	porcine	NOUN
ct-9336	181	30	plasma	plasma	NOUN
ct-9336	181	31	and	and	CCONJ
ct-9336	181	32	lung	lung	NOUN
ct-9336	181	33	.	.	PUNCT
ct-9336	182	1	j	j	PROPN
ct-9336	182	2	agric	agric	PROPN
ct-9336	182	3	food	food	PROPN
ct-9336	182	4	chem	chem	NOUN
ct-9336	182	5	2004;52:2179	2004;52:2179	PROPN
ct-9336	182	6	-	-	SYM
ct-9336	182	7	2191	2191	NUM
ct-9336	182	8	.	.	PUNCT
ct-9336	183	1	34	34	NUM
ct-9336	183	2	.	.	X
ct-9336	183	3	rivera	rivera	PROPN
ct-9336	183	4	jd	jd	PROPN
ct-9336	183	5	,	,	PUNCT
ct-9336	183	6	woolums	woolums	PROPN
ct-9336	183	7	ar	ar	PROPN
ct-9336	183	8	,	,	PUNCT
ct-9336	183	9	giguère	giguère	PROPN
ct-9336	183	10	s	s	PROPN
ct-9336	183	11	,	,	PUNCT
ct-9336	183	12	et	et	PROPN
ct-9336	183	13	al	al	PROPN
ct-9336	183	14	:	:	PUNCT
ct-9336	183	15	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	183	16	of	of	ADP
ct-9336	183	17	tulathromycin	tulathromycin	NOUN
ct-9336	183	18	following	follow	VERB
ct-9336	183	19	administration	administration	NOUN
ct-9336	183	20	to	to	ADP
ct-9336	183	21	stocker	stocker	NOUN
ct-9336	183	22	cattle	cattle	NOUN
ct-9336	183	23	with	with	ADP
ct-9336	183	24	remote	remote	ADJ
ct-9336	183	25	delivery	delivery	NOUN
ct-9336	183	26	devices	device	NOUN
ct-9336	183	27	.	.	PUNCT
ct-9336	184	1	j	j	PROPN
ct-9336	184	2	anim	anim	NOUN
ct-9336	184	3	sci	sci	PROPN
ct-9336	184	4	2019;97:4482	2019;97:4482	PROPN
ct-9336	184	5	-	-	PROPN
ct-9336	184	6	4487	4487	NUM
ct-9336	184	7	.	.	PUNCT
ct-9336	185	1	35	35	NUM
ct-9336	185	2	.	.	PUNCT
ct-9336	186	1	coetzee	coetzee	PROPN
ct-9336	186	2	jf	jf	PROPN
ct-9336	186	3	,	,	PUNCT
ct-9336	186	4	kleinhenz	kleinhenz	PROPN
ct-9336	186	5	md	md	PROPN
ct-9336	186	6	,	,	PUNCT
ct-9336	186	7	magstadt	magstadt	PROPN
ct-9336	186	8	dr	dr	PROPN
ct-9336	186	9	,	,	PUNCT
ct-9336	186	10	et	et	PROPN
ct-9336	186	11	al	al	PROPN
ct-9336	186	12	:	:	PUNCT
ct-9336	186	13	pneumatic	pneumatic	ADJ
ct-9336	186	14	dart	dart	NOUN
ct-9336	186	15	delivery	delivery	NOUN
ct-9336	186	16	of	of	ADP
ct-9336	186	17	tulathromycin	tulathromycin	NOUN
ct-9336	186	18	in	in	ADP
ct-9336	186	19	calves	calf	NOUN
ct-9336	186	20	results	result	NOUN
ct-9336	186	21	in	in	ADP
ct-9336	186	22	lower	low	ADJ
ct-9336	186	23	antimicrobial	antimicrobial	ADJ
ct-9336	186	24	concentrations	concentration	NOUN
ct-9336	186	25	and	and	CCONJ
ct-9336	186	26	increased	increase	VERB
ct-9336	186	27	biomarkers	biomarker	NOUN
ct-9336	186	28	of	of	ADP
ct-9336	186	29	stress	stress	NOUN
ct-9336	186	30	and	and	CCONJ
ct-9336	186	31	injection	injection	NOUN
ct-9336	186	32	site	site	NOUN
ct-9336	186	33	inflammation	inflammation	NOUN
ct-9336	186	34	compared	compare	VERB
ct-9336	186	35	with	with	ADP
ct-9336	186	36	subcutaneous	subcutaneous	ADJ
ct-9336	186	37	injection	injection	NOUN
ct-9336	186	38	.	.	PUNCT
ct-9336	187	1	j	j	PROPN
ct-9336	187	2	anim	anim	NOUN
ct-9336	187	3	sci	sci	PROPN
ct-9336	187	4	2018	2018	NUM
ct-9336	187	5	;	;	PUNCT
ct-9336	187	6	96:3089	96:3089	NUM
ct-9336	187	7	-	-	SYM
ct-9336	187	8	3101	3101	NUM
ct-9336	187	9	.	.	PUNCT
ct-9336	188	1	clinical	clinical	ADJ
ct-9336	188	2	theriogenology	theriogenology	NOUN
ct-9336	188	3	2021	2021	NUM
ct-9336	188	4	;	;	PUNCT
ct-9336	188	5	13	13	NUM
ct-9336	188	6	:	:	SYM
ct-9336	188	7	210	210	NUM
ct-9336	188	8	pharmacokinetics	pharmacokinetic	NOUN
ct-9336	188	9	of	of	ADP
ct-9336	188	10	oxytetracycline	oxytetracycline	NOUN
ct-9336	188	11	andtulathromycin	andtulathromycin	ADV
ct-9336	188	12	in	in	ADP
ct-9336	188	13	plasma	plasma	NOUN
ct-9336	188	14	and	and	CCONJ
ct-9336	188	15	semen	semen	NOUN
ct-9336	188	16	ofbeef	ofbeef	PROPN
ct-9336	188	17	bulls	bull	NOUN